-------------------------------------------------------------------------------
      name:  <unnamed>
       log:  /workspace/logs/covid_descriptive.log
  log type:  text
 opened on:  11 Jul 2022, 21:30:06

. clear

. 
. use ./output/covid_england.dta

. 
. **Descriptive statistics
. * By COVID-19 severity
. foreach stratum of varlist      covid_severity                          ///
>                                                         covid_acute_kidney_in
> jury       ///
>                                                         covid_krt            
>                            ///
>                                                         covid_vax_status     
>                    ///
>                                                         calendar_period {
  2.         by `stratum',sort: sum age baseline_egfr body_mass_index follow_up
> _time, de
  3.         total follow_up_time, over(`stratum')
  4.         }

-------------------------------------------------------------------------------
-> covid_severity = SARS-CoV-2 without hospitalisation

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           19             19
 5%           21             21
10%           22             22       Obs                  29
25%           37             32       Sum of Wgt.          29

50%           47                      Mean           46.75862
                        Largest       Std. Dev.      15.32891
75%           57             66
90%           70             70       Variance       234.9754
95%           71             71       Skewness       .0800986
99%           79             79       Kurtosis       2.396303

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     45.03493       45.03493
 5%     45.03493       53.87771
10%     53.87771        54.3444       Obs                  15
25%     57.67368       57.67368       Sum of Wgt.          15

50%     89.48856                      Mean            91.4637
                        Largest       Std. Dev.      32.48397
75%     113.4602       113.4602
90%     129.2872       114.0777       Variance       1055.208
95%     167.7762       129.2872       Skewness       .5941727
99%     167.7762       167.7762       Kurtosis        3.18685

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%       19.146         19.146
 5%     19.58415       19.58415
10%     19.71763       19.71763       Obs                  27
25%     22.91652       20.69388       Sum of Wgt.          27

50%     28.55655                      Mean           28.81476
                        Largest       Std. Dev.      7.082268
75%     33.68845       37.23933
90%     41.45909       41.45909       Variance       50.15852
95%     41.98534       41.98534       Skewness        .563554
99%     44.42567       44.42567       Kurtosis       2.510886

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -353           -353
 5%         -200           -200
10%          -14            -14       Obs                  29
25%          104             10       Sum of Wgt.          29

50%          284                      Mean           307.1724
                        Largest       Std. Dev.      278.9516
75%          529            658
90%          686            686       Variance          77814
95%          686            686       Skewness      -.3598872
99%          698            698       Kurtosis       2.451795

-------------------------------------------------------------------------------
-> covid_severity = COVID-19 with hospitalisation

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           59             59
 5%           59              .
10%           59              .       Obs                   1
25%           59              .       Sum of Wgt.           1

50%           59                      Mean                 59
                        Largest       Std. Dev.             .
75%           59              .
90%           59              .       Variance              .
95%           59              .       Skewness              .
99%           59             59       Kurtosis              .

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     47.48689       47.48689
 5%     47.48689              .
10%     47.48689              .       Obs                   1
25%     47.48689              .       Sum of Wgt.           1

50%     47.48689                      Mean           47.48689
                        Largest       Std. Dev.             .
75%     47.48689              .
90%     47.48689              .       Variance              .
95%     47.48689              .       Skewness              .
99%     47.48689       47.48689       Kurtosis              .

                       body_mass_index
-------------------------------------------------------------
no observations

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%           21             21
 5%           21              .
10%           21              .       Obs                   1
25%           21              .       Sum of Wgt.           1

50%           21                      Mean                 21
                        Largest       Std. Dev.             .
75%           21              .
90%           21              .       Variance              .
95%           21              .       Skewness              .
99%           21             21       Kurtosis              .

-------------------------------------------------------------------------------
-> covid_severity = COVID-19 with critical care

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             18
10%           23             18       Obs                 246
25%           29             18       Sum of Wgt.         246

50%         45.5                      Mean           46.87398
                        Largest       Std. Dev.      20.00276
75%           62             93
90%           75             93       Variance       400.1106
95%           82             93       Skewness       .3965061
99%           93             97       Kurtosis       2.145601

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     33.90339       26.08839
 5%     39.66091       33.90339
10%     44.69389       34.45767       Obs                 136
25%     62.85614       35.12712       Sum of Wgt.         136

50%     90.71617                      Mean            90.8268
                        Largest       Std. Dev.      34.57417
75%     112.9672       166.8836
90%     137.4674       169.3123       Variance       1195.373
95%      150.813        172.829       Skewness        .301887
99%      172.829       179.6919       Kurtosis       2.404047

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.21064       15.30837
 5%     17.55379       16.14765
10%      19.8695       16.21064       Obs                 223
25%     23.43722       16.46757       Sum of Wgt.         223

50%     27.51686                      Mean           28.39647
                        Largest       Std. Dev.      6.842327
75%     32.92219        44.2909
90%     38.29552        44.4332       Variance       46.81744
95%     40.72321       46.21986       Skewness       .3716889
99%      44.4332       47.37949       Kurtosis       2.618612

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -902          -1438
 5%         -301           -977
10%         -120           -902       Obs                 246
25%          107           -850       Sum of Wgt.         246

50%          353                      Mean           278.9187
                        Largest       Std. Dev.      330.9952
75%          510            686
90%          621            691       Variance       109557.9
95%          664            698       Skewness      -1.640532
99%          691            698       Kurtosis       7.106819


Total estimation                                   Number of obs   =        276

------------------------------------------------------------------------------
                             |      Total   Std. Err.     [95% Conf. Interval]
-----------------------------+------------------------------------------------
            c.follow_up_time@|
              covid_severity |
SARS-CoV-2 without hospit..  |       8908     1502.2      5950.726    11865.27
COVID-19 with hospitalisa..  |         21          .             .           .
COVID-19 with critical care  |      68614   5191.458      58393.95    78834.05
------------------------------------------------------------------------------

-------------------------------------------------------------------------------
-> covid_acute_kidney_injury = COVID-19 without acute kidney injury

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             18
10%           23             18       Obs                 265
25%           30             18       Sum of Wgt.         265

50%           46                      Mean           46.89434
                        Largest       Std. Dev.      19.57455
75%           60             93
90%           74             93       Variance        383.163
95%           81             93       Skewness        .391865
99%           93             97       Kurtosis       2.207964

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     34.45767       26.08839
 5%      40.4453       34.45767
10%      46.5692       35.12712       Obs                 147
25%     62.62798       37.13604       Sum of Wgt.         147

50%     90.62868                      Mean           91.15219
                        Largest       Std. Dev.      34.36745
75%     113.4602       167.7762
90%     137.4674       169.3123       Variance       1181.122
95%      150.813        172.829       Skewness       .3329399
99%      172.829       179.6919       Kurtosis       2.450031

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.21064       15.30837
 5%     17.55379       16.14765
10%     19.71763       16.21064       Obs                 239
25%     23.00953       16.46757       Sum of Wgt.         239

50%     27.32258                      Mean           28.31944
                        Largest       Std. Dev.      6.888246
75%     32.56302       44.42567
90%      38.4661        44.4332       Variance       47.44794
95%     41.45909       46.21986       Skewness       .4284884
99%      44.4332       47.37949       Kurtosis       2.640377

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -902          -1438
 5%         -270           -977
10%         -106           -902       Obs                 265
25%          104           -850       Sum of Wgt.         265

50%          351                      Mean           279.4189
                        Largest       Std. Dev.      326.2206
75%          505            691
90%          631            698       Variance       106419.9
95%          664            698       Skewness      -1.590963
99%          698            698       Kurtosis       7.061847

-------------------------------------------------------------------------------
-> covid_acute_kidney_injury = COVID-19 with acute kidney injury

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           18             25
10%           25             33       Obs                  11
25%           33             34       Sum of Wgt.          11

50%           52                      Mean           47.18182
                        Largest       Std. Dev.      18.96744
75%           63             58
90%           70             63       Variance       359.7636
95%           76             70       Skewness      -.0094742
99%           76             76       Kurtosis         1.7741

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     33.90339       33.90339
 5%     33.90339       53.96705
10%     33.90339       70.10205       Obs                   5
25%     53.96705       105.8352       Sum of Wgt.           5

50%     70.10205                      Mean           74.50304
                        Largest       Std. Dev.      32.56178
75%     105.8352       53.96705
90%     108.7075       70.10205       Variance       1060.269
95%     108.7075       105.8352       Skewness      -.0395991
99%     108.7075       108.7075       Kurtosis       1.453222

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     19.84716       19.84716
 5%     19.84716         25.888
10%       25.888       28.05218       Obs                  11
25%     28.05218       29.32987       Sum of Wgt.          11

50%     29.64249                      Mean           31.09669
                        Largest       Std. Dev.      5.727889
75%     35.47708       33.90064
90%     36.91491       35.47708       Variance       32.80871
95%     40.72321       36.91491       Skewness      -.2264428
99%     40.72321       40.72321       Kurtosis        2.76277

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -327           -327
 5%         -327             27
10%           27             43       Obs                  11
25%           43            168       Sum of Wgt.          11

50%          318                      Mean           317.9091
                        Largest       Std. Dev.      315.9903
75%          607            537
90%          635            607       Variance       99849.89
95%          668            635       Skewness      -.6586068
99%          668            668       Kurtosis       2.457775


Total estimation                                   Number of obs   =        276

------------------------------------------------------------------------------
                             |      Total   Std. Err.     [95% Conf. Interval]
-----------------------------+------------------------------------------------
            c.follow_up_time@|
   covid_acute_kidney_injury |
COVID-19 without acute ki..  |      74046   5310.487      63591.63    84500.37
COVID-19 with acute kidne..  |       3497   1048.021      1433.836    5560.164
------------------------------------------------------------------------------

-------------------------------------------------------------------------------
-> covid_krt = COVID-19 without kidney replacement therapy

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             18
10%           23             18       Obs                 255
25%           31             18       Sum of Wgt.         255

50%           47                      Mean           47.32157
                        Largest       Std. Dev.      19.45979
75%           62             92
90%           74             93       Variance       378.6836
95%           81             93       Skewness       .3284833
99%           93             97       Kurtosis       2.131415

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     34.45767       33.90339
 5%      40.4453       34.45767
10%      46.5692       35.12712       Obs                 141
25%     62.62798       37.13604       Sum of Wgt.         141

50%     89.48856                      Mean           90.70939
                        Largest       Std. Dev.      34.53917
75%     113.2177       167.7762
90%     137.4674       169.3123       Variance       1192.954
95%      150.813        172.829       Skewness       .3777808
99%      172.829       179.6919       Kurtosis       2.461011

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.21064       15.30837
 5%     18.15501       16.14765
10%     19.84716       16.21064       Obs                 234
25%     23.43722       16.46757       Sum of Wgt.         234

50%     27.46687                      Mean           28.56226
                        Largest       Std. Dev.        6.9625
75%     33.70999       44.42567
90%     38.64217        44.4332       Variance        48.4764
95%     41.45909       46.21986       Skewness       .3867444
99%      44.4332       47.37949       Kurtosis       2.540111

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -902          -1438
 5%         -301           -977
10%         -106           -902       Obs                 255
25%          101           -850       Sum of Wgt.         255

50%          336                      Mean           280.7098
                        Largest       Std. Dev.      330.2012
75%          517            691
90%          632            698       Variance       109032.8
95%          668            698       Skewness      -1.584504
99%          698            698       Kurtosis       6.994363

-------------------------------------------------------------------------------
-> covid_krt = COVID-19 with kidney replacement therapy

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           18             18
10%           21             21       Obs                  21
25%           29             22       Sum of Wgt.          21

50%           38                      Mean           41.85714
                        Largest       Std. Dev.      19.98571
75%           46             58
90%           64             64       Variance       399.4286
95%           82             82       Skewness       1.048785
99%           93             93       Kurtosis        3.59424

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     26.08839       26.08839
 5%     26.08839       55.74626
10%     55.74626       59.78634       Obs                  11
25%     59.78634       74.45628       Sum of Wgt.          11

50%     102.0283                      Mean           89.26034
                        Largest       Std. Dev.      33.15151
75%     112.3735       108.7075
90%     129.2872       112.3735       Variance       1099.023
95%     130.3382       129.2872       Skewness      -.4621157
99%     130.3382       130.3382       Kurtosis       2.181806

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.66023       16.66023
 5%     16.66023       21.02559
10%     21.02559       21.04724       Obs                  16
25%      21.7817       21.27453       Sum of Wgt.          16

50%     28.30437                      Mean            26.6776
                        Largest       Std. Dev.      4.855324
75%     30.46231       30.50228
90%     32.04815       30.76339       Variance       23.57417
95%      33.1998       32.04815       Skewness      -.5676173
99%      33.1998        33.1998       Kurtosis       2.151228

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -327           -327
 5%         -224           -224
10%          -83            -83       Obs                  21
25%          137             24       Sum of Wgt.          21

50%          375                      Mean           283.9048
                        Largest       Std. Dev.      265.9376
75%          453            495
90%          508            508       Variance       70722.79
95%          646            646       Skewness      -.8197818
99%          664            664       Kurtosis       2.914595


Total estimation                                   Number of obs   =        276

------------------------------------------------------------------------------
                             |      Total   Std. Err.     [95% Conf. Interval]
-----------------------------+------------------------------------------------
  c.follow_up_time@covid_krt |
COVID-19 without kidney r..  |      71581   5272.891      61200.64    81961.36
COVID-19 with kidney repl..  |       5962   1218.679      3562.874    8361.126
------------------------------------------------------------------------------

-------------------------------------------------------------------------------
-> covid_vax_status = SARS-CoV-2 after 1 vaccine dose

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           21             21
 5%           21             25
10%           21             29       Obs                   7
25%           25             33       Sum of Wgt.           7

50%           33                      Mean           39.14286
                        Largest       Std. Dev.      18.91585
75%           64             33
90%           68             34       Variance       357.8095
95%           68             64       Skewness       .7760388
99%           68             68       Kurtosis       1.877629

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     66.61589       66.61589
 5%     66.61589       71.83381
10%     66.61589       112.7166       Obs                   5
25%     71.83381       119.8434       Sum of Wgt.           5

50%     112.7166                      Mean           100.0785
                        Largest       Std. Dev.      28.83847
75%     119.8434       71.83381
90%     129.3829       112.7166       Variance       831.6572
95%     129.3829       119.8434       Skewness        -.29249
99%     129.3829       129.3829       Kurtosis       1.267715

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     21.04724       21.04724
 5%     21.04724       21.91759
10%     21.04724       34.45123       Obs                   5
25%     21.91759        37.7504       Sum of Wgt.           5

50%     34.45123                      Mean            31.0064
                        Largest       Std. Dev.      8.911013
75%      37.7504       21.91759
90%     39.86557       34.45123       Variance       79.40615
95%     39.86557        37.7504       Skewness      -.2748043
99%     39.86557       39.86557       Kurtosis       1.240554

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -224           -224
 5%         -224            107
10%         -224            130       Obs                   7
25%          107            227       Sum of Wgt.           7

50%          227                      Mean           234.2857
                        Largest       Std. Dev.      264.7525
75%          432            227
90%          583            385       Variance        70093.9
95%          583            432       Skewness      -.4451841
99%          583            583       Kurtosis       2.426922

-------------------------------------------------------------------------------
-> covid_vax_status = SARS-CoV-2 after 2 vaccine doses

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           26             26
 5%           26             26
10%           26             27       Obs                  15
25%           28             28       Sum of Wgt.          15

50%           58                      Mean           55.06667
                        Largest       Std. Dev.      23.68685
75%           74             74
90%           81             80       Variance       561.0667
95%           93             81       Skewness      -.0410125
99%           93             93       Kurtosis       1.535637

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     33.90339       33.90339
 5%     33.90339       34.45767
10%     33.90339       43.69467       Obs                   9
25%     43.69467       77.15189       Sum of Wgt.           9

50%     84.36843                      Mean           83.94024
                        Largest       Std. Dev.      40.03505
75%     105.8999       105.8061
90%     137.4674       105.8999       Variance       1602.805
95%     137.4674       132.7128       Skewness       -.044441
99%     137.4674       137.4674       Kurtosis       1.599383

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     21.02559       21.02559
 5%     21.02559        22.2047
10%      22.2047       22.43528       Obs                  13
25%     23.43722       23.43722       Sum of Wgt.          13

50%     28.35025                      Mean           29.53415
                        Largest       Std. Dev.      7.002965
75%     32.92219       32.92219
90%     38.64217       36.49083       Variance       49.04151
95%      44.2909       38.64217       Skewness        .685429
99%      44.2909        44.2909       Kurtosis       2.587328

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -264           -264
 5%         -264           -120
10%         -120            168       Obs                  15
25%          252            252       Sum of Wgt.          15

50%          351                      Mean              318.6
                        Largest       Std. Dev.      250.5679
75%          455            455
90%          621            588       Variance       62784.26
95%          655            621       Skewness       -.921384
99%          655            655       Kurtosis       3.490394

-------------------------------------------------------------------------------
-> covid_vax_status = SARS-CoV-2 after 3 vaccine doses

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             19
10%           22             20       Obs                  64
25%           33             20       Sum of Wgt.          64

50%         44.5                      Mean           47.46875
                        Largest       Std. Dev.       19.8246
75%           60             84
90%           79             92       Variance       393.0149
95%           84             93       Skewness       .5976122
99%           97             97       Kurtosis       2.733014

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     37.13604       37.13604
 5%     40.71684       40.71684
10%     44.69389       42.28809       Obs                  37
25%     59.87194       44.69389       Sum of Wgt.          37

50%     80.32216                      Mean           85.01847
                        Largest       Std. Dev.      33.46606
75%     101.8132        132.539
90%      132.539          139.2       Variance       1119.977
95%     166.8836       166.8836       Skewness       .8219153
99%     169.3123       169.3123       Kurtosis       3.183864

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.14765       16.14765
 5%     19.61238       17.24656
10%     21.11029       19.61238       Obs                  59
25%     23.71117       19.84716       Sum of Wgt.          59

50%      27.2604                      Mean           28.96557
                        Largest       Std. Dev.      7.123347
75%     33.90064       41.98534
90%     40.83304        43.6188       Variance       50.74207
95%      43.6188       44.42567       Skewness       .5467012
99%      44.4332        44.4332       Kurtosis       2.503035

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -850           -850
 5%         -213           -412
10%          -49           -270       Obs                  64
25%        195.5           -213       Sum of Wgt.          64

50%        374.5                      Mean           305.4844
                        Largest       Std. Dev.      286.9244
75%          492            658
90%          611            664       Variance       82325.62
95%          658            664       Skewness      -1.444848
99%          676            676       Kurtosis       5.957953

-------------------------------------------------------------------------------
-> covid_vax_status = SARS-CoV-2 after 4 vaccine doses

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             18
10%         22.5             18       Obs                 190
25%           30             18       Sum of Wgt.         190

50%           46                      Mean           46.35789
                        Largest       Std. Dev.      19.03682
75%           60             86
90%         73.5             87       Variance       362.4003
95%           78             87       Skewness       .2953487
99%           87             93       Kurtosis       2.054615

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     35.12712       26.08839
 5%      40.4453       35.12712
10%     48.50778       37.94268       Obs                 101
25%      63.0843       39.66091       Sum of Wgt.         101

50%     94.27428                      Mean           92.77574
                        Largest       Std. Dev.      34.50766
75%     113.4602       158.1576
90%      138.728       167.7762       Variance       1190.778
95%      150.813        172.829       Skewness       .2537482
99%      172.829       179.6919       Kurtosis       2.424602

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.21064       15.30837
 5%     17.47373       16.21064
10%     19.55231       16.46757       Obs                 173
25%     23.00953       16.63407       Sum of Wgt.         173

50%     27.41689                      Mean           28.10674
                        Largest       Std. Dev.      6.720603
75%     32.37663       43.00648
90%     36.73714       43.28804       Variance       45.16651
95%       39.526       46.21986       Skewness       .3237734
99%     46.21986       47.37949       Kurtosis       2.683887

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -977          -1438
 5%         -323           -977
10%         -129           -902       Obs                 190
25%           62           -784       Sum of Wgt.         190

50%        335.5                      Mean           271.4368
                        Largest       Std. Dev.      345.2682
75%          514            691
90%          638            698       Variance       119210.1
95%          676            698       Skewness      -1.569158
99%          698            698       Kurtosis       6.850603


Total estimation                                   Number of obs   =        276

------------------------------------------------------------------------------
                             |      Total   Std. Err.     [95% Conf. Interval]
-----------------------------+------------------------------------------------
            c.follow_up_time@|
            covid_vax_status |
SARS-CoV-2 after 1 vaccin..  |       1640   700.4694      261.0365    3018.964
SARS-CoV-2 after 2 vaccin..  |       4779   970.4452      2868.555    6689.445
SARS-CoV-2 after 3 vaccin..  |      19551   2295.395      15032.22    24069.78
SARS-CoV-2 after 4 vaccin..  |      51573   4759.194      42203.92    60942.08
------------------------------------------------------------------------------

-------------------------------------------------------------------------------
-> calendar_period = February 2020 to June 2020

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           19             19
 5%           21             20
10%           25             20       Obs                  71
25%           32             21       Sum of Wgt.          71

50%           54                      Mean           48.46479
                        Largest       Std. Dev.      17.43382
75%           61             74
90%           67             74       Variance        303.938
95%           74             84       Skewness       .0382189
99%           93             93       Kurtosis       2.215451

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     39.66091       39.66091
 5%     44.69389       40.09777
10%     51.52325       44.69389       Obs                  41
25%     62.62798        46.5692       Sum of Wgt.          41

50%     78.17989                      Mean           83.87714
                        Largest       Std. Dev.      30.53406
75%     99.46708         136.53
90%      132.539       137.4674       Variance       932.3286
95%     137.4674        138.728       Skewness       .8021743
99%     169.3123       169.3123       Kurtosis       3.134662

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.63407       16.63407
 5%     19.58415       16.85173
10%     20.03308       18.15501       Obs                  65
25%     22.87254       19.58415       Sum of Wgt.          65

50%     25.93522                      Mean           27.46104
                        Largest       Std. Dev.       6.19298
75%     31.31637       38.64217
90%     35.88559       40.72321       Variance         38.353
95%     38.64217       41.45909       Skewness        .519463
99%     43.00648       43.00648       Kurtosis       2.619652

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -784           -784
 5%          -28           -697
10%          240           -412       Obs                  71
25%          560            -28       Sum of Wgt.          71

50%          607                      Mean           518.7606
                        Largest       Std. Dev.      288.2455
75%          658            691
90%          680            698       Variance       83085.44
95%          691            698       Skewness      -3.097791
99%          698            698       Kurtosis       12.67665

-------------------------------------------------------------------------------
-> calendar_period = July 2020 to August 2020

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             20
10%           23             23       Obs                  23
25%           43             39       Sum of Wgt.          23

50%           52                      Mean            52.6087
                        Largest       Std. Dev.       18.0674
75%           65             73
90%           75             75       Variance       326.4308
95%           82             82       Skewness      -.2046452
99%           83             83       Kurtosis       2.484818

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     37.94268       37.94268
 5%     37.94268       56.98871
10%     37.94268       72.57602       Obs                   8
25%     64.78236       74.45628       Sum of Wgt.           8

50%     81.30868                      Mean           80.62817
                        Largest       Std. Dev.      24.89947
75%     103.0668       88.16107
90%     108.7669       102.5375       Variance       619.9834
95%     108.7669       103.5962       Skewness      -.4590555
99%     108.7669       108.7669       Kurtosis       2.028888

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     18.67979       18.67979
 5%     18.67979       19.91069
10%     19.91069       21.27453       Obs                  19
25%     22.42045       21.46758       Sum of Wgt.          19

50%     29.64249                      Mean           29.45799
                        Largest       Std. Dev.      7.021792
75%      35.0935       35.47708
90%     39.23372       38.71062       Variance       49.30556
95%     43.28804       39.23372       Skewness       .2044832
99%     43.28804       43.28804       Kurtosis       2.154033

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -902           -902
 5%          137            137
10%          237            237       Obs                  23
25%          499            493       Sum of Wgt.          23

50%          510                      Mean           424.6087
                        Largest       Std. Dev.      304.8369
75%          522            529
90%          537            537       Variance       92925.52
95%          542            542       Skewness      -3.854447
99%          544            544       Kurtosis       17.09742

-------------------------------------------------------------------------------
-> calendar_period = September 2020 to November 2020

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           19             18
10%           20             19       Obs                  42
25%           24             19       Sum of Wgt.          42

50%         35.5                      Mean           40.69048
                        Largest       Std. Dev.      20.42653
75%           54             74
90%           74             76       Variance       417.2433
95%           76             81       Skewness       .9246753
99%           97             97       Kurtosis       2.956043

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     34.45767       34.45767
 5%     42.28809       42.28809
10%     43.69467       43.69467       Obs                  25
25%     75.48242       48.50778       Sum of Wgt.          25

50%     91.27547                      Mean           95.43899
                        Largest       Std. Dev.      34.04987
75%     115.3175       136.2423
90%        139.2          139.2       Variance       1159.394
95%      150.813        150.813       Skewness       -.039312
99%     158.1576       158.1576       Kurtosis       2.241182

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.21064       16.21064
 5%     16.46757       16.46757
10%     17.00863       16.66023       Obs                  39
25%     21.91759       17.00863       Sum of Wgt.          39

50%     26.88726                      Mean           26.75617
                        Largest       Std. Dev.      6.786688
75%     30.52218       34.33144
90%     34.33144       38.29552       Variance       46.05914
95%     41.98534       41.98534       Skewness       .4262087
99%      44.2909        44.2909       Kurtosis       3.049649

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -233           -233
 5%          -67           -120
10%          -49            -67       Obs                  42
25%          401            -66       Sum of Wgt.          42

50%          437                      Mean           344.4048
                        Largest       Std. Dev.      205.8368
75%          462            481
90%          478            481       Variance       42368.78
95%          481            483       Skewness      -1.568381
99%          484            484       Kurtosis       3.854723

-------------------------------------------------------------------------------
-> calendar_period = December 2020 to February 2021

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           22             19
10%           26             22       Obs                  46
25%           30             25       Sum of Wgt.          46

50%           43                      Mean           46.36957
                        Largest       Std. Dev.      19.03956
75%           58             78
90%           78             80       Variance       362.5048
95%           80             83       Skewness       .6501163
99%           93             93       Kurtosis       2.534896

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     26.08839       26.08839
 5%     54.71526       54.71526
10%     56.15529       56.15529       Obs                  25
25%     84.64182       71.18946       Sum of Wgt.          25

50%     105.8352                      Mean           100.8767
                        Largest       Std. Dev.      29.64088
75%      123.839       129.3829
90%     132.7128       132.7128       Variance       878.5819
95%     140.8106       140.8106       Skewness      -.5837173
99%     152.3093       152.3093       Kurtosis        3.05663

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     16.81079       16.81079
 5%     19.55231        18.1883
10%     21.23726       19.55231       Obs                  44
25%     25.08268       21.04724       Sum of Wgt.          44

50%     29.59295                      Mean           29.49861
                        Largest       Std. Dev.      6.425835
75%     34.03486        37.7504
90%     37.23933       38.89808       Variance       41.29135
95%     38.89808         39.526       Skewness       .2731153
99%     47.37949       47.37949       Kurtosis       2.929158

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -977           -977
 5%         -224           -323
10%          -36           -224       Obs                  46
25%          315           -200       Sum of Wgt.          46

50%          344                      Mean           261.0435
                        Largest       Std. Dev.      253.0605
75%          381            397
90%          394            398       Variance        64039.6
95%          398            398       Skewness      -3.205635
99%          398            398       Kurtosis       14.30835

-------------------------------------------------------------------------------
-> calendar_period = March 2021 to November 2021

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           18             18
 5%           20             18
10%           22             20       Obs                  75
25%           29             20       Sum of Wgt.          75

50%           46                      Mean              47.36
                        Largest       Std. Dev.      20.59824
75%           63             86
90%           73             87       Variance       424.2876
95%           86             92       Skewness       .3470384
99%           93             93       Kurtosis       2.052614

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     33.90339       33.90339
 5%     37.13604       35.12712
10%     40.71684       37.13604       Obs                  46
25%     53.96705        40.4453       Sum of Wgt.          46

50%     89.88008                      Mean           90.77992
                        Largest       Std. Dev.      40.90691
75%     117.4332       166.8836
90%     144.0101       167.7762       Variance       1673.375
95%     167.7762        172.829       Skewness       .4602742
99%     179.6919       179.6919       Kurtosis       2.214303

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     17.47373       17.47373
 5%     19.63768       18.65497
10%     20.98696         19.146       Obs                  67
25%     23.71117       19.63768       Sum of Wgt.          67

50%     27.41689                      Mean           29.12626
                        Largest       Std. Dev.      6.893553
75%     34.40974       41.31467
90%     39.38448       41.57954       Variance       47.52107
95%     41.31467       44.42567       Skewness       .4287275
99%      44.4332        44.4332       Kurtosis       2.287288

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%         -850           -850
 5%         -306           -407
10%         -231           -327       Obs                  75
25%           42           -306       Sum of Wgt.          75

50%          176                      Mean           102.2533
                        Largest       Std. Dev.      212.6813
75%          254            300
90%          293            305       Variance       45233.33
95%          300            305       Skewness      -1.822527
99%          307            307       Kurtosis       7.209987

-------------------------------------------------------------------------------
-> calendar_period = December 2021 to January 2022

                             age
-------------------------------------------------------------
      Percentiles      Smallest
 1%           23             23
 5%           23             24
10%           24             26       Obs                  19
25%           27             27       Sum of Wgt.          19

50%           42                      Mean           47.42105
                        Largest       Std. Dev.      22.23939
75%           75             79
90%           81             79       Variance       494.5906
95%           87             81       Skewness       .5977275
99%           87             87       Kurtosis       1.858752

              Baseline eGFR at COVID diagnosis
-------------------------------------------------------------
      Percentiles      Smallest
 1%     43.72132       43.72132
 5%     43.72132        52.4517
10%     43.72132       74.88316       Obs                   7
25%      52.4517       89.48856       Sum of Wgt.           7

50%     89.48856                      Mean           86.30452
                        Largest       Std. Dev.      32.07822
75%      104.124       89.48856
90%     135.8852       103.5777       Variance       1029.012
95%     135.8852        104.124       Skewness       .0830209
99%     135.8852       135.8852       Kurtosis       1.992704

                       body_mass_index
-------------------------------------------------------------
      Percentiles      Smallest
 1%     15.30837       15.30837
 5%     15.30837       16.14765
10%     16.14765         18.595       Obs                  16
25%     21.01961        19.4929       Sum of Wgt.          16

50%     29.75995                      Mean           29.55328
                        Largest       Std. Dev.      9.675735
75%      36.2216       36.91491
90%      43.6188        41.9393       Variance       93.61985
95%     46.21986        43.6188       Skewness       .1461573
99%     46.21986       46.21986       Kurtosis       1.986763

                    Follow-up time (Days)
-------------------------------------------------------------
      Percentiles      Smallest
 1%        -1438          -1438
 5%        -1438           -749
10%         -749           -353       Obs                  19
25%         -216           -270       Sum of Wgt.          19

50%          -16                      Mean          -168.2632
                        Largest       Std. Dev.      363.3299
75%           11             15
90%           27             23       Variance       132008.6
95%           32             27       Skewness      -2.599493
99%           32             32       Kurtosis       9.173241


Total estimation                                   Number of obs   =        276

------------------------------------------------------------------------------
                             |      Total   Std. Err.     [95% Conf. Interval]
-----------------------------+------------------------------------------------
            c.follow_up_time@|
             calendar_period |
 February 2020 to June 2020  |      36832   2428.799       32050.6     41613.4
   July 2020 to August 2020  |       9766   1461.946      6887.972    12644.03
September 2020 to Novembe..  |      14465   1333.975       11838.9     17091.1
December 2020 to February..  |      12008    1716.34      8629.166    15386.83
March 2021 to November 2021  |       7669   1841.874      4043.036    11294.96
December 2021 to January ..  |      -3197   1583.719     -6314.752   -79.24759
------------------------------------------------------------------------------

. 
. foreach var of varlist  agegroup                                             
>    ///
>                                                 male                         
>                            ///
>                                                 imd                          
>                            ///
>                                                 ethnicity                    
>                            ///
>                                                 region_9                     
>                            ///
>                                                 stp                          
>                            ///
>                                                 baseline_egfr_cat            
>                    ///
>                                                 ckd_stage                    
>                            ///     
>                                                 atrial_fibrillation_or_flutte
> r  ///
>                                                 chronic_liver_disease        
>            ///
>                                                 diabetes                     
>                            ///
>                                                 haematological_cancer        
>            ///
>                                                 heart_failure                
>                    ///
>                                                 hiv                          
>                                    ///
>                                                 hypertension                 
>                    ///
>                                                 non_haematological_cancer    
>            ///
>                                                 myocardial_infarction        
>            ///
>                                                 peripheral_vascular_disease  
>            ///
>                                                 rheumatoid_arthritis         
>            ///
>                                                 stroke                       
>                            ///
>                                                 systemic_lupus_erythematosus 
>    ///
>                                                 immunosuppression            
>                    ///
>                                                 bmicat                       
>                            ///
>                                                 smoking {                    
>                            
  2.         tab     `var' covid_severity, m col chi
  3.         tab `var' covid_acute_kidney_injury, m col chi
  4.         tab `var' covid_krt, m col chi
  5.         tab `var' covid_vax_status, m col chi
  6.         tab `var' calendar_period, m col chi
  7.         }

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |       SARS-CoV-2 severity
 Age group | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
    18-<50 |        17          0        139 |       156 
           |     58.62       0.00      56.50 |     56.52 
-----------+---------------------------------+----------
    50-<60 |         6          1         37 |        44 
           |     20.69     100.00      15.04 |     15.94 
-----------+---------------------------------+----------
    60-<70 |         3          0         31 |        34 
           |     10.34       0.00      12.60 |     12.32 
-----------+---------------------------------+----------
    70-<80 |         3          0         22 |        25 
           |     10.34       0.00       8.94 |      9.06 
-----------+---------------------------------+----------
       80+ |         0          0         17 |        17 
           |      0.00       0.00       6.91 |      6.16 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(8) =   8.0066   Pr = 0.433

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
           |        injury
 Age group | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
    18-<50 |       151          5 |       156 
           |     56.98      45.45 |     56.52 
-----------+----------------------+----------
    50-<60 |        41          3 |        44 
           |     15.47      27.27 |     15.94 
-----------+----------------------+----------
    60-<70 |        33          1 |        34 
           |     12.45       9.09 |     12.32 
-----------+----------------------+----------
    70-<80 |        23          2 |        25 
           |      8.68      18.18 |      9.06 
-----------+----------------------+----------
       80+ |        17          0 |        17 
           |      6.42       0.00 |      6.16 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(4) =   3.0263   Pr = 0.553

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
           |  replacement therapy
 Age group | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
    18-<50 |       140         16 |       156 
           |     54.90      76.19 |     56.52 
-----------+----------------------+----------
    50-<60 |        42          2 |        44 
           |     16.47       9.52 |     15.94 
-----------+----------------------+----------
    60-<70 |        33          1 |        34 
           |     12.94       4.76 |     12.32 
-----------+----------------------+----------
    70-<80 |        25          0 |        25 
           |      9.80       0.00 |      9.06 
-----------+----------------------+----------
       80+ |        15          2 |        17 
           |      5.88       9.52 |      6.16 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(4) =   5.6732   Pr = 0.225

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |             Vaccination status
 Age group | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
    18-<50 |         5          6         38        107 |       156 
           |     71.43      40.00      59.38      56.32 |     56.52 
-----------+--------------------------------------------+----------
    50-<60 |         0          2          9         33 |        44 
           |      0.00      13.33      14.06      17.37 |     15.94 
-----------+--------------------------------------------+----------
    60-<70 |         2          1          9         22 |        34 
           |     28.57       6.67      14.06      11.58 |     12.32 
-----------+--------------------------------------------+----------
    70-<80 |         0          3          3         19 |        25 
           |      0.00      20.00       4.69      10.00 |      9.06 
-----------+--------------------------------------------+----------
       80+ |         0          3          5          9 |        17 
           |      0.00      20.00       7.81       4.74 |      6.16 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(12) =  14.9468   Pr = 0.244

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |                    Calendar period
 Age group | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
    18-<50 |        34         10         31         28         41 |       156 
           |     47.89      43.48      73.81      60.87      54.67 |     56.52 
-----------+-------------------------------------------------------+----------
    50-<60 |        15          5          3          7         12 |        44 
           |     21.13      21.74       7.14      15.22      16.00 |     15.94 
-----------+-------------------------------------------------------+----------
    60-<70 |        15          3          2          4         10 |        34 
           |     21.13      13.04       4.76       8.70      13.33 |     12.32 
-----------+-------------------------------------------------------+----------
    70-<80 |         5          3          4          4          6 |        25 
           |      7.04      13.04       9.52       8.70       8.00 |      9.06 
-----------+-------------------------------------------------------+----------
       80+ |         2          2          2          3          6 |        17 
           |      2.82       8.70       4.76       6.52       8.00 |      6.16 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
           |   period
 Age group | December  |     Total
-----------+-----------+----------
    18-<50 |        12 |       156 
           |     63.16 |     56.52 
-----------+-----------+----------
    50-<60 |         2 |        44 
           |     10.53 |     15.94 
-----------+-----------+----------
    60-<70 |         0 |        34 
           |      0.00 |     12.32 
-----------+-----------+----------
    70-<80 |         3 |        25 
           |     15.79 |      9.06 
-----------+-----------+----------
       80+ |         2 |        17 
           |     10.53 |      6.16 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

         Pearson chi2(20) =  22.0590   Pr = 0.337

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Sex (0=F |       SARS-CoV-2 severity
      1=M) | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
    Female |        15          1        125 |       141 
           |     51.72     100.00      50.81 |     51.09 
-----------+---------------------------------+----------
      Male |        14          0        121 |       135 
           |     48.28       0.00      49.19 |     48.91 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.9695   Pr = 0.616

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
  Sex (0=F |        injury
      1=M) | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
    Female |       135          6 |       141 
           |     50.94      54.55 |     51.09 
-----------+----------------------+----------
      Male |       130          5 |       135 
           |     49.06      45.45 |     48.91 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0548   Pr = 0.815

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
  Sex (0=F |  replacement therapy
      1=M) | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
    Female |       132          9 |       141 
           |     51.76      42.86 |     51.09 
-----------+----------------------+----------
      Male |       123         12 |       135 
           |     48.24      57.14 |     48.91 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.6161   Pr = 0.433

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Sex (0=F |             Vaccination status
      1=M) | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
    Female |         3         10         33         95 |       141 
           |     42.86      66.67      51.56      50.00 |     51.09 
-----------+--------------------------------------------+----------
      Male |         4          5         31         95 |       135 
           |     57.14      33.33      48.44      50.00 |     48.91 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.7424   Pr = 0.628

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Sex (0=F |                    Calendar period
      1=M) | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
    Female |        33         12         23         25         41 |       141 
           |     46.48      52.17      54.76      54.35      54.67 |     51.09 
-----------+-------------------------------------------------------+----------
      Male |        38         11         19         21         34 |       135 
           |     53.52      47.83      45.24      45.65      45.33 |     48.91 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
  Sex (0=F |   period
      1=M) | December  |     Total
-----------+-----------+----------
    Female |         7 |       141 
           |     36.84 |     51.09 
-----------+-----------+----------
      Male |        12 |       135 
           |     63.16 |     48.91 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   2.9645   Pr = 0.705

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

        Index of |
        Multiple |       SARS-CoV-2 severity
     Deprivation | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------------+---------------------------------+----------
1 least deprived |         7          0         50 |        57 
                 |     24.14       0.00      20.33 |     20.65 
-----------------+---------------------------------+----------
               2 |         5          0         57 |        62 
                 |     17.24       0.00      23.17 |     22.46 
-----------------+---------------------------------+----------
               3 |         4          0         49 |        53 
                 |     13.79       0.00      19.92 |     19.20 
-----------------+---------------------------------+----------
               4 |         7          1         44 |        52 
                 |     24.14     100.00      17.89 |     18.84 
-----------------+---------------------------------+----------
 5 most deprived |         6          0         46 |        52 
                 |     20.69       0.00      18.70 |     18.84 
-----------------+---------------------------------+----------
           Total |        29          1        246 |       276 
                 |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(8) =   6.0116   Pr = 0.646

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

        Index of | COVID-19 acute kidney
        Multiple |        injury
     Deprivation | COVID-19   COVID-19  |     Total
-----------------+----------------------+----------
1 least deprived |        56          1 |        57 
                 |     21.13       9.09 |     20.65 
-----------------+----------------------+----------
               2 |        60          2 |        62 
                 |     22.64      18.18 |     22.46 
-----------------+----------------------+----------
               3 |        51          2 |        53 
                 |     19.25      18.18 |     19.20 
-----------------+----------------------+----------
               4 |        50          2 |        52 
                 |     18.87      18.18 |     18.84 
-----------------+----------------------+----------
 5 most deprived |        48          4 |        52 
                 |     18.11      36.36 |     18.84 
-----------------+----------------------+----------
           Total |       265         11 |       276 
                 |    100.00     100.00 |    100.00 

          Pearson chi2(4) =   2.7110   Pr = 0.607

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

        Index of |    COVID-19 kidney
        Multiple |  replacement therapy
     Deprivation | COVID-19   COVID-19  |     Total
-----------------+----------------------+----------
1 least deprived |        52          5 |        57 
                 |     20.39      23.81 |     20.65 
-----------------+----------------------+----------
               2 |        57          5 |        62 
                 |     22.35      23.81 |     22.46 
-----------------+----------------------+----------
               3 |        48          5 |        53 
                 |     18.82      23.81 |     19.20 
-----------------+----------------------+----------
               4 |        48          4 |        52 
                 |     18.82      19.05 |     18.84 
-----------------+----------------------+----------
 5 most deprived |        50          2 |        52 
                 |     19.61       9.52 |     18.84 
-----------------+----------------------+----------
           Total |       255         21 |       276 
                 |    100.00     100.00 |    100.00 

          Pearson chi2(4) =   1.4269   Pr = 0.840

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

        Index of |
        Multiple |             Vaccination status
     Deprivation | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------------+--------------------------------------------+----------
1 least deprived |         3          4         12         38 |        57 
                 |     42.86      26.67      18.75      20.00 |     20.65 
-----------------+--------------------------------------------+----------
               2 |         1          3         19         39 |        62 
                 |     14.29      20.00      29.69      20.53 |     22.46 
-----------------+--------------------------------------------+----------
               3 |         0          5         10         38 |        53 
                 |      0.00      33.33      15.62      20.00 |     19.20 
-----------------+--------------------------------------------+----------
               4 |         3          1         12         36 |        52 
                 |     42.86       6.67      18.75      18.95 |     18.84 
-----------------+--------------------------------------------+----------
 5 most deprived |         0          2         11         39 |        52 
                 |      0.00      13.33      17.19      20.53 |     18.84 
-----------------+--------------------------------------------+----------
           Total |         7         15         64        190 |       276 
                 |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(12) =  12.7958   Pr = 0.384

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

        Index of |
        Multiple |               Calendar period
     Deprivation | February   July 2020  September  December  |     Total
-----------------+--------------------------------------------+----------
1 least deprived |        10          4         16          7 |        57 
                 |     14.08      17.39      38.10      15.22 |     20.65 
-----------------+--------------------------------------------+----------
               2 |        11          7         10          8 |        62 
                 |     15.49      30.43      23.81      17.39 |     22.46 
-----------------+--------------------------------------------+----------
               3 |        17          7          5          9 |        53 
                 |     23.94      30.43      11.90      19.57 |     19.20 
-----------------+--------------------------------------------+----------
               4 |        14          3          7          8 |        52 
                 |     19.72      13.04      16.67      17.39 |     18.84 
-----------------+--------------------------------------------+----------
 5 most deprived |        19          2          4         14 |        52 
                 |     26.76       8.70       9.52      30.43 |     18.84 
-----------------+--------------------------------------------+----------
           Total |        71         23         42         46 |       276 
                 |    100.00     100.00     100.00     100.00 |    100.00 


        Index of |
        Multiple |    Calendar period
     Deprivation | March 202  December  |     Total
-----------------+----------------------+----------
1 least deprived |        15          5 |        57 
                 |     20.00      26.32 |     20.65 
-----------------+----------------------+----------
               2 |        20          6 |        62 
                 |     26.67      31.58 |     22.46 
-----------------+----------------------+----------
               3 |        12          3 |        53 
                 |     16.00      15.79 |     19.20 
-----------------+----------------------+----------
               4 |        17          3 |        52 
                 |     22.67      15.79 |     18.84 
-----------------+----------------------+----------
 5 most deprived |        11          2 |        52 
                 |     14.67      10.53 |     18.84 
-----------------+----------------------+----------
           Total |        75         19 |       276 
                 |    100.00     100.00 |    100.00 

         Pearson chi2(20) =  28.3236   Pr = 0.102

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |       SARS-CoV-2 severity
            Ethnicity | SARS-CoV-  COVID-19   COVID-19  |     Total
----------------------+---------------------------------+----------
                White |        14          1        153 |       168 
                      |     48.28     100.00      62.20 |     60.87 
----------------------+---------------------------------+----------
Asian or Asian Britis |         2          0         19 |        21 
                      |      6.90       0.00       7.72 |      7.61 
----------------------+---------------------------------+----------
                Other |         3          0         25 |        28 
                      |     10.34       0.00      10.16 |     10.14 
----------------------+---------------------------------+----------
              Unknown |        10          0         49 |        59 
                      |     34.48       0.00      19.92 |     21.38 
----------------------+---------------------------------+----------
                Total |        29          1        246 |       276 
                      |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(6) =   4.0692   Pr = 0.667

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      | COVID-19 acute kidney
                      |        injury
            Ethnicity | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
                White |       162          6 |       168 
                      |     61.13      54.55 |     60.87 
----------------------+----------------------+----------
Asian or Asian Britis |        21          0 |        21 
                      |      7.92       0.00 |      7.61 
----------------------+----------------------+----------
                Other |        26          2 |        28 
                      |      9.81      18.18 |     10.14 
----------------------+----------------------+----------
              Unknown |        56          3 |        59 
                      |     21.13      27.27 |     21.38 
----------------------+----------------------+----------
                Total |       265         11 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.8627   Pr = 0.601

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |    COVID-19 kidney
                      |  replacement therapy
            Ethnicity | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
                White |       155         13 |       168 
                      |     60.78      61.90 |     60.87 
----------------------+----------------------+----------
Asian or Asian Britis |        20          1 |        21 
                      |      7.84       4.76 |      7.61 
----------------------+----------------------+----------
                Other |        26          2 |        28 
                      |     10.20       9.52 |     10.14 
----------------------+----------------------+----------
              Unknown |        54          5 |        59 
                      |     21.18      23.81 |     21.38 
----------------------+----------------------+----------
                Total |       255         21 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(3) =   0.3177   Pr = 0.957

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |             Vaccination status
            Ethnicity | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
----------------------+--------------------------------------------+----------
                White |         3          9         41        115 |       168 
                      |     42.86      60.00      64.06      60.53 |     60.87 
----------------------+--------------------------------------------+----------
Asian or Asian Britis |         0          0          5         16 |        21 
                      |      0.00       0.00       7.81       8.42 |      7.61 
----------------------+--------------------------------------------+----------
                Other |         1          5          3         19 |        28 
                      |     14.29      33.33       4.69      10.00 |     10.14 
----------------------+--------------------------------------------+----------
              Unknown |         3          1         15         40 |        59 
                      |     42.86       6.67      23.44      21.05 |     21.38 
----------------------+--------------------------------------------+----------
                Total |         7         15         64        190 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(9) =  15.4453   Pr = 0.079

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |               Calendar period
            Ethnicity | February   July 2020  September  December  |     Total
----------------------+--------------------------------------------+----------
                White |        43         14         26         30 |       168 
                      |     60.56      60.87      61.90      65.22 |     60.87 
----------------------+--------------------------------------------+----------
Asian or Asian Britis |         8          1          1          3 |        21 
                      |     11.27       4.35       2.38       6.52 |      7.61 
----------------------+--------------------------------------------+----------
                Other |         9          0          7          2 |        28 
                      |     12.68       0.00      16.67       4.35 |     10.14 
----------------------+--------------------------------------------+----------
              Unknown |        11          8          8         11 |        59 
                      |     15.49      34.78      19.05      23.91 |     21.38 
----------------------+--------------------------------------------+----------
                Total |        71         23         42         46 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 


                      |    Calendar period
            Ethnicity | March 202  December  |     Total
----------------------+----------------------+----------
                White |        42         13 |       168 
                      |     56.00      68.42 |     60.87 
----------------------+----------------------+----------
Asian or Asian Britis |         7          1 |        21 
                      |      9.33       5.26 |      7.61 
----------------------+----------------------+----------
                Other |         9          1 |        28 
                      |     12.00       5.26 |     10.14 
----------------------+----------------------+----------
              Unknown |        17          4 |        59 
                      |     22.67      21.05 |     21.38 
----------------------+----------------------+----------
                Total |        75         19 |       276 
                      |    100.00     100.00 |    100.00 

         Pearson chi2(15) =  14.3577   Pr = 0.499

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

 Region of England (9 |       SARS-CoV-2 severity
             regions) | SARS-CoV-  COVID-19   COVID-19  |     Total
----------------------+---------------------------------+----------
        East Midlands |         4          0         26 |        30 
                      |     13.79       0.00      10.57 |     10.87 
----------------------+---------------------------------+----------
                 East |         1          0         27 |        28 
                      |      3.45       0.00      10.98 |     10.14 
----------------------+---------------------------------+----------
               London |         4          1         54 |        59 
                      |     13.79     100.00      21.95 |     21.38 
----------------------+---------------------------------+----------
           North East |         2          0         21 |        23 
                      |      6.90       0.00       8.54 |      8.33 
----------------------+---------------------------------+----------
           North West |         2          0         23 |        25 
                      |      6.90       0.00       9.35 |      9.06 
----------------------+---------------------------------+----------
           South East |         3          0         28 |        31 
                      |     10.34       0.00      11.38 |     11.23 
----------------------+---------------------------------+----------
           South West |         5          0         18 |        23 
                      |     17.24       0.00       7.32 |      8.33 
----------------------+---------------------------------+----------
        West Midlands |         7          0         25 |        32 
                      |     24.14       0.00      10.16 |     11.59 
----------------------+---------------------------------+----------
Yorkshire and The Hum |         1          0         24 |        25 
                      |      3.45       0.00       9.76 |      9.06 
----------------------+---------------------------------+----------
                Total |        29          1        246 |       276 
                      |    100.00     100.00     100.00 |    100.00 

         Pearson chi2(16) =  15.0525   Pr = 0.521

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      | COVID-19 acute kidney
 Region of England (9 |        injury
             regions) | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
        East Midlands |        28          2 |        30 
                      |     10.57      18.18 |     10.87 
----------------------+----------------------+----------
                 East |        25          3 |        28 
                      |      9.43      27.27 |     10.14 
----------------------+----------------------+----------
               London |        55          4 |        59 
                      |     20.75      36.36 |     21.38 
----------------------+----------------------+----------
           North East |        22          1 |        23 
                      |      8.30       9.09 |      8.33 
----------------------+----------------------+----------
           North West |        24          1 |        25 
                      |      9.06       9.09 |      9.06 
----------------------+----------------------+----------
           South East |        31          0 |        31 
                      |     11.70       0.00 |     11.23 
----------------------+----------------------+----------
           South West |        23          0 |        23 
                      |      8.68       0.00 |      8.33 
----------------------+----------------------+----------
        West Midlands |        32          0 |        32 
                      |     12.08       0.00 |     11.59 
----------------------+----------------------+----------
Yorkshire and The Hum |        25          0 |        25 
                      |      9.43       0.00 |      9.06 
----------------------+----------------------+----------
                Total |       265         11 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(8) =   9.6957   Pr = 0.287

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |    COVID-19 kidney
 Region of England (9 |  replacement therapy
             regions) | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
        East Midlands |        29          1 |        30 
                      |     11.37       4.76 |     10.87 
----------------------+----------------------+----------
                 East |        25          3 |        28 
                      |      9.80      14.29 |     10.14 
----------------------+----------------------+----------
               London |        55          4 |        59 
                      |     21.57      19.05 |     21.38 
----------------------+----------------------+----------
           North East |        21          2 |        23 
                      |      8.24       9.52 |      8.33 
----------------------+----------------------+----------
           North West |        23          2 |        25 
                      |      9.02       9.52 |      9.06 
----------------------+----------------------+----------
           South East |        29          2 |        31 
                      |     11.37       9.52 |     11.23 
----------------------+----------------------+----------
           South West |        22          1 |        23 
                      |      8.63       4.76 |      8.33 
----------------------+----------------------+----------
        West Midlands |        28          4 |        32 
                      |     10.98      19.05 |     11.59 
----------------------+----------------------+----------
Yorkshire and The Hum |        23          2 |        25 
                      |      9.02       9.52 |      9.06 
----------------------+----------------------+----------
                Total |       255         21 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(8) =   2.7675   Pr = 0.948

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

 Region of England (9 |             Vaccination status
             regions) | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
----------------------+--------------------------------------------+----------
        East Midlands |         1          2          9         18 |        30 
                      |     14.29      13.33      14.06       9.47 |     10.87 
----------------------+--------------------------------------------+----------
                 East |         0          0          7         21 |        28 
                      |      0.00       0.00      10.94      11.05 |     10.14 
----------------------+--------------------------------------------+----------
               London |         2          4         17         36 |        59 
                      |     28.57      26.67      26.56      18.95 |     21.38 
----------------------+--------------------------------------------+----------
           North East |         0          0          5         18 |        23 
                      |      0.00       0.00       7.81       9.47 |      8.33 
----------------------+--------------------------------------------+----------
           North West |         1          2          6         16 |        25 
                      |     14.29      13.33       9.38       8.42 |      9.06 
----------------------+--------------------------------------------+----------
           South East |         2          1          6         22 |        31 
                      |     28.57       6.67       9.38      11.58 |     11.23 
----------------------+--------------------------------------------+----------
           South West |         0          3          5         15 |        23 
                      |      0.00      20.00       7.81       7.89 |      8.33 
----------------------+--------------------------------------------+----------
        West Midlands |         1          1          3         27 |        32 
                      |     14.29       6.67       4.69      14.21 |     11.59 
----------------------+--------------------------------------------+----------
Yorkshire and The Hum |         0          2          6         17 |        25 
                      |      0.00      13.33       9.38       8.95 |      9.06 
----------------------+--------------------------------------------+----------
                Total |         7         15         64        190 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(24) =  18.5041   Pr = 0.778

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

 Region of England (9 |               Calendar period
             regions) | February   July 2020  September  December  |     Total
----------------------+--------------------------------------------+----------
        East Midlands |         9          3          4          2 |        30 
                      |     12.68      13.04       9.52       4.35 |     10.87 
----------------------+--------------------------------------------+----------
                 East |         9          5          3          6 |        28 
                      |     12.68      21.74       7.14      13.04 |     10.14 
----------------------+--------------------------------------------+----------
               London |        15          4          9          8 |        59 
                      |     21.13      17.39      21.43      17.39 |     21.38 
----------------------+--------------------------------------------+----------
           North East |         6          2          3          5 |        23 
                      |      8.45       8.70       7.14      10.87 |      8.33 
----------------------+--------------------------------------------+----------
           North West |         3          2          9          4 |        25 
                      |      4.23       8.70      21.43       8.70 |      9.06 
----------------------+--------------------------------------------+----------
           South East |         9          3          8          3 |        31 
                      |     12.68      13.04      19.05       6.52 |     11.23 
----------------------+--------------------------------------------+----------
           South West |         5          2          3          4 |        23 
                      |      7.04       8.70       7.14       8.70 |      8.33 
----------------------+--------------------------------------------+----------
        West Midlands |         8          2          2          8 |        32 
                      |     11.27       8.70       4.76      17.39 |     11.59 
----------------------+--------------------------------------------+----------
Yorkshire and The Hum |         7          0          1          6 |        25 
                      |      9.86       0.00       2.38      13.04 |      9.06 
----------------------+--------------------------------------------+----------
                Total |        71         23         42         46 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 


 Region of England (9 |    Calendar period
             regions) | March 202  December  |     Total
----------------------+----------------------+----------
        East Midlands |        10          2 |        30 
                      |     13.33      10.53 |     10.87 
----------------------+----------------------+----------
                 East |         4          1 |        28 
                      |      5.33       5.26 |     10.14 
----------------------+----------------------+----------
               London |        20          3 |        59 
                      |     26.67      15.79 |     21.38 
----------------------+----------------------+----------
           North East |         5          2 |        23 
                      |      6.67      10.53 |      8.33 
----------------------+----------------------+----------
           North West |         6          1 |        25 
                      |      8.00       5.26 |      9.06 
----------------------+----------------------+----------
           South East |         6          2 |        31 
                      |      8.00      10.53 |     11.23 
----------------------+----------------------+----------
           South West |         6          3 |        23 
                      |      8.00      15.79 |      8.33 
----------------------+----------------------+----------
        West Midlands |         8          4 |        32 
                      |     10.67      21.05 |     11.59 
----------------------+----------------------+----------
Yorkshire and The Hum |        10          1 |        25 
                      |     13.33       5.26 |      9.06 
----------------------+----------------------+----------
                Total |        75         19 |       276 
                      |    100.00     100.00 |    100.00 

         Pearson chi2(40) =  38.0500   Pr = 0.558

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |       SARS-CoV-2 severity
       stp | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         1 |         5          0         18 |        23 
           |     17.24       0.00       7.32 |      8.33 
-----------+---------------------------------+----------
         2 |         5          0         26 |        31 
           |     17.24       0.00      10.57 |     11.23 
-----------+---------------------------------+----------
         3 |         3          0         24 |        27 
           |     10.34       0.00       9.76 |      9.78 
-----------+---------------------------------+----------
         4 |         4          0         27 |        31 
           |     13.79       0.00      10.98 |     11.23 
-----------+---------------------------------+----------
         5 |         4          0         20 |        24 
           |     13.79       0.00       8.13 |      8.70 
-----------+---------------------------------+----------
         6 |         3          1         28 |        32 
           |     10.34     100.00      11.38 |     11.59 
-----------+---------------------------------+----------
         7 |         0          0         31 |        31 
           |      0.00       0.00      12.60 |     11.23 
-----------+---------------------------------+----------
         8 |         2          0         31 |        33 
           |      6.90       0.00      12.60 |     11.96 
-----------+---------------------------------+----------
         9 |         1          0         18 |        19 
           |      3.45       0.00       7.32 |      6.88 
-----------+---------------------------------+----------
        10 |         2          0         23 |        25 
           |      6.90       0.00       9.35 |      9.06 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

         Pearson chi2(18) =  18.0307   Pr = 0.454

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
           |        injury
       stp | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         1 |        20          3 |        23 
           |      7.55      27.27 |      8.33 
-----------+----------------------+----------
         2 |        31          0 |        31 
           |     11.70       0.00 |     11.23 
-----------+----------------------+----------
         3 |        27          0 |        27 
           |     10.19       0.00 |      9.78 
-----------+----------------------+----------
         4 |        30          1 |        31 
           |     11.32       9.09 |     11.23 
-----------+----------------------+----------
         5 |        23          1 |        24 
           |      8.68       9.09 |      8.70 
-----------+----------------------+----------
         6 |        30          2 |        32 
           |     11.32      18.18 |     11.59 
-----------+----------------------+----------
         7 |        31          0 |        31 
           |     11.70       0.00 |     11.23 
-----------+----------------------+----------
         8 |        32          1 |        33 
           |     12.08       9.09 |     11.96 
-----------+----------------------+----------
         9 |        19          0 |        19 
           |      7.17       0.00 |      6.88 
-----------+----------------------+----------
        10 |        22          3 |        25 
           |      8.30      27.27 |      9.06 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(9) =  14.1671   Pr = 0.117

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
           |  replacement therapy
       stp | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         1 |        21          2 |        23 
           |      8.24       9.52 |      8.33 
-----------+----------------------+----------
         2 |        28          3 |        31 
           |     10.98      14.29 |     11.23 
-----------+----------------------+----------
         3 |        26          1 |        27 
           |     10.20       4.76 |      9.78 
-----------+----------------------+----------
         4 |        29          2 |        31 
           |     11.37       9.52 |     11.23 
-----------+----------------------+----------
         5 |        21          3 |        24 
           |      8.24      14.29 |      8.70 
-----------+----------------------+----------
         6 |        29          3 |        32 
           |     11.37      14.29 |     11.59 
-----------+----------------------+----------
         7 |        30          1 |        31 
           |     11.76       4.76 |     11.23 
-----------+----------------------+----------
         8 |        29          4 |        33 
           |     11.37      19.05 |     11.96 
-----------+----------------------+----------
         9 |        18          1 |        19 
           |      7.06       4.76 |      6.88 
-----------+----------------------+----------
        10 |        24          1 |        25 
           |      9.41       4.76 |      9.06 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(9) =   4.2458   Pr = 0.895

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |             Vaccination status
       stp | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         1 |         0          1          6         16 |        23 
           |      0.00       6.67       9.38       8.42 |      8.33 
-----------+--------------------------------------------+----------
         2 |         1          2          8         20 |        31 
           |     14.29      13.33      12.50      10.53 |     11.23 
-----------+--------------------------------------------+----------
         3 |         1          1          5         20 |        27 
           |     14.29       6.67       7.81      10.53 |      9.78 
-----------+--------------------------------------------+----------
         4 |         1          2          9         19 |        31 
           |     14.29      13.33      14.06      10.00 |     11.23 
-----------+--------------------------------------------+----------
         5 |         0          0          7         17 |        24 
           |      0.00       0.00      10.94       8.95 |      8.70 
-----------+--------------------------------------------+----------
         6 |         0          2          7         23 |        32 
           |      0.00      13.33      10.94      12.11 |     11.59 
-----------+--------------------------------------------+----------
         7 |         0          2          6         23 |        31 
           |      0.00      13.33       9.38      12.11 |     11.23 
-----------+--------------------------------------------+----------
         8 |         1          1          7         24 |        33 
           |     14.29       6.67      10.94      12.63 |     11.96 
-----------+--------------------------------------------+----------
         9 |         2          3          2         12 |        19 
           |     28.57      20.00       3.12       6.32 |      6.88 
-----------+--------------------------------------------+----------
        10 |         1          1          7         16 |        25 
           |     14.29       6.67      10.94       8.42 |      9.06 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(27) =  17.9671   Pr = 0.905

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |                    Calendar period
       stp | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         1 |         2          1          3          5          8 |        23 
           |      2.82       4.35       7.14      10.87      10.67 |      8.33 
-----------+-------------------------------------------------------+----------
         2 |         8          0          6          7         10 |        31 
           |     11.27       0.00      14.29      15.22      13.33 |     11.23 
-----------+-------------------------------------------------------+----------
         3 |         7          1          3          5          9 |        27 
           |      9.86       4.35       7.14      10.87      12.00 |      9.78 
-----------+-------------------------------------------------------+----------
         4 |         8          2          5          6          9 |        31 
           |     11.27       8.70      11.90      13.04      12.00 |     11.23 
-----------+-------------------------------------------------------+----------
         5 |         5          4          5          2          4 |        24 
           |      7.04      17.39      11.90       4.35       5.33 |      8.70 
-----------+-------------------------------------------------------+----------
         6 |         9          1          7          6          8 |        32 
           |     12.68       4.35      16.67      13.04      10.67 |     11.59 
-----------+-------------------------------------------------------+----------
         7 |        12          7          0          3          8 |        31 
           |     16.90      30.43       0.00       6.52      10.67 |     11.23 
-----------+-------------------------------------------------------+----------
         8 |        10          2          8          6          6 |        33 
           |     14.08       8.70      19.05      13.04       8.00 |     11.96 
-----------+-------------------------------------------------------+----------
         9 |         6          1          4          2          4 |        19 
           |      8.45       4.35       9.52       4.35       5.33 |      6.88 
-----------+-------------------------------------------------------+----------
        10 |         4          4          1          4          9 |        25 
           |      5.63      17.39       2.38       8.70      12.00 |      9.06 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
           |   period
       stp | December  |     Total
-----------+-----------+----------
         1 |         4 |        23 
           |     21.05 |      8.33 
-----------+-----------+----------
         2 |         0 |        31 
           |      0.00 |     11.23 
-----------+-----------+----------
         3 |         2 |        27 
           |     10.53 |      9.78 
-----------+-----------+----------
         4 |         1 |        31 
           |      5.26 |     11.23 
-----------+-----------+----------
         5 |         4 |        24 
           |     21.05 |      8.70 
-----------+-----------+----------
         6 |         1 |        32 
           |      5.26 |     11.59 
-----------+-----------+----------
         7 |         1 |        31 
           |      5.26 |     11.23 
-----------+-----------+----------
         8 |         1 |        33 
           |      5.26 |     11.96 
-----------+-----------+----------
         9 |         2 |        19 
           |     10.53 |      6.88 
-----------+-----------+----------
        10 |         3 |        25 
           |     15.79 |      9.06 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

         Pearson chi2(45) =  55.0702   Pr = 0.144

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Baseline |       SARS-CoV-2 severity
      eGFR | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
     15-29 |         0          0          1 |         1 
           |      0.00       0.00       0.41 |      0.36 
-----------+---------------------------------+----------
     30-44 |         0          0         13 |        13 
           |      0.00       0.00       5.28 |      4.71 
-----------+---------------------------------+----------
     45-59 |         4          1         17 |        22 
           |     13.79     100.00       6.91 |      7.97 
-----------+---------------------------------+----------
     60-74 |         0          0         20 |        20 
           |      0.00       0.00       8.13 |      7.25 
-----------+---------------------------------+----------
     75-89 |         4          0         16 |        20 
           |     13.79       0.00       6.50 |      7.25 
-----------+---------------------------------+----------
    90-104 |         3          0         21 |        24 
           |     10.34       0.00       8.54 |      8.70 
-----------+---------------------------------+----------
      ≥105 |         4          0         48 |        52 
           |     13.79       0.00      19.51 |     18.84 
-----------+---------------------------------+----------
         . |        14          0        110 |       124 
           |     48.28       0.00      44.72 |     44.93 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

         Pearson chi2(14) =  19.6749   Pr = 0.141

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
  Baseline |        injury
      eGFR | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
     15-29 |         1          0 |         1 
           |      0.38       0.00 |      0.36 
-----------+----------------------+----------
     30-44 |        12          1 |        13 
           |      4.53       9.09 |      4.71 
-----------+----------------------+----------
     45-59 |        21          1 |        22 
           |      7.92       9.09 |      7.97 
-----------+----------------------+----------
     60-74 |        19          1 |        20 
           |      7.17       9.09 |      7.25 
-----------+----------------------+----------
     75-89 |        20          0 |        20 
           |      7.55       0.00 |      7.25 
-----------+----------------------+----------
    90-104 |        24          0 |        24 
           |      9.06       0.00 |      8.70 
-----------+----------------------+----------
      ≥105 |        50          2 |        52 
           |     18.87      18.18 |     18.84 
-----------+----------------------+----------
         . |       118          6 |       124 
           |     44.53      54.55 |     44.93 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(7) =   2.6451   Pr = 0.916

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
  Baseline |  replacement therapy
      eGFR | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
     15-29 |         0          1 |         1 
           |      0.00       4.76 |      0.36 
-----------+----------------------+----------
     30-44 |        13          0 |        13 
           |      5.10       0.00 |      4.71 
-----------+----------------------+----------
     45-59 |        20          2 |        22 
           |      7.84       9.52 |      7.97 
-----------+----------------------+----------
     60-74 |        19          1 |        20 
           |      7.45       4.76 |      7.25 
-----------+----------------------+----------
     75-89 |        19          1 |        20 
           |      7.45       4.76 |      7.25 
-----------+----------------------+----------
    90-104 |        23          1 |        24 
           |      9.02       4.76 |      8.70 
-----------+----------------------+----------
      ≥105 |        47          5 |        52 
           |     18.43      23.81 |     18.84 
-----------+----------------------+----------
         . |       114         10 |       124 
           |     44.71      47.62 |     44.93 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(7) =  14.4084   Pr = 0.044

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Baseline |             Vaccination status
      eGFR | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
     15-29 |         0          0          0          1 |         1 
           |      0.00       0.00       0.00       0.53 |      0.36 
-----------+--------------------------------------------+----------
     30-44 |         0          3          4          6 |        13 
           |      0.00      20.00       6.25       3.16 |      4.71 
-----------+--------------------------------------------+----------
     45-59 |         0          0          6         16 |        22 
           |      0.00       0.00       9.38       8.42 |      7.97 
-----------+--------------------------------------------+----------
     60-74 |         2          0          6         12 |        20 
           |     28.57       0.00       9.38       6.32 |      7.25 
-----------+--------------------------------------------+----------
     75-89 |         0          2          9          9 |        20 
           |      0.00      13.33      14.06       4.74 |      7.25 
-----------+--------------------------------------------+----------
    90-104 |         0          0          4         20 |        24 
           |      0.00       0.00       6.25      10.53 |      8.70 
-----------+--------------------------------------------+----------
      ≥105 |         3          4          8         37 |        52 
           |     42.86      26.67      12.50      19.47 |     18.84 
-----------+--------------------------------------------+----------
         . |         2          6         27         89 |       124 
           |     28.57      40.00      42.19      46.84 |     44.93 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(21) =  32.4997   Pr = 0.052

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

  Baseline |                    Calendar period
      eGFR | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
     15-29 |         0          0          0          1          0 |         1 
           |      0.00       0.00       0.00       2.17       0.00 |      0.36 
-----------+-------------------------------------------------------+----------
     30-44 |         3          1          3          0          5 |        13 
           |      4.23       4.35       7.14       0.00       6.67 |      4.71 
-----------+-------------------------------------------------------+----------
     45-59 |         7          1          1          2         10 |        22 
           |      9.86       4.35       2.38       4.35      13.33 |      7.97 
-----------+-------------------------------------------------------+----------
     60-74 |         8          2          2          2          5 |        20 
           |     11.27       8.70       4.76       4.35       6.67 |      7.25 
-----------+-------------------------------------------------------+----------
     75-89 |         8          1          5          2          3 |        20 
           |     11.27       4.35      11.90       4.35       4.00 |      7.25 
-----------+-------------------------------------------------------+----------
    90-104 |         7          2          4          5          4 |        24 
           |      9.86       8.70       9.52      10.87       5.33 |      8.70 
-----------+-------------------------------------------------------+----------
      ≥105 |         8          1         10         13         19 |        52 
           |     11.27       4.35      23.81      28.26      25.33 |     18.84 
-----------+-------------------------------------------------------+----------
         . |        30         15         17         21         29 |       124 
           |     42.25      65.22      40.48      45.65      38.67 |     44.93 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
  Baseline |   period
      eGFR | December  |     Total
-----------+-----------+----------
     15-29 |         0 |         1 
           |      0.00 |      0.36 
-----------+-----------+----------
     30-44 |         1 |        13 
           |      5.26 |      4.71 
-----------+-----------+----------
     45-59 |         1 |        22 
           |      5.26 |      7.97 
-----------+-----------+----------
     60-74 |         1 |        20 
           |      5.26 |      7.25 
-----------+-----------+----------
     75-89 |         1 |        20 
           |      5.26 |      7.25 
-----------+-----------+----------
    90-104 |         2 |        24 
           |     10.53 |      8.70 
-----------+-----------+----------
      ≥105 |         1 |        52 
           |      5.26 |     18.84 
-----------+-----------+----------
         . |        12 |       124 
           |     63.16 |     44.93 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

         Pearson chi2(35) =  38.7474   Pr = 0.304

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                    |       SARS-CoV-2 severity
          CKD stage | SARS-CoV-  COVID-19   COVID-19  |     Total
--------------------+---------------------------------+----------
              CKD 4 |         0          0          1 |         1 
                    |      0.00       0.00       0.41 |      0.36 
--------------------+---------------------------------+----------
             CKD 3B |         0          0         13 |        13 
                    |      0.00       0.00       5.28 |      4.71 
--------------------+---------------------------------+----------
             CKD 3A |         4          1         17 |        22 
                    |     13.79     100.00       6.91 |      7.97 
--------------------+---------------------------------+----------
             No CKD |        11          0        105 |       116 
                    |     37.93       0.00      42.68 |     42.03 
--------------------+---------------------------------+----------
No eGFR measurement |        14          0        110 |       124 
                    |     48.28       0.00      44.72 |     44.93 
--------------------+---------------------------------+----------
              Total |        29          1        246 |       276 
                    |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(8) =  14.9981   Pr = 0.059

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                    | COVID-19 acute kidney
                    |        injury
          CKD stage | COVID-19   COVID-19  |     Total
--------------------+----------------------+----------
              CKD 4 |         1          0 |         1 
                    |      0.38       0.00 |      0.36 
--------------------+----------------------+----------
             CKD 3B |        12          1 |        13 
                    |      4.53       9.09 |      4.71 
--------------------+----------------------+----------
             CKD 3A |        21          1 |        22 
                    |      7.92       9.09 |      7.97 
--------------------+----------------------+----------
             No CKD |       113          3 |       116 
                    |     42.64      27.27 |     42.03 
--------------------+----------------------+----------
No eGFR measurement |       118          6 |       124 
                    |     44.53      54.55 |     44.93 
--------------------+----------------------+----------
              Total |       265         11 |       276 
                    |    100.00     100.00 |    100.00 

          Pearson chi2(4) =   1.3558   Pr = 0.852

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                    |    COVID-19 kidney
                    |  replacement therapy
          CKD stage | COVID-19   COVID-19  |     Total
--------------------+----------------------+----------
              CKD 4 |         0          1 |         1 
                    |      0.00       4.76 |      0.36 
--------------------+----------------------+----------
             CKD 3B |        13          0 |        13 
                    |      5.10       0.00 |      4.71 
--------------------+----------------------+----------
             CKD 3A |        20          2 |        22 
                    |      7.84       9.52 |      7.97 
--------------------+----------------------+----------
             No CKD |       108          8 |       116 
                    |     42.35      38.10 |     42.03 
--------------------+----------------------+----------
No eGFR measurement |       114         10 |       124 
                    |     44.71      47.62 |     44.93 
--------------------+----------------------+----------
              Total |       255         21 |       276 
                    |    100.00     100.00 |    100.00 

          Pearson chi2(4) =  13.4025   Pr = 0.009

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                    |             Vaccination status
          CKD stage | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
--------------------+--------------------------------------------+----------
              CKD 4 |         0          0          0          1 |         1 
                    |      0.00       0.00       0.00       0.53 |      0.36 
--------------------+--------------------------------------------+----------
             CKD 3B |         0          3          4          6 |        13 
                    |      0.00      20.00       6.25       3.16 |      4.71 
--------------------+--------------------------------------------+----------
             CKD 3A |         0          0          6         16 |        22 
                    |      0.00       0.00       9.38       8.42 |      7.97 
--------------------+--------------------------------------------+----------
             No CKD |         5          6         27         78 |       116 
                    |     71.43      40.00      42.19      41.05 |     42.03 
--------------------+--------------------------------------------+----------
No eGFR measurement |         2          6         27         89 |       124 
                    |     28.57      40.00      42.19      46.84 |     44.93 
--------------------+--------------------------------------------+----------
              Total |         7         15         64        190 |       276 
                    |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(12) =  13.7392   Pr = 0.318

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                    |               Calendar period
          CKD stage | February   July 2020  September  December  |     Total
--------------------+--------------------------------------------+----------
              CKD 4 |         0          0          0          1 |         1 
                    |      0.00       0.00       0.00       2.17 |      0.36 
--------------------+--------------------------------------------+----------
             CKD 3B |         3          1          3          0 |        13 
                    |      4.23       4.35       7.14       0.00 |      4.71 
--------------------+--------------------------------------------+----------
             CKD 3A |         7          1          1          2 |        22 
                    |      9.86       4.35       2.38       4.35 |      7.97 
--------------------+--------------------------------------------+----------
             No CKD |        31          6         21         22 |       116 
                    |     43.66      26.09      50.00      47.83 |     42.03 
--------------------+--------------------------------------------+----------
No eGFR measurement |        30         15         17         21 |       124 
                    |     42.25      65.22      40.48      45.65 |     44.93 
--------------------+--------------------------------------------+----------
              Total |        71         23         42         46 |       276 
                    |    100.00     100.00     100.00     100.00 |    100.00 


                    |    Calendar period
          CKD stage | March 202  December  |     Total
--------------------+----------------------+----------
              CKD 4 |         0          0 |         1 
                    |      0.00       0.00 |      0.36 
--------------------+----------------------+----------
             CKD 3B |         5          1 |        13 
                    |      6.67       5.26 |      4.71 
--------------------+----------------------+----------
             CKD 3A |        10          1 |        22 
                    |     13.33       5.26 |      7.97 
--------------------+----------------------+----------
             No CKD |        31          5 |       116 
                    |     41.33      26.32 |     42.03 
--------------------+----------------------+----------
No eGFR measurement |        29         12 |       124 
                    |     38.67      63.16 |     44.93 
--------------------+----------------------+----------
              Total |        75         19 |       276 
                    |    100.00     100.00 |    100.00 

         Pearson chi2(20) =  22.3733   Pr = 0.321

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

atrial_fib |
rillation_ |       SARS-CoV-2 severity
or_flutter | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        28          1        229 |       258 
           |     96.55     100.00      93.09 |     93.48 
-----------+---------------------------------+----------
         1 |         1          0         17 |        18 
           |      3.45       0.00       6.91 |      6.52 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.5801   Pr = 0.748

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

atrial_fib | COVID-19 acute kidney
rillation_ |        injury
or_flutter | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       249          9 |       258 
           |     93.96      81.82 |     93.48 
-----------+----------------------+----------
         1 |        16          2 |        18 
           |      6.04      18.18 |      6.52 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   2.5550   Pr = 0.110

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

atrial_fib |    COVID-19 kidney
rillation_ |  replacement therapy
or_flutter | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       240         18 |       258 
           |     94.12      85.71 |     93.48 
-----------+----------------------+----------
         1 |        15          3 |        18 
           |      5.88      14.29 |      6.52 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   2.2474   Pr = 0.134

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

atrial_fib |
rillation_ |             Vaccination status
or_flutter | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         6         12         60        180 |       258 
           |     85.71      80.00      93.75      94.74 |     93.48 
-----------+--------------------------------------------+----------
         1 |         1          3          4         10 |        18 
           |     14.29      20.00       6.25       5.26 |      6.52 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   5.6633   Pr = 0.129

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

atrial_fib |
rillation_ |                    Calendar period
or_flutter | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        69         22         39         43         68 |       258 
           |     97.18      95.65      92.86      93.48      90.67 |     93.48 
-----------+-------------------------------------------------------+----------
         1 |         2          1          3          3          7 |        18 
           |      2.82       4.35       7.14       6.52       9.33 |      6.52 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


atrial_fib |  Calendar
rillation_ |   period
or_flutter | December  |     Total
-----------+-----------+----------
         0 |        17 |       258 
           |     89.47 |     93.48 
-----------+-----------+----------
         1 |         2 |        18 
           |     10.53 |      6.52 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   3.2757   Pr = 0.658

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

chronic_li |
ver_diseas |       SARS-CoV-2 severity
         e | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        28          1        242 |       271 
           |     96.55     100.00      98.37 |     98.19 
-----------+---------------------------------+----------
         1 |         1          0          4 |         5 
           |      3.45       0.00       1.63 |      1.81 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.5028   Pr = 0.778

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

chronic_li | COVID-19 acute kidney
ver_diseas |        injury
         e | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       260         11 |       271 
           |     98.11     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.89       0.00 |      1.81 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2114   Pr = 0.646

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

chronic_li |    COVID-19 kidney
ver_diseas |  replacement therapy
         e | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       250         21 |       271 
           |     98.04     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.96       0.00 |      1.81 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.4194   Pr = 0.517

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

chronic_li |
ver_diseas |             Vaccination status
         e | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         6         15         61        189 |       271 
           |     85.71     100.00      95.31      99.47 |     98.19 
-----------+--------------------------------------------+----------
         1 |         1          0          3          1 |         5 
           |     14.29       0.00       4.69       0.53 |      1.81 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =  11.1406   Pr = 0.011

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

chronic_li |
ver_diseas |                    Calendar period
         e | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        70         22         40         46         74 |       271 
           |     98.59      95.65      95.24     100.00      98.67 |     98.19 
-----------+-------------------------------------------------------+----------
         1 |         1          1          2          0          1 |         5 
           |      1.41       4.35       4.76       0.00       1.33 |      1.81 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


chronic_li |  Calendar
ver_diseas |   period
         e | December  |     Total
-----------+-----------+----------
         0 |        19 |       271 
           |    100.00 |     98.19 
-----------+-----------+----------
         1 |         0 |         5 
           |      0.00 |      1.81 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   4.2476   Pr = 0.514

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |       SARS-CoV-2 severity
  diabetes | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        27          1        192 |       220 
           |     93.10     100.00      78.05 |     79.71 
-----------+---------------------------------+----------
         1 |         2          0         54 |        56 
           |      6.90       0.00      21.95 |     20.29 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   3.8909   Pr = 0.143

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
           |        injury
  diabetes | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       211          9 |       220 
           |     79.62      81.82 |     79.71 
-----------+----------------------+----------
         1 |        54          2 |        56 
           |     20.38      18.18 |     20.29 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0315   Pr = 0.859

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
           |  replacement therapy
  diabetes | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       203         17 |       220 
           |     79.61      80.95 |     79.71 
-----------+----------------------+----------
         1 |        52          4 |        56 
           |     20.39      19.05 |     20.29 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0217   Pr = 0.883

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |             Vaccination status
  diabetes | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         5         12         52        151 |       220 
           |     71.43      80.00      81.25      79.47 |     79.71 
-----------+--------------------------------------------+----------
         1 |         2          3         12         39 |        56 
           |     28.57      20.00      18.75      20.53 |     20.29 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   0.3980   Pr = 0.941

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |                    Calendar period
  diabetes | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        53         20         34         38         60 |       220 
           |     74.65      86.96      80.95      82.61      80.00 |     79.71 
-----------+-------------------------------------------------------+----------
         1 |        18          3          8          8         15 |        56 
           |     25.35      13.04      19.05      17.39      20.00 |     20.29 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
           |   period
  diabetes | December  |     Total
-----------+-----------+----------
         0 |        15 |       220 
           |     78.95 |     79.71 
-----------+-----------+----------
         1 |         4 |        56 
           |     21.05 |     20.29 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   2.1615   Pr = 0.826

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

haematolog |
ical_cance |       SARS-CoV-2 severity
         r | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        243 |       273 
           |    100.00     100.00      98.78 |     98.91 
-----------+---------------------------------+----------
         1 |         0          0          3 |         3 
           |      0.00       0.00       1.22 |      1.09 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.3699   Pr = 0.831

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

haematolog | COVID-19 acute kidney
ical_cance |        injury
         r | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       262         11 |       273 
           |     98.87     100.00 |     98.91 
-----------+----------------------+----------
         1 |         3          0 |         3 
           |      1.13       0.00 |      1.09 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.1259   Pr = 0.723

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

haematolog |    COVID-19 kidney
ical_cance |  replacement therapy
         r | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       252         21 |       273 
           |     98.82     100.00 |     98.91 
-----------+----------------------+----------
         1 |         3          0 |         3 
           |      1.18       0.00 |      1.09 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2498   Pr = 0.617

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

haematolog |
ical_cance |             Vaccination status
         r | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         15         64        187 |       273 
           |    100.00     100.00     100.00      98.42 |     98.91 
-----------+--------------------------------------------+----------
         1 |         0          0          0          3 |         3 
           |      0.00       0.00       0.00       1.58 |      1.09 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.3728   Pr = 0.712

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

haematolog |
ical_cance |                    Calendar period
         r | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        71         23         42         44         75 |       273 
           |    100.00     100.00     100.00      95.65     100.00 |     98.91 
-----------+-------------------------------------------------------+----------
         1 |         0          0          0          2          0 |         3 
           |      0.00       0.00       0.00       4.35       0.00 |      1.09 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


haematolog |  Calendar
ical_cance |   period
         r | December  |     Total
-----------+-----------+----------
         0 |        18 |       273 
           |     94.74 |     98.91 
-----------+-----------+----------
         1 |         1 |         3 
           |      5.26 |      1.09 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   9.9503   Pr = 0.077

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

heart_fail |       SARS-CoV-2 severity
       ure | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        240 |       270 
           |    100.00     100.00      97.56 |     97.83 
-----------+---------------------------------+----------
         1 |         0          0          6 |         6 
           |      0.00       0.00       2.44 |      2.17 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.7480   Pr = 0.688

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
heart_fail |        injury
       ure | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       260         10 |       270 
           |     98.11      90.91 |     97.83 
-----------+----------------------+----------
         1 |         5          1 |         6 
           |      1.89       9.09 |      2.17 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   2.5775   Pr = 0.108

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
heart_fail |  replacement therapy
       ure | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       250         20 |       270 
           |     98.04      95.24 |     97.83 
-----------+----------------------+----------
         1 |         5          1 |         6 
           |      1.96       4.76 |      2.17 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.7158   Pr = 0.398

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

heart_fail |             Vaccination status
       ure | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         14         64        185 |       270 
           |    100.00      93.33     100.00      97.37 |     97.83 
-----------+--------------------------------------------+----------
         1 |         0          1          0          5 |         6 
           |      0.00       6.67       0.00       2.63 |      2.17 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   3.1886   Pr = 0.363

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

heart_fail |                    Calendar period
       ure | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        70         23         41         45         72 |       270 
           |     98.59     100.00      97.62      97.83      96.00 |     97.83 
-----------+-------------------------------------------------------+----------
         1 |         1          0          1          1          3 |         6 
           |      1.41       0.00       2.38       2.17       4.00 |      2.17 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
heart_fail |   period
       ure | December  |     Total
-----------+-----------+----------
         0 |        19 |       270 
           |    100.00 |     97.83 
-----------+-----------+----------
         1 |         0 |         6 
           |      0.00 |      2.17 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   2.3134   Pr = 0.804

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |       SARS-CoV-2 severity
       hiv | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        28          1        242 |       271 
           |     96.55     100.00      98.37 |     98.19 
-----------+---------------------------------+----------
         1 |         1          0          4 |         5 
           |      3.45       0.00       1.63 |      1.81 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.5028   Pr = 0.778

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
           |        injury
       hiv | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       260         11 |       271 
           |     98.11     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.89       0.00 |      1.81 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2114   Pr = 0.646

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
           |  replacement therapy
       hiv | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       250         21 |       271 
           |     98.04     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.96       0.00 |      1.81 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.4194   Pr = 0.517

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |             Vaccination status
       hiv | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         15         61        188 |       271 
           |    100.00     100.00      95.31      98.95 |     98.19 
-----------+--------------------------------------------+----------
         1 |         0          0          3          2 |         5 
           |      0.00       0.00       4.69       1.05 |      1.81 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   3.9970   Pr = 0.262

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |                    Calendar period
       hiv | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        69         23         41         46         74 |       271 
           |     97.18     100.00      97.62     100.00      98.67 |     98.19 
-----------+-------------------------------------------------------+----------
         1 |         2          0          1          0          1 |         5 
           |      2.82       0.00       2.38       0.00       1.33 |      1.81 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
           |   period
       hiv | December  |     Total
-----------+-----------+----------
         0 |        18 |       271 
           |     94.74 |     98.19 
-----------+-----------+----------
         1 |         1 |         5 
           |      5.26 |      1.81 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   3.1220   Pr = 0.681

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

hypertensi |       SARS-CoV-2 severity
        on | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        25          1        193 |       219 
           |     86.21     100.00      78.46 |     79.35 
-----------+---------------------------------+----------
         1 |         4          0         53 |        57 
           |     13.79       0.00      21.54 |     20.65 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   1.2124   Pr = 0.545

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
hypertensi |        injury
        on | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       209         10 |       219 
           |     78.87      90.91 |     79.35 
-----------+----------------------+----------
         1 |        56          1 |        57 
           |     21.13       9.09 |     20.65 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.9345   Pr = 0.334

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
hypertensi |  replacement therapy
        on | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       203         16 |       219 
           |     79.61      76.19 |     79.35 
-----------+----------------------+----------
         1 |        52          5 |        57 
           |     20.39      23.81 |     20.65 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.1383   Pr = 0.710

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

hypertensi |             Vaccination status
        on | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         12         49        151 |       219 
           |    100.00      80.00      76.56      79.47 |     79.35 
-----------+--------------------------------------------+----------
         1 |         0          3         15         39 |        57 
           |      0.00      20.00      23.44      20.53 |     20.65 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   2.1306   Pr = 0.546

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

hypertensi |                    Calendar period
        on | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        63         16         32         35         59 |       219 
           |     88.73      69.57      76.19      76.09      78.67 |     79.35 
-----------+-------------------------------------------------------+----------
         1 |         8          7         10         11         16 |        57 
           |     11.27      30.43      23.81      23.91      21.33 |     20.65 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
hypertensi |   period
        on | December  |     Total
-----------+-----------+----------
         0 |        14 |       219 
           |     73.68 |     79.35 
-----------+-----------+----------
         1 |         5 |        57 
           |     26.32 |     20.65 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   6.1061   Pr = 0.296

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

non_haemat |
ological_c |       SARS-CoV-2 severity
     ancer | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        241 |       271 
           |    100.00     100.00      97.97 |     98.19 
-----------+---------------------------------+----------
         1 |         0          0          5 |         5 
           |      0.00       0.00       2.03 |      1.81 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.6210   Pr = 0.733

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

non_haemat | COVID-19 acute kidney
ological_c |        injury
     ancer | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       260         11 |       271 
           |     98.11     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.89       0.00 |      1.81 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2114   Pr = 0.646

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

non_haemat |    COVID-19 kidney
ological_c |  replacement therapy
     ancer | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       250         21 |       271 
           |     98.04     100.00 |     98.19 
-----------+----------------------+----------
         1 |         5          0 |         5 
           |      1.96       0.00 |      1.81 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.4194   Pr = 0.517

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

non_haemat |
ological_c |             Vaccination status
     ancer | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         15         62        187 |       271 
           |    100.00     100.00      96.88      98.42 |     98.19 
-----------+--------------------------------------------+----------
         1 |         0          0          2          3 |         5 
           |      0.00       0.00       3.12       1.58 |      1.81 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.0844   Pr = 0.781

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

non_haemat |
ological_c |                    Calendar period
     ancer | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        70         23         42         45         73 |       271 
           |     98.59     100.00     100.00      97.83      97.33 |     98.19 
-----------+-------------------------------------------------------+----------
         1 |         1          0          0          1          2 |         5 
           |      1.41       0.00       0.00       2.17       2.67 |      1.81 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


non_haemat |  Calendar
ological_c |   period
     ancer | December  |     Total
-----------+-----------+----------
         0 |        18 |       271 
           |     94.74 |     98.19 
-----------+-----------+----------
         1 |         1 |         5 
           |      5.26 |      1.81 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   2.8789   Pr = 0.719

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

myocardial |
_infarctio |       SARS-CoV-2 severity
         n | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        25          1        219 |       245 
           |     86.21     100.00      89.02 |     88.77 
-----------+---------------------------------+----------
         1 |         4          0         27 |        31 
           |     13.79       0.00      10.98 |     11.23 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.3335   Pr = 0.846

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

myocardial | COVID-19 acute kidney
_infarctio |        injury
         n | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       235         10 |       245 
           |     88.68      90.91 |     88.77 
-----------+----------------------+----------
         1 |        30          1 |        31 
           |     11.32       9.09 |     11.23 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0527   Pr = 0.818

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

myocardial |    COVID-19 kidney
_infarctio |  replacement therapy
         n | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       227         18 |       245 
           |     89.02      85.71 |     88.77 
-----------+----------------------+----------
         1 |        28          3 |        31 
           |     10.98      14.29 |     11.23 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2126   Pr = 0.645

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

myocardial |
_infarctio |             Vaccination status
         n | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         6         12         60        167 |       245 
           |     85.71      80.00      93.75      87.89 |     88.77 
-----------+--------------------------------------------+----------
         1 |         1          3          4         23 |        31 
           |     14.29      20.00       6.25      12.11 |     11.23 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   2.9606   Pr = 0.398

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

myocardial |
_infarctio |                    Calendar period
         n | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        65         22         36         42         64 |       245 
           |     91.55      95.65      85.71      91.30      85.33 |     88.77 
-----------+-------------------------------------------------------+----------
         1 |         6          1          6          4         11 |        31 
           |      8.45       4.35      14.29       8.70      14.67 |     11.23 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


myocardial |  Calendar
_infarctio |   period
         n | December  |     Total
-----------+-----------+----------
         0 |        16 |       245 
           |     84.21 |     88.77 
-----------+-----------+----------
         1 |         3 |        31 
           |     15.79 |     11.23 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   3.6170   Pr = 0.606

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

peripheral |
_vascular_ |       SARS-CoV-2 severity
   disease | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        235 |       265 
           |    100.00     100.00      95.53 |     96.01 
-----------+---------------------------------+----------
         1 |         0          0         11 |        11 
           |      0.00       0.00       4.47 |      3.99 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   1.3971   Pr = 0.497

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

peripheral | COVID-19 acute kidney
_vascular_ |        injury
   disease | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       254         11 |       265 
           |     95.85     100.00 |     96.01 
-----------+----------------------+----------
         1 |        11          0 |        11 
           |      4.15       0.00 |      3.99 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.4756   Pr = 0.490

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

peripheral |    COVID-19 kidney
_vascular_ |  replacement therapy
   disease | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       246         19 |       265 
           |     96.47      90.48 |     96.01 
-----------+----------------------+----------
         1 |         9          2 |        11 
           |      3.53       9.52 |      3.99 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   1.8219   Pr = 0.177

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

peripheral |
_vascular_ |             Vaccination status
   disease | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         14         60        184 |       265 
           |    100.00      93.33      93.75      96.84 |     96.01 
-----------+--------------------------------------------+----------
         1 |         0          1          4          6 |        11 
           |      0.00       6.67       6.25       3.16 |      3.99 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.7701   Pr = 0.621

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

peripheral |
_vascular_ |                    Calendar period
   disease | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        66         22         40         45         74 |       265 
           |     92.96      95.65      95.24      97.83      98.67 |     96.01 
-----------+-------------------------------------------------------+----------
         1 |         5          1          2          1          1 |        11 
           |      7.04       4.35       4.76       2.17       1.33 |      3.99 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


peripheral |  Calendar
_vascular_ |   period
   disease | December  |     Total
-----------+-----------+----------
         0 |        18 |       265 
           |     94.74 |     96.01 
-----------+-----------+----------
         1 |         1 |        11 
           |      5.26 |      3.99 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   3.6619   Pr = 0.599

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

rheumatoid |       SARS-CoV-2 severity
_arthritis | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        237 |       267 
           |    100.00     100.00      96.34 |     96.74 
-----------+---------------------------------+----------
         1 |         0          0          9 |         9 
           |      0.00       0.00       3.66 |      3.26 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   1.1346   Pr = 0.567

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
rheumatoid |        injury
_arthritis | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       256         11 |       267 
           |     96.60     100.00 |     96.74 
-----------+----------------------+----------
         1 |         9          0 |         9 
           |      3.40       0.00 |      3.26 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.3862   Pr = 0.534

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
rheumatoid |  replacement therapy
_arthritis | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       247         20 |       267 
           |     96.86      95.24 |     96.74 
-----------+----------------------+----------
         1 |         8          1 |         9 
           |      3.14       4.76 |      3.26 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.1623   Pr = 0.687

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

rheumatoid |             Vaccination status
_arthritis | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         14         62        184 |       267 
           |    100.00      93.33      96.88      96.84 |     96.74 
-----------+--------------------------------------------+----------
         1 |         0          1          2          6 |         9 
           |      0.00       6.67       3.12       3.16 |      3.26 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   0.7976   Pr = 0.850

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

rheumatoid |                    Calendar period
_arthritis | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        66         23         42         45         73 |       267 
           |     92.96     100.00     100.00      97.83      97.33 |     96.74 
-----------+-------------------------------------------------------+----------
         1 |         5          0          0          1          2 |         9 
           |      7.04       0.00       0.00       2.17       2.67 |      3.26 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
rheumatoid |   period
_arthritis | December  |     Total
-----------+-----------+----------
         0 |        18 |       267 
           |     94.74 |     96.74 
-----------+-----------+----------
         1 |         1 |         9 
           |      5.26 |      3.26 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   5.9070   Pr = 0.315

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |       SARS-CoV-2 severity
    stroke | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        29          1        244 |       274 
           |    100.00     100.00      99.19 |     99.28 
-----------+---------------------------------+----------
         1 |         0          0          2 |         2 
           |      0.00       0.00       0.81 |      0.72 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.2457   Pr = 0.884

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
           |        injury
    stroke | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       263         11 |       274 
           |     99.25     100.00 |     99.28 
-----------+----------------------+----------
         1 |         2          0 |         2 
           |      0.75       0.00 |      0.72 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0836   Pr = 0.772

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
           |  replacement therapy
    stroke | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       253         21 |       274 
           |     99.22     100.00 |     99.28 
-----------+----------------------+----------
         1 |         2          0 |         2 
           |      0.78       0.00 |      0.72 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.1659   Pr = 0.684

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |             Vaccination status
    stroke | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         15         63        189 |       274 
           |    100.00     100.00      98.44      99.47 |     99.28 
-----------+--------------------------------------------+----------
         1 |         0          0          1          1 |         2 
           |      0.00       0.00       1.56       0.53 |      0.72 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   0.8890   Pr = 0.828

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |                    Calendar period
    stroke | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        71         22         42         46         74 |       274 
           |    100.00      95.65     100.00     100.00      98.67 |     99.28 
-----------+-------------------------------------------------------+----------
         1 |         0          1          0          0          1 |         2 
           |      0.00       4.35       0.00       0.00       1.33 |      0.72 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
           |   period
    stroke | December  |     Total
-----------+-----------+----------
         0 |        19 |       274 
           |    100.00 |     99.28 
-----------+-----------+----------
         1 |         0 |         2 
           |      0.00 |      0.72 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   5.8826   Pr = 0.318

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

systemic_l |
upus_eryth |       SARS-CoV-2 severity
  ematosus | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        28          1        240 |       269 
           |     96.55     100.00      97.56 |     97.46 
-----------+---------------------------------+----------
         1 |         1          0          6 |         7 
           |      3.45       0.00       2.44 |      2.54 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.1330   Pr = 0.936

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

systemic_l | COVID-19 acute kidney
upus_eryth |        injury
  ematosus | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       258         11 |       269 
           |     97.36     100.00 |     97.46 
-----------+----------------------+----------
         1 |         7          0 |         7 
           |      2.64       0.00 |      2.54 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.2981   Pr = 0.585

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

systemic_l |    COVID-19 kidney
upus_eryth |  replacement therapy
  ematosus | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       248         21 |       269 
           |     97.25     100.00 |     97.46 
-----------+----------------------+----------
         1 |         7          0 |         7 
           |      2.75       0.00 |      2.54 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.5915   Pr = 0.442

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

systemic_l |
upus_eryth |             Vaccination status
  ematosus | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         15         63        184 |       269 
           |    100.00     100.00      98.44      96.84 |     97.46 
-----------+--------------------------------------------+----------
         1 |         0          0          1          6 |         7 
           |      0.00       0.00       1.56       3.16 |      2.54 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.1150   Pr = 0.773

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

systemic_l |
upus_eryth |                    Calendar period
  ematosus | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        70         23         40         45         72 |       269 
           |     98.59     100.00      95.24      97.83      96.00 |     97.46 
-----------+-------------------------------------------------------+----------
         1 |         1          0          2          1          3 |         7 
           |      1.41       0.00       4.76       2.17       4.00 |      2.54 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


systemic_l |  Calendar
upus_eryth |   period
  ematosus | December  |     Total
-----------+-----------+----------
         0 |        19 |       269 
           |    100.00 |     97.46 
-----------+-----------+----------
         1 |         0 |         7 
           |      0.00 |      2.54 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   2.9744   Pr = 0.704

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

immunosupp |       SARS-CoV-2 severity
   ression | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        28          1        234 |       263 
           |     96.55     100.00      95.12 |     95.29 
-----------+---------------------------------+----------
         1 |         1          0         12 |        13 
           |      3.45       0.00       4.88 |      4.71 
-----------+---------------------------------+----------
     Total |        29          1        246 |       276 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.1678   Pr = 0.920

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           | COVID-19 acute kidney
immunosupp |        injury
   ression | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       254          9 |       263 
           |     95.85      81.82 |     95.29 
-----------+----------------------+----------
         1 |        11          2 |        13 
           |      4.15      18.18 |      4.71 
-----------+----------------------+----------
     Total |       265         11 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   4.6325   Pr = 0.031

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

           |    COVID-19 kidney
immunosupp |  replacement therapy
   ression | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       243         20 |       263 
           |     95.29      95.24 |     95.29 
-----------+----------------------+----------
         1 |        12          1 |        13 
           |      4.71       4.76 |      4.71 
-----------+----------------------+----------
     Total |       255         21 |       276 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0001   Pr = 0.991

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

immunosupp |             Vaccination status
   ression | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         14         57        185 |       263 
           |    100.00      93.33      89.06      97.37 |     95.29 
-----------+--------------------------------------------+----------
         1 |         0          1          7          5 |        13 
           |      0.00       6.67      10.94       2.63 |      4.71 
-----------+--------------------------------------------+----------
     Total |         7         15         64        190 |       276 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   7.8326   Pr = 0.050

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

immunosupp |                    Calendar period
   ression | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        66         23         41         44         72 |       263 
           |     92.96     100.00      97.62      95.65      96.00 |     95.29 
-----------+-------------------------------------------------------+----------
         1 |         5          0          1          2          3 |        13 
           |      7.04       0.00       2.38       4.35       4.00 |      4.71 
-----------+-------------------------------------------------------+----------
     Total |        71         23         42         46         75 |       276 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


           |  Calendar
immunosupp |   period
   ression | December  |     Total
-----------+-----------+----------
         0 |        17 |       263 
           |     89.47 |     95.29 
-----------+-----------+----------
         1 |         2 |        13 
           |     10.53 |      4.71 
-----------+-----------+----------
     Total |        19 |       276 
           |    100.00 |    100.00 

          Pearson chi2(5) =   4.0346   Pr = 0.544

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                     |       SARS-CoV-2 severity
        BMI category | SARS-CoV-  COVID-19   COVID-19  |     Total
---------------------+---------------------------------+----------
 Underweight (<18.5) |         0          0         14 |        14 
                     |      0.00       0.00       5.69 |      5.07 
---------------------+---------------------------------+----------
  Normal (18.5-24.9) |         9          0         63 |        72 
                     |     31.03       0.00      25.61 |     26.09 
---------------------+---------------------------------+----------
Overweight (25-29.9) |         7          0         59 |        66 
                     |     24.14       0.00      23.98 |     23.91 
---------------------+---------------------------------+----------
   Obese I (30-34.9) |         6          0         46 |        52 
                     |     20.69       0.00      18.70 |     18.84 
---------------------+---------------------------------+----------
  Obese II (35-39.9) |         2          0         29 |        31 
                     |      6.90       0.00      11.79 |     11.23 
---------------------+---------------------------------+----------
     Obese III (40+) |         3          0         12 |        15 
                     |     10.34       0.00       4.88 |      5.43 
---------------------+---------------------------------+----------
                   . |         2          1         23 |        26 
                     |      6.90     100.00       9.35 |      9.42 
---------------------+---------------------------------+----------
               Total |        29          1        246 |       276 
                     |    100.00     100.00     100.00 |    100.00 

         Pearson chi2(12) =  13.7992   Pr = 0.314

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                     | COVID-19 acute kidney
                     |        injury
        BMI category | COVID-19   COVID-19  |     Total
---------------------+----------------------+----------
 Underweight (<18.5) |        14          0 |        14 
                     |      5.28       0.00 |      5.07 
---------------------+----------------------+----------
  Normal (18.5-24.9) |        71          1 |        72 
                     |     26.79       9.09 |     26.09 
---------------------+----------------------+----------
Overweight (25-29.9) |        61          5 |        66 
                     |     23.02      45.45 |     23.91 
---------------------+----------------------+----------
   Obese I (30-34.9) |        50          2 |        52 
                     |     18.87      18.18 |     18.84 
---------------------+----------------------+----------
  Obese II (35-39.9) |        29          2 |        31 
                     |     10.94      18.18 |     11.23 
---------------------+----------------------+----------
     Obese III (40+) |        14          1 |        15 
                     |      5.28       9.09 |      5.43 
---------------------+----------------------+----------
                   . |        26          0 |        26 
                     |      9.81       0.00 |      9.42 
---------------------+----------------------+----------
               Total |       265         11 |       276 
                     |    100.00     100.00 |    100.00 

          Pearson chi2(6) =   5.9293   Pr = 0.431

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                     |    COVID-19 kidney
                     |  replacement therapy
        BMI category | COVID-19   COVID-19  |     Total
---------------------+----------------------+----------
 Underweight (<18.5) |        13          1 |        14 
                     |      5.10       4.76 |      5.07 
---------------------+----------------------+----------
  Normal (18.5-24.9) |        68          4 |        72 
                     |     26.67      19.05 |     26.09 
---------------------+----------------------+----------
Overweight (25-29.9) |        60          6 |        66 
                     |     23.53      28.57 |     23.91 
---------------------+----------------------+----------
   Obese I (30-34.9) |        47          5 |        52 
                     |     18.43      23.81 |     18.84 
---------------------+----------------------+----------
  Obese II (35-39.9) |        31          0 |        31 
                     |     12.16       0.00 |     11.23 
---------------------+----------------------+----------
     Obese III (40+) |        15          0 |        15 
                     |      5.88       0.00 |      5.43 
---------------------+----------------------+----------
                   . |        21          5 |        26 
                     |      8.24      23.81 |      9.42 
---------------------+----------------------+----------
               Total |       255         21 |       276 
                     |    100.00     100.00 |    100.00 

          Pearson chi2(6) =   9.7242   Pr = 0.137

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                     |             Vaccination status
        BMI category | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
---------------------+--------------------------------------------+----------
 Underweight (<18.5) |         0          0          2         12 |        14 
                     |      0.00       0.00       3.12       6.32 |      5.07 
---------------------+--------------------------------------------+----------
  Normal (18.5-24.9) |         2          4         20         46 |        72 
                     |     28.57      26.67      31.25      24.21 |     26.09 
---------------------+--------------------------------------------+----------
Overweight (25-29.9) |         0          4         13         49 |        66 
                     |      0.00      26.67      20.31      25.79 |     23.91 
---------------------+--------------------------------------------+----------
   Obese I (30-34.9) |         1          2         11         38 |        52 
                     |     14.29      13.33      17.19      20.00 |     18.84 
---------------------+--------------------------------------------+----------
  Obese II (35-39.9) |         2          2          7         20 |        31 
                     |     28.57      13.33      10.94      10.53 |     11.23 
---------------------+--------------------------------------------+----------
     Obese III (40+) |         0          1          6          8 |        15 
                     |      0.00       6.67       9.38       4.21 |      5.43 
---------------------+--------------------------------------------+----------
                   . |         2          2          5         17 |        26 
                     |     28.57      13.33       7.81       8.95 |      9.42 
---------------------+--------------------------------------------+----------
               Total |         7         15         64        190 |       276 
                     |    100.00     100.00     100.00     100.00 |    100.00 

         Pearson chi2(18) =  13.9839   Pr = 0.730

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                     |               Calendar period
        BMI category | February   July 2020  September  December  |     Total
---------------------+--------------------------------------------+----------
 Underweight (<18.5) |         3          0          6          2 |        14 
                     |      4.23       0.00      14.29       4.35 |      5.07 
---------------------+--------------------------------------------+----------
  Normal (18.5-24.9) |        25          6         10          8 |        72 
                     |     35.21      26.09      23.81      17.39 |     26.09 
---------------------+--------------------------------------------+----------
Overweight (25-29.9) |        16          5         11         14 |        66 
                     |     22.54      21.74      26.19      30.43 |     23.91 
---------------------+--------------------------------------------+----------
   Obese I (30-34.9) |        10          3          9         12 |        52 
                     |     14.08      13.04      21.43      26.09 |     18.84 
---------------------+--------------------------------------------+----------
  Obese II (35-39.9) |         8          4          1          7 |        31 
                     |     11.27      17.39       2.38      15.22 |     11.23 
---------------------+--------------------------------------------+----------
     Obese III (40+) |         3          1          2          1 |        15 
                     |      4.23       4.35       4.76       2.17 |      5.43 
---------------------+--------------------------------------------+----------
                   . |         6          4          3          2 |        26 
                     |      8.45      17.39       7.14       4.35 |      9.42 
---------------------+--------------------------------------------+----------
               Total |        71         23         42         46 |       276 
                     |    100.00     100.00     100.00     100.00 |    100.00 


                     |    Calendar period
        BMI category | March 202  December  |     Total
---------------------+----------------------+----------
 Underweight (<18.5) |         1          2 |        14 
                     |      1.33      10.53 |      5.07 
---------------------+----------------------+----------
  Normal (18.5-24.9) |        20          3 |        72 
                     |     26.67      15.79 |     26.09 
---------------------+----------------------+----------
Overweight (25-29.9) |        17          3 |        66 
                     |     22.67      15.79 |     23.91 
---------------------+----------------------+----------
   Obese I (30-34.9) |        15          3 |        52 
                     |     20.00      15.79 |     18.84 
---------------------+----------------------+----------
  Obese II (35-39.9) |         9          2 |        31 
                     |     12.00      10.53 |     11.23 
---------------------+----------------------+----------
     Obese III (40+) |         5          3 |        15 
                     |      6.67      15.79 |      5.43 
---------------------+----------------------+----------
                   . |         8          3 |        26 
                     |     10.67      15.79 |      9.42 
---------------------+----------------------+----------
               Total |        75         19 |       276 
                     |    100.00     100.00 |    100.00 

         Pearson chi2(30) =  34.0050   Pr = 0.281

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |       SARS-CoV-2 severity
       Smoking status | SARS-CoV-  COVID-19   COVID-19  |     Total
----------------------+---------------------------------+----------
           Non-smoker |        26          1        198 |       225 
                      |     89.66     100.00      80.49 |     81.52 
----------------------+---------------------------------+----------
Current/former smoker |         3          0         48 |        51 
                      |     10.34       0.00      19.51 |     18.48 
----------------------+---------------------------------+----------
                Total |        29          1        246 |       276 
                      |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   1.6748   Pr = 0.433

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      | COVID-19 acute kidney
                      |        injury
       Smoking status | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
           Non-smoker |       215         10 |       225 
                      |     81.13      90.91 |     81.52 
----------------------+----------------------+----------
Current/former smoker |        50          1 |        51 
                      |     18.87       9.09 |     18.48 
----------------------+----------------------+----------
                Total |       265         11 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.6702   Pr = 0.413

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |    COVID-19 kidney
                      |  replacement therapy
       Smoking status | COVID-19   COVID-19  |     Total
----------------------+----------------------+----------
           Non-smoker |       210         15 |       225 
                      |     82.35      71.43 |     81.52 
----------------------+----------------------+----------
Current/former smoker |        45          6 |        51 
                      |     17.65      28.57 |     18.48 
----------------------+----------------------+----------
                Total |       255         21 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   1.5371   Pr = 0.215

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |             Vaccination status
       Smoking status | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
----------------------+--------------------------------------------+----------
           Non-smoker |         6         14         52        153 |       225 
                      |     85.71      93.33      81.25      80.53 |     81.52 
----------------------+--------------------------------------------+----------
Current/former smoker |         1          1         12         37 |        51 
                      |     14.29       6.67      18.75      19.47 |     18.48 
----------------------+--------------------------------------------+----------
                Total |         7         15         64        190 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.5990   Pr = 0.660

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

                      |               Calendar period
       Smoking status | February   July 2020  September  December  |     Total
----------------------+--------------------------------------------+----------
           Non-smoker |        57         18         34         34 |       225 
                      |     80.28      78.26      80.95      73.91 |     81.52 
----------------------+--------------------------------------------+----------
Current/former smoker |        14          5          8         12 |        51 
                      |     19.72      21.74      19.05      26.09 |     18.48 
----------------------+--------------------------------------------+----------
                Total |        71         23         42         46 |       276 
                      |    100.00     100.00     100.00     100.00 |    100.00 


                      |    Calendar period
       Smoking status | March 202  December  |     Total
----------------------+----------------------+----------
           Non-smoker |        65         17 |       225 
                      |     86.67      89.47 |     81.52 
----------------------+----------------------+----------
Current/former smoker |        10          2 |        51 
                      |     13.33      10.53 |     18.48 
----------------------+----------------------+----------
                Total |        75         19 |       276 
                      |    100.00     100.00 |    100.00 

          Pearson chi2(5) =   4.1272   Pr = 0.531

. 
. * End-stage renal disease (stratified)
. sum krt_outcome

    Variable |        Obs        Mean    Std. Dev.       Min        Max
-------------+---------------------------------------------------------
 krt_outcome |         37       22285    150.3226      21984      22569

. sum egfr_below15_outcome_date

    Variable |        Obs        Mean    Std. Dev.       Min        Max
-------------+---------------------------------------------------------
egfr_below~e |          0

. stset exit_date, fail(esrd_date) origin(index_date) id(patient_id) scale(365.
> 25)

                id:  patient_id
     failure event:  esrd_date != 0 & esrd_date < .
obs. time interval:  (exit_date[_n-1], exit_date]
 exit on or before:  failure
    t for analysis:  (time-origin)/365.25
            origin:  time index_date

------------------------------------------------------------------------------
        276  total observations
         43  observations end on or before enter()
------------------------------------------------------------------------------
        233  observations remaining, representing
        233  subjects
         14  failures in single-failure-per-subject data
    245.749  total analysis time at risk and under observation
                                                at risk from t =         0
                                     earliest observed entry t =         0
                                          last observed exit t =   1.91102

. foreach stratum of varlist      covid_severity                          ///
>                                                         covid_acute_kidney_in
> jury       ///
>                                                         covid_krt            
>                            ///
>                                                         covid_vax_status     
>                    ///
>                                                         calendar_period {
  2.         tab _d `stratum', col chi
  3.         strate `stratum'
  4.         strate `stratum' agegroup
  5.         strate `stratum' male
  6.         strate `stratum' ethnicity
  7.         strate `stratum' imd
  8.         strate `stratum' baseline_egfr_cat
  9.         strate `stratum' diabetes
 10.         sts graph, failure by(`stratum') title(Cumulative ESRD after SARS-
> CoV-2 survival by `stratum') ylab(0(0.02)0.20, angle(horizontal)) ytitle(Cumu
> lative ESRD) xtitle(Follow-up (years))
 11.         graph export ./output/esrd_`stratum'.svg,  replace
 12.         }

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |       SARS-CoV-2 severity
  censored | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        24          0        195 |       219 
           |     92.31       0.00      94.66 |     93.99 
-----------+---------------------------------+----------
         1 |         2          1         11 |        14 
           |      7.69     100.00       5.34 |      6.01 
-----------+---------------------------------+----------
     Total |        26          1        206 |       233 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =  15.9365   Pr = 0.000

         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------+
  |                     covid_severity    D          Y       Rate      Lower   
>    Upper |
  |----------------------------------------------------------------------------
> ---------|
  | SARS-CoV-2 without hospitalisation    2    25.9411   0.077098   0.019282   
> 0.308270 |
  |      COVID-19 with hospitalisation    1     0.0575    1.7e+01   2.450019   
>  1.2e+02 |
  |        COVID-19 with critical care   11   219.7509   0.050057   0.027721   
> 0.090388 |
  +----------------------------------------------------------------------------
> ---------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------+
  |                     covid_severity   agegroup   D          Y        Rate   
>     Lower       Upper |
  |----------------------------------------------------------------------------
> ----------------------|
  | SARS-CoV-2 without hospitalisation     18-<50   1    16.4244   0.0608851   
> 0.0085765   0.4322280 |
  | SARS-CoV-2 without hospitalisation     50-<60   0     7.0007     0.0e+00   
>         .           . |
  | SARS-CoV-2 without hospitalisation     60-<70   0     1.8946     0.0e+00   
>         .           . |
  | SARS-CoV-2 without hospitalisation     70-<80   1     0.6215     1.6e+00   
> 0.2266537     1.1e+01 |
  |      COVID-19 with hospitalisation     50-<60   1     0.0575     1.7e+01   
>   2.5e+00     1.2e+02 |
  |----------------------------------------------------------------------------
> ----------------------|
  |        COVID-19 with critical care     18-<50   4   120.7365   0.0331300   
> 0.0124343   0.0882719 |
  |        COVID-19 with critical care     50-<60   2    34.7598   0.0575378   
> 0.0143901   0.2300614 |
  |        COVID-19 with critical care     60-<70   2    31.1266   0.0642537   
> 0.0160697   0.2569143 |
  |        COVID-19 with critical care     70-<80   2    19.9014   0.1004953   
> 0.0251336   0.4018241 |
  |        COVID-19 with critical care        80+   1    13.2266   0.0756055   
> 0.0106500   0.5367286 |
  +----------------------------------------------------------------------------
> ----------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                     covid_severity     male   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 without hospitalisation   Female   1    13.4155   0.0745408   0.
> 0105001   0.5291706 |
  | SARS-CoV-2 without hospitalisation     Male   1    12.5257   0.0798361   0.
> 0112460   0.5667619 |
  |      COVID-19 with hospitalisation   Female   1     0.0575     1.7e+01     
> 2.5e+00     1.2e+02 |
  |        COVID-19 with critical care   Female   3   116.7173   0.0257031   0.
> 0082898   0.0796943 |
  |        COVID-19 with critical care     Male   8   103.0335   0.0776446   0.
> 0388299   0.1552589 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------+
  |                     covid_severity                ethnicity   D          Y 
>       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 without hospitalisation                    White   1    13.6591 
>   0.073211   0.010313   0.519731 |
  | SARS-CoV-2 without hospitalisation   Asian or Asian British   0     1.8782 
>   0.000000          .          . |
  | SARS-CoV-2 without hospitalisation                    Other   1     0.4709 
>   2.123547   0.299130    1.5e+01 |
  | SARS-CoV-2 without hospitalisation                  Unknown   0     9.9329 
>   0.000000          .          . |
  |      COVID-19 with hospitalisation                    White   1     0.0575 
>    1.7e+01   2.450019    1.2e+02 |
  |----------------------------------------------------------------------------
> ---------------------------------|
  |        COVID-19 with critical care                    White   7   133.9713 
>   0.052250   0.024909   0.109600 |
  |        COVID-19 with critical care   Asian or Asian British   4    15.3046 
>   0.261360   0.098093   0.696369 |
  |        COVID-19 with critical care                    Other   0    23.8768 
>   0.000000          .          . |
  |        COVID-19 with critical care                  Unknown   0    46.5982 
>   0.000000          .          . |
  +----------------------------------------------------------------------------
> ---------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------+
  |                     covid_severity                imd   D         Y        
> Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------------|
  | SARS-CoV-2 without hospitalisation   1 least deprived   2    5.1088   0.391
> 4791   0.0979080     1.6e+00 |
  | SARS-CoV-2 without hospitalisation                  2   0    4.1862     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  3   0    5.5989     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  4   0    4.6872     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation    5 most deprived   0    6.3600     0.0
> e+00           .           . |
  |----------------------------------------------------------------------------
> -----------------------------|
  |      COVID-19 with hospitalisation                  4   1    0.0575     1.7
> e+01     2.5e+00     1.2e+02 |
  |        COVID-19 with critical care   1 least deprived   2   41.2266   0.048
> 5124   0.0121328   0.1939739 |
  |        COVID-19 with critical care                  2   1   45.3854   0.022
> 0335   0.0031037   0.1564177 |
  |        COVID-19 with critical care                  3   1   46.1930   0.021
> 6483   0.0030495   0.1536828 |
  |        COVID-19 with critical care                  4   5   38.8830   0.128
> 5910   0.0535232   0.3089439 |
  |----------------------------------------------------------------------------
> -----------------------------|
  |        COVID-19 with critical care    5 most deprived   2   48.0630   0.041
> 6121   0.0104071   0.1663833 |
  +----------------------------------------------------------------------------
> -----------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(126 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------+
  |                     covid_severity   baseli~t   D         Y        Rate    
>    Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------|
  | SARS-CoV-2 without hospitalisation      45-59   0    4.3149     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation      75-89   0    2.2094     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation     90-104   0    4.2081     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation       ≥105   1    2.8720   0.3481888   0
> .0490471     2.5e+00 |
  |      COVID-19 with hospitalisation      45-59   1    0.0575     1.7e+01    
>  2.5e+00     1.2e+02 |
  |----------------------------------------------------------------------------
> ---------------------|
  |        COVID-19 with critical care      15-29   1    0.0657     1.5e+01    
>  2.1e+00     1.1e+02 |
  |        COVID-19 with critical care      30-44   0   11.6222     0.0e+00    
>        .           . |
  |        COVID-19 with critical care      45-59   0   14.0945     0.0e+00    
>        .           . |
  |        COVID-19 with critical care      60-74   1   17.1526   0.0583001   0
> .0082124   0.4138764 |
  |        COVID-19 with critical care      75-89   1   19.4743   0.0513496   0
> .0072333   0.3645348 |
  |----------------------------------------------------------------------------
> ---------------------|
  |        COVID-19 with critical care     90-104   3   18.7680   0.1598468   0
> .0515540   0.4956162 |
  |        COVID-19 with critical care       ≥105   1   36.5448   0.0273636   0
> .0038545   0.1942565 |
  +----------------------------------------------------------------------------
> ---------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------+
  |                     covid_severity   diabetes    D          Y        Rate  
>      Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------|
  | SARS-CoV-2 without hospitalisation          0    2    22.6831   0.0881714  
>  0.0220515   0.3525479 |
  | SARS-CoV-2 without hospitalisation          1    0     3.2580     0.0e+00  
>          .           . |
  |      COVID-19 with hospitalisation          0    1     0.0575     1.7e+01  
>    2.5e+00     1.2e+02 |
  |        COVID-19 with critical care          0   10   171.7235   0.0582332  
>  0.0313326   0.1082291 |
  |        COVID-19 with critical care          1    1    48.0274   0.0208215  
>  0.0029330   0.1478130 |
  +----------------------------------------------------------------------------
> -----------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/esrd_covid_severity.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 | COVID-19 acute kidney
        if |        injury
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       209         10 |       219 
           |     93.72     100.00 |     93.99 
-----------+----------------------+----------
         1 |        14          0 |        14 
           |      6.28       0.00 |      6.01 
-----------+----------------------+----------
     Total |       223         10 |       233 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.6679   Pr = 0.414

         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------+
  |            covid_acute_kidney_injury    D          Y       Rate      Lower 
>      Upper |
  |----------------------------------------------------------------------------
> -----------|
  | COVID-19 without acute kidney injury   14   235.2799   0.059504   0.035241 
>   0.100470 |
  |    COVID-19 with acute kidney injury    0    10.4695   0.000000          . 
>          . |
  +----------------------------------------------------------------------------
> -----------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------+
  |            covid_acute_kidney_injury   agegroup   D          Y       Rate  
>     Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------|
  | COVID-19 without acute kidney injury     18-<50   5   133.4018   0.037481  
>  0.015601   0.090049 |
  | COVID-19 without acute kidney injury     50-<60   3    37.9083   0.079138  
>  0.025524   0.245374 |
  | COVID-19 without acute kidney injury     60-<70   2    31.5510   0.063389  
>  0.015854   0.253459 |
  | COVID-19 without acute kidney injury     70-<80   3    19.1923   0.156312  
>  0.050414   0.484657 |
  | COVID-19 without acute kidney injury        80+   1    13.2266   0.075605  
>  0.010650   0.536729 |
  |----------------------------------------------------------------------------
> ---------------------|
  |    COVID-19 with acute kidney injury     18-<50   0     3.7591   0.000000  
>         .          . |
  |    COVID-19 with acute kidney injury     50-<60   0     3.9097   0.000000  
>         .          . |
  |    COVID-19 with acute kidney injury     60-<70   0     1.4702   0.000000  
>         .          . |
  |    COVID-19 with acute kidney injury     70-<80   0     1.3306   0.000000  
>         .          . |
  +----------------------------------------------------------------------------
> ---------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |            covid_acute_kidney_injury     male   D          Y       Rate    
>   Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------|
  | COVID-19 without acute kidney injury   Female   5   124.2738   0.040234   0
> .016746   0.096663 |
  | COVID-19 without acute kidney injury     Male   9   111.0062   0.081077   0
> .042185   0.155822 |
  |    COVID-19 with acute kidney injury   Female   0     5.9165   0.000000    
>       .          . |
  |    COVID-19 with acute kidney injury     Male   0     4.5530   0.000000    
>       .          . |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------------+
  |            covid_acute_kidney_injury                ethnicity   D          
> Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------------|
  | COVID-19 without acute kidney injury                    White   9   140.424
> 4   0.0640914   0.0333477   0.1231782 |
  | COVID-19 without acute kidney injury   Asian or Asian British   4    17.182
> 8   0.2327916   0.0873708   0.6202518 |
  | COVID-19 without acute kidney injury                    Other   1    23.770
> 0   0.0420698   0.0059261   0.2986565 |
  | COVID-19 without acute kidney injury                  Unknown   0    53.902
> 8     0.0e+00           .           . |
  |    COVID-19 with acute kidney injury                    White   0     7.263
> 5     0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------------|
  |    COVID-19 with acute kidney injury                    Other   0     0.577
> 7     0.0e+00           .           . |
  |    COVID-19 with acute kidney injury                  Unknown   0     2.628
> 3     0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |            covid_acute_kidney_injury                imd   D         Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without acute kidney injury   1 least deprived   4   45.8754   0.0
> 871926   0.0327250   0.2323168 |
  | COVID-19 without acute kidney injury                  2   1   47.7153   0.0
> 209577   0.0029522   0.1487799 |
  | COVID-19 without acute kidney injury                  3   1   50.2478   0.0
> 199014   0.0028034   0.1412813 |
  | COVID-19 without acute kidney injury                  4   6   42.7570   0.1
> 403278   0.0630438   0.3123528 |
  | COVID-19 without acute kidney injury    5 most deprived   2   48.6845   0.0
> 410809   0.0102742   0.1642593 |
  |----------------------------------------------------------------------------
> -------------------------------|
  |    COVID-19 with acute kidney injury   1 least deprived   0    0.4600     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury                  2   0    1.8563     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury                  3   0    1.5441     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury                  4   0    0.8706     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury    5 most deprived   0    5.7385     0
> .0e+00           .           . |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(126 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------+
  |            covid_acute_kidney_injury   baseli~t   D         Y        Rate  
>      Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------|
  | COVID-19 without acute kidney injury      15-29   1    0.0657     1.5e+01  
>    2.1e+00     1.1e+02 |
  | COVID-19 without acute kidney injury      30-44   0   11.1622     0.0e+00  
>          .           . |
  | COVID-19 without acute kidney injury      45-59   1   17.6674   0.0566016  
>  0.0079731   0.4018187 |
  | COVID-19 without acute kidney injury      60-74   1   15.4141   0.0648757  
>  0.0091386   0.4605570 |
  | COVID-19 without acute kidney injury      75-89   1   21.6838   0.0461174  
>  0.0064963   0.3273909 |
  |----------------------------------------------------------------------------
> -----------------------|
  | COVID-19 without acute kidney injury     90-104   3   22.9760   0.1305708  
>  0.0421119   0.4048438 |
  | COVID-19 without acute kidney injury       ≥105   2   38.5462   0.0518858  
>  0.0129765   0.2074621 |
  |    COVID-19 with acute kidney injury      30-44   0    0.4600     0.0e+00  
>          .           . |
  |    COVID-19 with acute kidney injury      45-59   0    0.7995     0.0e+00  
>          .           . |
  |    COVID-19 with acute kidney injury      60-74   0    1.7385     0.0e+00  
>          .           . |
  |----------------------------------------------------------------------------
> -----------------------|
  |    COVID-19 with acute kidney injury       ≥105   0    0.8706     0.0e+00  
>          .           . |
  +----------------------------------------------------------------------------
> -----------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------+
  |            covid_acute_kidney_injury   diabetes    D          Y        Rate
>        Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------|
  | COVID-19 without acute kidney injury          0   13   186.1930   0.0698200
>    0.0405414   0.1202433 |
  | COVID-19 without acute kidney injury          1    1    49.0869   0.0203720
>    0.0028697   0.1446224 |
  |    COVID-19 with acute kidney injury          0    0     8.2710     0.0e+00
>            .           . |
  |    COVID-19 with acute kidney injury          1    0     2.1985     0.0e+00
>            .           . |
  +----------------------------------------------------------------------------
> -------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/esrd_covid_acute_kidney_injury.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |    COVID-19 kidney
        if |  replacement therapy
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       204         15 |       219 
           |     94.88      83.33 |     93.99 
-----------+----------------------+----------
         1 |        11          3 |        14 
           |      5.12      16.67 |      6.01 
-----------+----------------------+----------
     Total |       215         18 |       233 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   3.9236   Pr = 0.048

         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                                   covid_krt    D          Y       Rate     
>  Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------|
  | COVID-19 without kidney replacement therapy   11   227.6906   0.048311   0.
> 026755   0.087236 |
  |    COVID-19 with kidney replacement therapy    3    18.0589   0.166123   0.
> 053578   0.515077 |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |                                   covid_krt   agegroup   D          Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without kidney replacement therapy     18-<50   3   123.9754   0.0
> 241984   0.0078045   0.0750287 |
  | COVID-19 without kidney replacement therapy     50-<60   3    39.3265   0.0
> 762845   0.0246034   0.2365253 |
  | COVID-19 without kidney replacement therapy     60-<70   1    32.9555   0.0
> 303439   0.0042744   0.2154138 |
  | COVID-19 without kidney replacement therapy     70-<80   3    20.5229   0.1
> 461780   0.0471455   0.4532349 |
  | COVID-19 without kidney replacement therapy        80+   1    10.9103   0.0
> 916562   0.0129110   0.6506740 |
  |----------------------------------------------------------------------------
> -------------------------------|
  |    COVID-19 with kidney replacement therapy     18-<50   2    13.1855   0.1
> 516819   0.0379353   0.6064907 |
  |    COVID-19 with kidney replacement therapy     50-<60   0     2.4914     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy     60-<70   1     0.0657     1
> .5e+01     2.1e+00     1.1e+02 |
  |    COVID-19 with kidney replacement therapy        80+   0     2.3162     0
> .0e+00           .           . |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                                   covid_krt     male   D          Y       R
> ate      Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  | COVID-19 without kidney replacement therapy   Female   4   124.4381   0.032
> 145   0.012064   0.085646 |
  | COVID-19 without kidney replacement therapy     Male   7   103.2526   0.067
> 795   0.032320   0.142207 |
  |    COVID-19 with kidney replacement therapy   Female   1     5.7522   0.173
> 846   0.024489   1.234144 |
  |    COVID-19 with kidney replacement therapy     Male   2    12.3066   0.162
> 514   0.040644   0.649802 |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------------------+
  |                                   covid_krt                ethnicity   D   
>        Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------------------------------|
  | COVID-19 without kidney replacement therapy                    White   6   
> 137.8672   0.0435201   0.0195519   0.0968706 |
  | COVID-19 without kidney replacement therapy   Asian or Asian British   4   
>  15.9425   0.2509016   0.0941678   0.6685043 |
  | COVID-19 without kidney replacement therapy                    Other   1   
>  22.1109   0.0452266   0.0063708   0.3210668 |
  | COVID-19 without kidney replacement therapy                  Unknown   0   
>  51.7700     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                    White   3   
>   9.8207   0.3054781   0.0985232   0.9471561 |
  |----------------------------------------------------------------------------
> ---------------------------------------------|
  |    COVID-19 with kidney replacement therapy   Asian or Asian British   0   
>   1.2402     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                    Other   0   
>   2.2368     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  Unknown   0   
>   4.7611     0.0e+00           .           . |
  +----------------------------------------------------------------------------
> ---------------------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------------+
  |                                   covid_krt                imd   D         
> Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------------|
  | COVID-19 without kidney replacement therapy   1 least deprived   3   40.824
> 1   0.0734860   0.0237008   0.2278485 |
  | COVID-19 without kidney replacement therapy                  2   1   47.485
> 3   0.0210592   0.0029665   0.1495005 |
  | COVID-19 without kidney replacement therapy                  3   1   45.727
> 6   0.0218686   0.0030805   0.1552470 |
  | COVID-19 without kidney replacement therapy                  4   5   40.391
> 5   0.1237884   0.0515242   0.2974054 |
  | COVID-19 without kidney replacement therapy    5 most deprived   1   53.262
> 1   0.0187751   0.0026447   0.1332855 |
  |----------------------------------------------------------------------------
> --------------------------------------|
  |    COVID-19 with kidney replacement therapy   1 least deprived   1    5.511
> 3   0.1814456   0.0255591     1.3e+00 |
  |    COVID-19 with kidney replacement therapy                  2   0    2.086
> 2     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  3   0    6.064
> 3     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  4   1    3.236
> 1   0.3090102   0.0435282     2.2e+00 |
  |    COVID-19 with kidney replacement therapy    5 most deprived   1    1.160
> 8   0.8614387   0.1213453     6.1e+00 |
  +----------------------------------------------------------------------------
> --------------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(126 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------+
  |                                   covid_krt   baseli~t   D         Y       
>  Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------------|
  | COVID-19 without kidney replacement therapy      30-44   0   11.6222     0.
> 0e+00           .           . |
  | COVID-19 without kidney replacement therapy      45-59   1   16.5257   0.06
> 05119   0.0085239   0.4295785 |
  | COVID-19 without kidney replacement therapy      60-74   1   15.7974   0.06
> 33016   0.0089169   0.4493823 |
  | COVID-19 without kidney replacement therapy      75-89   1   20.7228   0.04
> 82560   0.0067975   0.3425731 |
  | COVID-19 without kidney replacement therapy     90-104   3   21.7002   0.13
> 82475   0.0445878   0.4286461 |
  |----------------------------------------------------------------------------
> ------------------------------|
  | COVID-19 without kidney replacement therapy       ≥105   1   35.6988   0.02
> 80121   0.0039459   0.1988600 |
  |    COVID-19 with kidney replacement therapy      15-29   1    0.0657     1.
> 5e+01     2.1e+00     1.1e+02 |
  |    COVID-19 with kidney replacement therapy      45-59   0    1.9411     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      60-74   0    1.3552     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      75-89   0    0.9610     0.
> 0e+00           .           . |
  |----------------------------------------------------------------------------
> ------------------------------|
  |    COVID-19 with kidney replacement therapy     90-104   0    1.2758     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy       ≥105   1    3.7180   0.26
> 89617   0.0378869     1.9e+00 |
  +----------------------------------------------------------------------------
> ------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |                                   covid_krt   diabetes    D          Y     
>    Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  | COVID-19 without kidney replacement therapy          0   10   179.7372   0.
> 0556368   0.0299356   0.1034036 |
  | COVID-19 without kidney replacement therapy          1    1    47.9535   0.
> 0208536   0.0029375   0.1480409 |
  |    COVID-19 with kidney replacement therapy          0    3    14.7269   0.
> 2037089   0.0657005   0.6316135 |
  |    COVID-19 with kidney replacement therapy          1    0     3.3320     
> 0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/esrd_covid_krt.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |             Vaccination status
  censored | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         6         13         51        149 |       219 
           |    100.00     100.00      92.73      93.71 |     93.99 
-----------+--------------------------------------------+----------
         1 |         0          0          4         10 |        14 
           |      0.00       0.00       7.27       6.29 |      6.01 
-----------+--------------------------------------------+----------
     Total |         6         13         55        159 |       233 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.3924   Pr = 0.707

         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------+
  |                 covid_vax_status    D          Y       Rate      Lower     
>  Upper |
  |----------------------------------------------------------------------------
> -------|
  |  SARS-CoV-2 after 1 vaccine dose    0     5.1034   0.000000          .     
>      . |
  | SARS-CoV-2 after 2 vaccine doses    0    14.1355   0.000000          .     
>      . |
  | SARS-CoV-2 after 3 vaccine doses    4    59.2526   0.067508   0.025337   0.
> 179868 |
  | SARS-CoV-2 after 4 vaccine doses   10   167.2580   0.059788   0.032169   0.
> 111119 |
  +----------------------------------------------------------------------------
> -------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |                 covid_vax_status   agegroup   D         Y        Rate      
>  Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------|
  |  SARS-CoV-2 after 1 vaccine dose     18-<50   0    3.1513     0.0e+00      
>      .           . |
  |  SARS-CoV-2 after 1 vaccine dose     60-<70   0    1.9521     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses     18-<50   0    4.4545     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses     50-<60   0    1.6235     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses     60-<70   0    1.7002     0.0e+00      
>      .           . |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 2 vaccine doses     70-<80   0    3.4990     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses        80+   0    2.8583     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses     18-<50   2   37.3060   0.0536107   0.0
> 134079   0.2143592 |
  | SARS-CoV-2 after 3 vaccine doses     50-<60   0    9.9110     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses     60-<70   1    6.7543   0.1480543   0.0
> 208554     1.1e+00 |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 3 vaccine doses     70-<80   0    0.8378     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses        80+   1    4.4435   0.2250462   0.0
> 317008     1.6e+00 |
  | SARS-CoV-2 after 4 vaccine doses     18-<50   3   92.2491   0.0325206   0.0
> 104886   0.1008325 |
  | SARS-CoV-2 after 4 vaccine doses     50-<60   3   30.2834   0.0990643   0.0
> 319504   0.3071557 |
  | SARS-CoV-2 after 4 vaccine doses     60-<70   1   22.6146   0.0442191   0.0
> 062289   0.3139147 |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 4 vaccine doses     70-<80   3   16.1862   0.1853434   0.0
> 597772   0.5746700 |
  | SARS-CoV-2 after 4 vaccine doses        80+   0    5.9247     0.0e+00      
>      .           . |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------+
  |                 covid_vax_status     male   D         Y       Rate      Low
> er      Upper |
  |----------------------------------------------------------------------------
> --------------|
  |  SARS-CoV-2 after 1 vaccine dose   Female   0    1.4100   0.000000         
>  .          . |
  |  SARS-CoV-2 after 1 vaccine dose     Male   0    3.6934   0.000000         
>  .          . |
  | SARS-CoV-2 after 2 vaccine doses   Female   0   10.6913   0.000000         
>  .          . |
  | SARS-CoV-2 after 2 vaccine doses     Male   0    3.4442   0.000000         
>  .          . |
  | SARS-CoV-2 after 3 vaccine doses   Female   2   33.3224   0.060020   0.0150
> 11   0.239985 |
  |----------------------------------------------------------------------------
> --------------|
  | SARS-CoV-2 after 3 vaccine doses     Male   2   25.9302   0.077130   0.0192
> 90   0.308400 |
  | SARS-CoV-2 after 4 vaccine doses   Female   3   84.7666   0.035391   0.0114
> 14   0.109733 |
  | SARS-CoV-2 after 4 vaccine doses     Male   7   82.4914   0.084857   0.0404
> 54   0.177997 |
  +----------------------------------------------------------------------------
> --------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------+
  |                 covid_vax_status                ethnicity   D         Y    
>     Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------------------|
  |  SARS-CoV-2 after 1 vaccine dose                    White   0    1.8891    
>  0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                    Other   0    0.3559    
>  0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                  Unknown   0    2.8583    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    White   0    8.3559    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    Other   0    5.0568    
>  0.0e+00           .           . |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  Unknown   0    0.7228    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                    White   4   38.1793   0
> .1047687   0.0393216   0.2791467 |
  | SARS-CoV-2 after 3 vaccine doses   Asian or Asian British   0    2.6639    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                    Other   0    3.0089    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                  Unknown   0   15.4004    
>  0.0e+00           .           . |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 after 4 vaccine doses                    White   5   99.2635   0
> .0503710   0.0209658   0.1210178 |
  | SARS-CoV-2 after 4 vaccine doses   Asian or Asian British   4   14.5188   0
> .2755044   0.1034017   0.7340563 |
  | SARS-CoV-2 after 4 vaccine doses                    Other   1   15.9261   0
> .0627901   0.0088448   0.4457514 |
  | SARS-CoV-2 after 4 vaccine doses                  Unknown   0   37.5496    
>  0.0e+00           .           . |
  +----------------------------------------------------------------------------
> ---------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------+
  |                 covid_vax_status                imd   D         Y        Ra
> te       Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------------|
  |  SARS-CoV-2 after 1 vaccine dose   1 least deprived   0    1.9685     0.0e+
> 00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                  4   0    3.1348     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 2 vaccine doses   1 least deprived   0    2.6667     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                  2   0    2.4230     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                  3   0    6.3463     0.0e+
> 00           .           . |
  |----------------------------------------------------------------------------
> ---------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  4   0    0.6899     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 2 vaccine doses    5 most deprived   0    2.0096     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 3 vaccine doses   1 least deprived   2    9.6591   0.20705
> 78   0.0517847   0.8279079 |
  | SARS-CoV-2 after 3 vaccine doses                  2   1   17.1855   0.05818
> 86   0.0081967   0.4130852 |
  | SARS-CoV-2 after 3 vaccine doses                  3   0    9.8590     0.0e+
> 00           .           . |
  |----------------------------------------------------------------------------
> ---------------------------|
  | SARS-CoV-2 after 3 vaccine doses                  4   1   11.2799   0.08865
> 29   0.0124880   0.6293534 |
  | SARS-CoV-2 after 3 vaccine doses    5 most deprived   0   11.2690     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 4 vaccine doses   1 least deprived   2   32.0411   0.06241
> 99   0.0156111   0.2495821 |
  | SARS-CoV-2 after 4 vaccine doses                  2   0   29.9630     0.0e+
> 00           .           . |
  | SARS-CoV-2 after 4 vaccine doses                  3   1   35.5866   0.02810
> 05   0.0039583   0.1994873 |
  |----------------------------------------------------------------------------
> ---------------------------|
  | SARS-CoV-2 after 4 vaccine doses                  4   5   28.5229   0.17529
> 76   0.0729637   0.4211577 |
  | SARS-CoV-2 after 4 vaccine doses    5 most deprived   2   41.1444   0.04860
> 93   0.0121571   0.1943611 |
  +----------------------------------------------------------------------------
> ---------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(126 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |                 covid_vax_status   baseli~t   D         Y        Rate      
>  Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------|
  |  SARS-CoV-2 after 1 vaccine dose      60-74   0    1.9521     0.0e+00      
>      .           . |
  |  SARS-CoV-2 after 1 vaccine dose       ≥105   0    1.9685     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses      30-44   0    2.9131     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses      75-89   0    2.7543     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 2 vaccine doses       ≥105   0    3.3457     0.0e+00      
>      .           . |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 3 vaccine doses      30-44   0    3.7016     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses      45-59   0    6.2560     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses      60-74   0    6.2012     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 3 vaccine doses      75-89   1    9.4921   0.1053504   0.0
> 148400   0.7478903 |
  | SARS-CoV-2 after 3 vaccine doses     90-104   0    5.6646     0.0e+00      
>      .           . |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 3 vaccine doses       ≥105   1    5.5469   0.1802813   0.0
> 253951     1.3e+00 |
  | SARS-CoV-2 after 4 vaccine doses      15-29   1    0.0657     1.5e+01     2
> .1e+00     1.1e+02 |
  | SARS-CoV-2 after 4 vaccine doses      30-44   0    5.0075     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 4 vaccine doses      45-59   1   12.2108   0.0818946   0.0
> 115360   0.5813757 |
  | SARS-CoV-2 after 4 vaccine doses      60-74   1    8.9993   0.1111196   0.0
> 156527   0.7888457 |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 after 4 vaccine doses      75-89   0    9.4374     0.0e+00      
>      .           . |
  | SARS-CoV-2 after 4 vaccine doses     90-104   3   17.3114   0.1732959   0.0
> 558916   0.5373160 |
  | SARS-CoV-2 after 4 vaccine doses       ≥105   1   28.5558   0.0350192   0.0
> 049329   0.2486036 |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                 covid_vax_status   diabetes   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  |  SARS-CoV-2 after 1 vaccine dose          0   0     3.2142     0.0e+00     
>       .           . |
  |  SARS-CoV-2 after 1 vaccine dose          1   0     1.8891     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses          0   0    12.7146     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses          1   0     1.4209     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses          0   4    45.7358   0.0874588   0.
> 0328249   0.2330261 |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 3 vaccine doses          1   0    13.5168     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 4 vaccine doses          0   9   132.7995   0.0677714   0.
> 0352624   0.1302507 |
  | SARS-CoV-2 after 4 vaccine doses          1   1    34.4586   0.0290203   0.
> 0040879   0.2060175 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/esrd_covid_vax_status.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |                    Calendar period
  censored | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        61         20         34         38         59 |       219 
           |     91.04      90.91      94.44      92.68      98.33 |     93.99 
-----------+-------------------------------------------------------+----------
         1 |         6          2          2          3          1 |        14 
           |      8.96       9.09       5.56       7.32       1.67 |      6.01 
-----------+-------------------------------------------------------+----------
     Total |        67         22         36         41         60 |       233 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


      1 if |
failure; 0 |  Calendar
        if |   period
  censored | December  |     Total
-----------+-----------+----------
         0 |         7 |       219 
           |    100.00 |     93.99 
-----------+-----------+----------
         1 |         0 |        14 
           |      0.00 |      6.01 
-----------+-----------+----------
     Total |         7 |       233 
           |    100.00 |    100.00 

          Pearson chi2(5) =   3.9879   Pr = 0.551

         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------+
  |                 calendar_period   D          Y        Rate       Lower     
>   Upper |
  |----------------------------------------------------------------------------
> --------|
  |      February 2020 to June 2020   6   106.0999   0.0565505   0.0254059   0.
> 1258745 |
  |        July 2020 to August 2020   2    29.2074   0.0684758   0.0171256   0.
> 2737963 |
  | September 2020 to November 2020   2    41.1389   0.0486157   0.0121587   0.
> 1943870 |
  |  December 2020 to February 2021   3    37.6947   0.0795867   0.0256684   0.
> 2467641 |
  |     March 2021 to November 2021   1    31.2635   0.0319862   0.0045057   0.
> 2270721 |
  |----------------------------------------------------------------------------
> --------|
  |   December 2021 to January 2022   0     0.3450     0.0e+00           .     
>       . |
  +----------------------------------------------------------------------------
> --------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 calendar_period   agegroup   D         Y        Rate       
> Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |      February 2020 to June 2020     18-<50   2   53.0513   0.0376993   0.00
> 94285   0.1507385 |
  |      February 2020 to June 2020     50-<60   2   24.0055   0.0833143   0.02
> 08367   0.3331272 |
  |      February 2020 to June 2020     60-<70   0   21.1472     0.0e+00       
>     .           . |
  |      February 2020 to June 2020     70-<80   2    6.2231   0.3213814   0.08
> 03767     1.3e+00 |
  |      February 2020 to June 2020        80+   0    1.6728     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |        July 2020 to August 2020     18-<50   1   12.9336   0.0773180   0.01
> 08913   0.5488857 |
  |        July 2020 to August 2020     50-<60   0    5.6810     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     60-<70   0    4.1862     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     70-<80   0    4.4025     0.0e+00       
>     .           . |
  |        July 2020 to August 2020        80+   1    2.0041   0.4989754   0.07
> 02874     3.5e+00 |
  |----------------------------------------------------------------------------
> ------------------|
  | September 2020 to November 2020     18-<50   0   29.4100     0.0e+00       
>     .           . |
  | September 2020 to November 2020     50-<60   0    3.6167     0.0e+00       
>     .           . |
  | September 2020 to November 2020     60-<70   1    1.7248   0.5797619   0.08
> 16673     4.1e+00 |
  | September 2020 to November 2020     70-<80   1    3.8631   0.2588590   0.03
> 64638     1.8e+00 |
  | September 2020 to November 2020        80+   0    2.5243     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |  December 2020 to February 2021     18-<50   2   24.5284   0.0815381   0.02
> 03925   0.3260251 |
  |  December 2020 to February 2021     50-<60   0    4.6215     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     60-<70   1    3.0363   0.3293508   0.04
> 63935     2.3e+00 |
  |  December 2020 to February 2021     70-<80   0    2.5982     0.0e+00       
>     .           . |
  |  December 2020 to February 2021        80+   0    2.9103     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |     March 2021 to November 2021     18-<50   0   17.0349     0.0e+00       
>     .           . |
  |     March 2021 to November 2021     50-<60   1    3.8001   0.2631484   0.03
> 70680     1.9e+00 |
  |     March 2021 to November 2021     60-<70   0    2.9268     0.0e+00       
>     .           . |
  |     March 2021 to November 2021     70-<80   0    3.4086     0.0e+00       
>     .           . |
  |     March 2021 to November 2021        80+   0    4.0931     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |   December 2021 to January 2022     18-<50   0    0.2026     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     50-<60   0    0.0931     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     70-<80   0    0.0274     0.0e+00       
>     .           . |
  |   December 2021 to January 2022        80+   0    0.0219     0.0e+00       
>     .           . |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 calendar_period     male   D         Y        Rate       Lo
> wer       Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020   Female   1   51.6578   0.0193582   0.0027
> 269   0.1374250 |
  |      February 2020 to June 2020     Male   5   54.4422   0.0918406   0.0382
> 266   0.2206498 |
  |        July 2020 to August 2020   Female   1   14.6557   0.0682328   0.0096
> 115   0.4843893 |
  |        July 2020 to August 2020     Male   1   14.5517   0.0687206   0.0096
> 802   0.4878525 |
  | September 2020 to November 2020   Female   1   25.3936   0.0393801   0.0055
> 472   0.2795618 |
  |----------------------------------------------------------------------------
> ----------------|
  | September 2020 to November 2020     Male   1   15.7454   0.0635107   0.0089
> 463   0.4508669 |
  |  December 2020 to February 2021   Female   1   22.0835   0.0452827   0.0063
> 787   0.3214649 |
  |  December 2020 to February 2021     Male   2   15.6112   0.1281129   0.0320
> 407   0.5122517 |
  |     March 2021 to November 2021   Female   1   16.2738   0.0614485   0.0086
> 559   0.4362274 |
  |     March 2021 to November 2021     Male   0   14.9897     0.0e+00         
>   .           . |
  |----------------------------------------------------------------------------
> ----------------|
  |   December 2021 to January 2022   Female   0    0.1259     0.0e+00         
>   .           . |
  |   December 2021 to January 2022     Male   0    0.2190     0.0e+00         
>   .           . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |                 calendar_period                ethnicity   D         Y     
>    Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  |      February 2020 to June 2020                    White   3   64.7995   0.
> 0462967   0.0149317   0.1435461 |
  |      February 2020 to June 2020   Asian or Asian British   2   10.8255   0.
> 1847496   0.0462054   0.7387099 |
  |      February 2020 to June 2020                    Other   1   12.1588   0.
> 0822450   0.0115853   0.5838631 |
  |      February 2020 to June 2020                  Unknown   0   18.3162     
> 0.0e+00           .           . |
  |        July 2020 to August 2020                    White   1   19.1376   0.
> 0522532   0.0073606   0.3709493 |
  |----------------------------------------------------------------------------
> --------------------------------|
  |        July 2020 to August 2020   Asian or Asian British   1    0.3751     
> 2.7e+00   0.3755503     1.9e+01 |
  |        July 2020 to August 2020                  Unknown   0    9.6947     
> 0.0e+00           .           . |
  | September 2020 to November 2020                    White   2   22.5298   0.
> 0887714   0.0222015   0.3549470 |
  | September 2020 to November 2020   Asian or Asian British   0    1.2402     
> 0.0e+00           .           . |
  | September 2020 to November 2020                    Other   0    7.4634     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  | September 2020 to November 2020                  Unknown   0    9.9055     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                    White   2   24.3094   0.
> 0822728   0.0205762   0.3289626 |
  |  December 2020 to February 2021   Asian or Asian British   1    2.1520   0.
> 4646947   0.0654585     3.3e+00 |
  |  December 2020 to February 2021                    Other   0    0.9610     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                  Unknown   0   10.2724     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |     March 2021 to November 2021                    White   1   16.6379   0.
> 0601037   0.0084664   0.4266802 |
  |     March 2021 to November 2021   Asian or Asian British   0    2.5900     
> 0.0e+00           .           . |
  |     March 2021 to November 2021                    Other   0    3.7344     
> 0.0e+00           .           . |
  |     March 2021 to November 2021                  Unknown   0    8.3012     
> 0.0e+00           .           . |
  |   December 2021 to January 2022                    White   0    0.2738     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |   December 2021 to January 2022                    Other   0    0.0301     
> 0.0e+00           .           . |
  |   December 2021 to January 2022                  Unknown   0    0.0411     
> 0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                 calendar_period                imd   D         Y        Rat
> e       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  |      February 2020 to June 2020   1 least deprived   1   15.1923   0.065822
> 7   0.0092720   0.4672798 |
  |      February 2020 to June 2020                  2   0   19.0527     0.0e+0
> 0           .           . |
  |      February 2020 to June 2020                  3   1   24.5667   0.040705
> 4   0.0057339   0.2889709 |
  |      February 2020 to June 2020                  4   4   16.8542   0.237329
> 4   0.0890740   0.6323425 |
  |      February 2020 to June 2020    5 most deprived   0   30.4339     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |        July 2020 to August 2020   1 least deprived   0    5.6920     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  2   1    8.9966   0.111153
> 4   0.0156575   0.7890858 |
  |        July 2020 to August 2020                  3   0    8.4162     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  4   1    3.2717   0.305648
> 5   0.0430547     2.2e+00 |
  |        July 2020 to August 2020    5 most deprived   0    2.8309     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  | September 2020 to November 2020   1 least deprived   2   14.1848   0.140995
> 9   0.0352628   0.5637636 |
  | September 2020 to November 2020                  2   0    8.9993     0.0e+0
> 0           .           . |
  | September 2020 to November 2020                  3   0    5.8946     0.0e+0
> 0           .           . |
  | September 2020 to November 2020                  4   0    8.5503     0.0e+0
> 0           .           . |
  | September 2020 to November 2020    5 most deprived   0    3.5099     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |  December 2020 to February 2021   1 least deprived   1    6.6037   0.151430
> 3   0.0213310     1.1e+00 |
  |  December 2020 to February 2021                  2   0    4.9446     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  3   0    7.6851     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  4   0    7.8795     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021    5 most deprived   2   10.5818   0.189003
> 9   0.0472694   0.7557203 |
  |----------------------------------------------------------------------------
> --------------------------|
  |     March 2021 to November 2021   1 least deprived   0    4.5065     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  2   0    7.4935     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  3   0    5.1554     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  4   1    7.0719   0.141405
> 3   0.0199189     1.0e+00 |
  |     March 2021 to November 2021    5 most deprived   0    7.0363     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |   December 2021 to January 2022   1 least deprived   0    0.1561     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  2   0    0.0849     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  3   0    0.0739     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022    5 most deprived   0    0.0301     0.0e+0
> 0           .           . |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(126 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 calendar_period   baseli~t   D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020      30-44   0    5.4894   0.000000        
>   .          . |
  |      February 2020 to June 2020      45-59   0    9.9302   0.000000        
>   .          . |
  |      February 2020 to June 2020      60-74   1   10.4668   0.095540   0.013
> 458   0.678246 |
  |      February 2020 to June 2020      75-89   0   11.8987   0.000000        
>   .          . |
  |      February 2020 to June 2020     90-104   1   11.4196   0.087569   0.012
> 335   0.621658 |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020       ≥105   0   13.6701   0.000000        
>   .          . |
  |        July 2020 to August 2020      45-59   0    1.4839   0.000000        
>   .          . |
  |        July 2020 to August 2020      60-74   0    2.7242   0.000000        
>   .          . |
  |        July 2020 to August 2020      75-89   0    1.3826   0.000000        
>   .          . |
  |        July 2020 to August 2020     90-104   1    1.7577   0.568925   0.080
> 141   4.038841 |
  |----------------------------------------------------------------------------
> ---------------|
  |        July 2020 to August 2020       ≥105   0    1.3662   0.000000        
>   .          . |
  | September 2020 to November 2020      30-44   0    3.6906   0.000000        
>   .          . |
  | September 2020 to November 2020      45-59   0    1.2485   0.000000        
>   .          . |
  | September 2020 to November 2020      60-74   0    1.3169   0.000000        
>   .          . |
  | September 2020 to November 2020      75-89   1    5.2129   0.191833   0.027
> 022   1.361836 |
  |----------------------------------------------------------------------------
> ---------------|
  | September 2020 to November 2020     90-104   1    3.9754   0.251550   0.035
> 434   1.785768 |
  | September 2020 to November 2020       ≥105   0    7.2115   0.000000        
>   .          . |
  |  December 2020 to February 2021      15-29   1    0.0657    1.5e+01   2.143
> 766    1.1e+02 |
  |  December 2020 to February 2021      45-59   0    2.0123   0.000000        
>   .          . |
  |  December 2020 to February 2021      60-74   0    0.8460   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |  December 2020 to February 2021      75-89   0    1.9795   0.000000        
>   .          . |
  |  December 2020 to February 2021     90-104   0    4.0438   0.000000        
>   .          . |
  |  December 2020 to February 2021       ≥105   2    9.5551   0.209312   0.052
> 349   0.836922 |
  |     March 2021 to November 2021      30-44   0    2.4422   0.000000        
>   .          . |
  |     March 2021 to November 2021      45-59   1    3.7919   0.263718   0.037
> 148   1.872156 |
  |----------------------------------------------------------------------------
> ---------------|
  |     March 2021 to November 2021      60-74   0    1.7988   0.000000        
>   .          . |
  |     March 2021 to November 2021      75-89   0    1.2101   0.000000        
>   .          . |
  |     March 2021 to November 2021     90-104   0    1.7495   0.000000        
>   .          . |
  |     March 2021 to November 2021       ≥105   0    7.6140   0.000000        
>   .          . |
  |   December 2021 to January 2022     90-104   0    0.0301   0.000000        
>   .          . |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(233 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 calendar_period   diabetes   D         Y        Rate       
> Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |      February 2020 to June 2020          0   5   78.9624   0.0633213   0.02
> 63561   0.1521314 |
  |      February 2020 to June 2020          1   1   27.1376   0.0368493   0.00
> 51907   0.2615956 |
  |        July 2020 to August 2020          0   2   26.4394   0.0756446   0.01
> 89185   0.3024603 |
  |        July 2020 to August 2020          1   0    2.7680     0.0e+00       
>     .           . |
  | September 2020 to November 2020          0   2   32.4517   0.0616300   0.01
> 54135   0.2464236 |
  |----------------------------------------------------------------------------
> ------------------|
  | September 2020 to November 2020          1   0    8.6872     0.0e+00       
>     .           . |
  |  December 2020 to February 2021          0   3   30.1766   0.0994148   0.03
> 20634   0.3082425 |
  |  December 2020 to February 2021          1   0    7.5181     0.0e+00       
>     .           . |
  |     March 2021 to November 2021          0   1   26.1191   0.0382862   0.00
> 53931   0.2717962 |
  |     March 2021 to November 2021          1   0    5.1444     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |   December 2021 to January 2022          0   0    0.3149     0.0e+00       
>     .           . |
  |   December 2021 to January 2022          1   0    0.0301     0.0e+00       
>     .           . |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  esrd_date
   analysis time _t:  (exit_date-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/esrd_calendar_period.svg written in SVG format)

. 
. * 50% reduction in eGFR (stratified)
. stset exit_date_egfr_reduction, fail(egfr_reduction50_outcome_date) origin(in
> dex_date_egfr_reduction) id(patient_id) scale(365.25)

                id:  patient_id
     failure event:  egfr_reduction50_outcome_date != 0 & egfr_reduction50_outc
> ome_date < .
obs. time interval:  (exit_date_egfr_reduction[_n-1], exit_date_egfr_reduction]
 exit on or before:  failure
    t for analysis:  (time-origin)/365.25
            origin:  time index_date_egfr_reduction

------------------------------------------------------------------------------
        276  total observations
        124  ignored because never entered
         19  observations end on or before enter()
------------------------------------------------------------------------------
        133  observations remaining, representing
        133  subjects
         62  failures in single-failure-per-subject data
    100.758  total analysis time at risk and under observation
                                                at risk from t =         0
                                     earliest observed entry t =         0
                                          last observed exit t =  1.891855

. foreach stratum of varlist      covid_severity                          ///
>                                                         covid_acute_kidney_in
> jury       ///
>                                                         covid_krt            
>                            ///
>                                                         covid_vax_status     
>                    ///
>                                                         calendar_period {
  2.         tab _d `stratum', col chi
  3.         strate `stratum'
  4.         strate `stratum' agegroup
  5.         strate `stratum' male
  6.         strate `stratum' ethnicity
  7.         strate `stratum' imd
  8.         strate `stratum' baseline_egfr_cat
  9.         strate `stratum' diabetes
 10.         sts graph, failure by(`stratum') title(Cumulative 50% eGFR reducti
> on after SARS-CoV-2 survival by `stratum') ylab(0(0.02)0.20, angle(horizontal
> )) ytitle(Cumulative 50% eGFR reduction) xtitle(Follow-up (years))
 11.         graph export ./output/egfr_reduction_`stratum'.svg,  replace
 12.         }

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |       SARS-CoV-2 severity
  censored | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |         8          0         63 |        71 
           |     57.14       0.00      53.39 |     53.38 
-----------+---------------------------------+----------
         1 |         6          1         55 |        62 
           |     42.86     100.00      46.61 |     46.62 
-----------+---------------------------------+----------
     Total |        14          1        118 |       133 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   1.2247   Pr = 0.542

         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ------+
  |                     covid_severity    D         Y       Rate     Lower     
> Upper |
  |----------------------------------------------------------------------------
> ------|
  | SARS-CoV-2 without hospitalisation    6   10.8282    0.55411   0.24894   1.
> 23338 |
  |      COVID-19 with hospitalisation    1    0.0575   17.39286   2.45002   1.
> 2e+02 |
  |        COVID-19 with critical care   55   89.8727    0.61198   0.46985   0.
> 79710 |
  +----------------------------------------------------------------------------
> ------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |                     covid_severity   agegroup    D         Y       Rate    
>   Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 without hospitalisation     18-<50    2    6.7132   0.297920   0
> .074509   1.191215 |
  | SARS-CoV-2 without hospitalisation     50-<60    3    3.6824   0.814684   0
> .262753   2.525984 |
  | SARS-CoV-2 without hospitalisation     60-<70    0    0.2272   0.000000    
>       .          . |
  | SARS-CoV-2 without hospitalisation     70-<80    1    0.2053   4.870000   0
> .686005    3.5e+01 |
  |      COVID-19 with hospitalisation     50-<60    1    0.0575    1.7e+01   2
> .450019    1.2e+02 |
  |----------------------------------------------------------------------------
> -------------------|
  |        COVID-19 with critical care     18-<50   26   47.8877   0.542936   0
> .369670   0.797413 |
  |        COVID-19 with critical care     50-<60   10   10.1383   0.986362   0
> .530717   1.833201 |
  |        COVID-19 with critical care     60-<70    7   13.7221   0.510126   0
> .243194   1.070043 |
  |        COVID-19 with critical care     70-<80    7   13.1773   0.531218   0
> .253249   1.114285 |
  |        COVID-19 with critical care        80+    5    4.9473   1.010653   0
> .420662   2.428125 |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------+
  |                     covid_severity     male    D         Y       Rate      
> Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 without hospitalisation   Female    4    4.3477   0.920025   0.3
> 45302   2.451323 |
  | SARS-CoV-2 without hospitalisation     Male    2    6.4805   0.308619   0.0
> 77185   1.233992 |
  |      COVID-19 with hospitalisation   Female    1    0.0575    1.7e+01   2.4
> 50019    1.2e+02 |
  |        COVID-19 with critical care   Female   29   44.9692   0.644886   0.4
> 48145   0.927998 |
  |        COVID-19 with critical care     Male   26   44.9035   0.579020   0.3
> 94238   0.850409 |
  +----------------------------------------------------------------------------
> -----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------+
  |                     covid_severity                ethnicity    D         Y 
>       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 without hospitalisation                    White    2    7.2717 
>   0.275038   0.068786   1.099721 |
  | SARS-CoV-2 without hospitalisation   Asian or Asian British    2    0.3176 
>   6.297414   1.574968    2.5e+01 |
  | SARS-CoV-2 without hospitalisation                    Other    0    0.2272 
>   0.000000          .          . |
  | SARS-CoV-2 without hospitalisation                  Unknown    2    3.0116 
>   0.664091   0.166088   2.655326 |
  |      COVID-19 with hospitalisation                    White    1    0.0575 
>    1.7e+01   2.450019    1.2e+02 |
  |----------------------------------------------------------------------------
> ---------------------------------|
  |        COVID-19 with critical care                    White   38   56.7721 
>   0.669343   0.487041   0.919882 |
  |        COVID-19 with critical care   Asian or Asian British    3    5.5934 
>   0.536344   0.172982   1.662971 |
  |        COVID-19 with critical care                    Other    3    8.8816 
>   0.337777   0.108940   1.047302 |
  |        COVID-19 with critical care                  Unknown   11   18.6256 
>   0.590585   0.327066   1.066423 |
  +----------------------------------------------------------------------------
> ---------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                     covid_severity                imd    D         Y       
> Rate     Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  | SARS-CoV-2 without hospitalisation   1 least deprived    2    3.0965    0.6
> 4589   0.16154    2.58255 |
  | SARS-CoV-2 without hospitalisation                  2    0    2.0835    0.0
> 0000         .          . |
  | SARS-CoV-2 without hospitalisation                  3    2    0.4052    4.9
> 3581   1.23443   19.73553 |
  | SARS-CoV-2 without hospitalisation                  4    0    1.4593    0.0
> 0000         .          . |
  | SARS-CoV-2 without hospitalisation    5 most deprived    2    3.7837    0.5
> 2858   0.13220    2.11350 |
  |----------------------------------------------------------------------------
> --------------------------|
  |      COVID-19 with hospitalisation                  4    1    0.0575   17.3
> 9286   2.45002    1.2e+02 |
  |        COVID-19 with critical care   1 least deprived   12   18.9432    0.6
> 3347   0.35976    1.11545 |
  |        COVID-19 with critical care                  2   11   17.3552    0.6
> 3381   0.35101    1.14448 |
  |        COVID-19 with critical care                  3   13   22.2615    0.5
> 8397   0.33909    1.00570 |
  |        COVID-19 with critical care                  4    6   16.8542    0.3
> 5599   0.15993    0.79240 |
  |----------------------------------------------------------------------------
> --------------------------|
  |        COVID-19 with critical care    5 most deprived   13   14.4586    0.8
> 9912   0.52208    1.54845 |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |                     covid_severity   baseli~t    D         Y       Rate    
>   Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------|
  | SARS-CoV-2 without hospitalisation      45-59    0    4.3149   0.000000    
>       .          . |
  | SARS-CoV-2 without hospitalisation      75-89    1    1.9138   0.522532   0
> .073606   3.709493 |
  | SARS-CoV-2 without hospitalisation     90-104    1    3.9973   0.250171   0
> .035240   1.775983 |
  | SARS-CoV-2 without hospitalisation       ≥105    4    0.6023   6.640909   2
> .492452    1.8e+01 |
  |      COVID-19 with hospitalisation      45-59    1    0.0575    1.7e+01   2
> .450019    1.2e+02 |
  |----------------------------------------------------------------------------
> -------------------|
  |        COVID-19 with critical care      15-29    1    0.0657    1.5e+01   2
> .143766    1.1e+02 |
  |        COVID-19 with critical care      30-44    0   11.6222   0.000000    
>       .          . |
  |        COVID-19 with critical care      45-59    0   14.0945   0.000000    
>       .          . |
  |        COVID-19 with critical care      60-74    4   15.6030   0.256361   0
> .096217   0.683050 |
  |        COVID-19 with critical care      75-89    7   14.4695   0.483775   0
> .230632   1.014769 |
  |----------------------------------------------------------------------------
> -------------------|
  |        COVID-19 with critical care     90-104   13   13.6975   0.949081   0
> .551090   1.634496 |
  |        COVID-19 with critical care       ≥105   30   20.3203   1.476354   1
> .032246   2.111533 |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------+
  |                     covid_severity   diabetes    D         Y       Rate    
>  Lower     Upper |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 without hospitalisation          0    6    8.9500    0.67039   0
> .30118   1.49220 |
  | SARS-CoV-2 without hospitalisation          1    0    1.8782    0.00000    
>      .         . |
  |      COVID-19 with hospitalisation          0    1    0.0575   17.39286   2
> .45002   1.2e+02 |
  |        COVID-19 with critical care          0   45   67.6222    0.66546   0
> .49686   0.89128 |
  |        COVID-19 with critical care          1   10   22.2505    0.44943   0
> .24182   0.83528 |
  +----------------------------------------------------------------------------
> -----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id
(file ./output/egfr_reduction_covid_severity.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 | COVID-19 acute kidney
        if |        injury
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |        69          2 |        71 
           |     53.49      50.00 |     53.38 
-----------+----------------------+----------
         1 |        60          2 |        62 
           |     46.51      50.00 |     46.62 
-----------+----------------------+----------
     Total |       129          4 |       133 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0190   Pr = 0.890

         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------+
  |            covid_acute_kidney_injury    D         Y      Rate     Lower    
>  Upper |
  |----------------------------------------------------------------------------
> -------|
  | COVID-19 without acute kidney injury   60   97.3963   0.61604   0.47832   0
> .79341 |
  |    COVID-19 with acute kidney injury    2    3.3621   0.59487   0.14878   2
> .37855 |
  +----------------------------------------------------------------------------
> -------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------+
  |            covid_acute_kidney_injury   agegroup    D         Y       Rate  
>     Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------|
  | COVID-19 without acute kidney injury     18-<50   27   52.9062   0.510337  
>  0.349980   0.744168 |
  | COVID-19 without acute kidney injury     50-<60   14   13.0787   1.070442  
>  0.633972   1.807408 |
  | COVID-19 without acute kidney injury     60-<70    7   13.9493   0.501816  
>  0.239232   1.052611 |
  | COVID-19 without acute kidney injury     70-<80    7   12.5147   0.559342  
>  0.266657   1.173278 |
  | COVID-19 without acute kidney injury        80+    5    4.9473   1.010653  
>  0.420662   2.428125 |
  |----------------------------------------------------------------------------
> ---------------------|
  |    COVID-19 with acute kidney injury     18-<50    1    1.6947   0.590065  
>  0.083119   4.188911 |
  |    COVID-19 with acute kidney injury     50-<60    0    0.7995   0.000000  
>         .          . |
  |    COVID-19 with acute kidney injury     70-<80    1    0.8679   1.152208  
>  0.162304   8.179608 |
  +----------------------------------------------------------------------------
> ---------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |            covid_acute_kidney_injury     male    D         Y       Rate    
>   Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------|
  | COVID-19 without acute kidney injury   Female   33   46.4203   0.710896   0
> .505395   0.999957 |
  | COVID-19 without acute kidney injury     Male   27   50.9760   0.529661   0
> .363232   0.772345 |
  |    COVID-19 with acute kidney injury   Female    1    2.9541   0.338508   0
> .047683   2.403092 |
  |    COVID-19 with acute kidney injury     Male    1    0.4079   2.451342   0
> .345305    1.7e+01 |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |            covid_acute_kidney_injury                ethnicity    D         
> Y      Rate     Lower     Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  | COVID-19 without acute kidney injury                    White   39   61.998
> 6   0.62905   0.45960   0.86096 |
  | COVID-19 without acute kidney injury   Asian or Asian British    5    5.911
> 0   0.84588   0.35208   2.03225 |
  | COVID-19 without acute kidney injury                    Other    3    8.648
> 9   0.34687   0.11187   1.07548 |
  | COVID-19 without acute kidney injury                  Unknown   13   20.837
> 8   0.62387   0.36225   1.07442 |
  |    COVID-19 with acute kidney injury                    White    2    2.102
> 7   0.95117   0.23789   3.80320 |
  |----------------------------------------------------------------------------
> --------------------------------|
  |    COVID-19 with acute kidney injury                    Other    0    0.460
> 0   0.00000         .         . |
  |    COVID-19 with acute kidney injury                  Unknown    0    0.799
> 5   0.00000         .         . |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------+
  |            covid_acute_kidney_injury                imd    D         Y     
>   Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------------------|
  | COVID-19 without acute kidney injury   1 least deprived   14   21.5797   0.
> 648757   0.384228   1.095406 |
  | COVID-19 without acute kidney injury                  2   10   17.7440   0.
> 563570   0.303232   1.047422 |
  | COVID-19 without acute kidney injury                  3   15   22.6667   0.
> 661765   0.398955   1.097698 |
  | COVID-19 without acute kidney injury                  4    6   17.9630   0.
> 334019   0.150062   0.743486 |
  | COVID-19 without acute kidney injury    5 most deprived   15   17.4428   0.
> 859951   0.518435   1.426439 |
  |----------------------------------------------------------------------------
> -----------------------------|
  |    COVID-19 with acute kidney injury   1 least deprived    0    0.4600   0.
> 000000          .          . |
  |    COVID-19 with acute kidney injury                  2    1    1.6947   0.
> 590065   0.083119   4.188911 |
  |    COVID-19 with acute kidney injury                  4    1    0.4079   2.
> 451342   0.345305    1.7e+01 |
  |    COVID-19 with acute kidney injury    5 most deprived    0    0.7995   0.
> 000000          .          . |
  +----------------------------------------------------------------------------
> -----------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------+
  |            covid_acute_kidney_injury   baseli~t    D         Y        Rate 
>       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------|
  | COVID-19 without acute kidney injury      15-29    1    0.0657     1.5e+01 
>     2.1e+00     1.1e+02 |
  | COVID-19 without acute kidney injury      30-44    0   11.1622     0.0e+00 
>           .           . |
  | COVID-19 without acute kidney injury      45-59    1   17.6674   0.0566016 
>   0.0079731   0.4018187 |
  | COVID-19 without acute kidney injury      60-74    3   13.9083   0.2156988 
>   0.0695675   0.6687891 |
  | COVID-19 without acute kidney injury      75-89    8   16.3833   0.4883021 
>   0.2441987   0.9764136 |
  |----------------------------------------------------------------------------
> ------------------------|
  | COVID-19 without acute kidney injury     90-104   14   17.6947   0.7911960 
>   0.4685877     1.3e+00 |
  | COVID-19 without acute kidney injury       ≥105   33   20.5147     1.6e+00 
>     1.1e+00     2.3e+00 |
  |    COVID-19 with acute kidney injury      30-44    0    0.4600     0.0e+00 
>           .           . |
  |    COVID-19 with acute kidney injury      45-59    0    0.7995     0.0e+00 
>           .           . |
  |    COVID-19 with acute kidney injury      60-74    1    1.6947   0.5900646 
>   0.0831186     4.2e+00 |
  |----------------------------------------------------------------------------
> ------------------------|
  |    COVID-19 with acute kidney injury       ≥105    1    0.4079     2.5e+00 
>   0.3453046     1.7e+01 |
  +----------------------------------------------------------------------------
> ------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------+
  |            covid_acute_kidney_injury   diabetes    D         Y       Rate  
>     Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------|
  | COVID-19 without acute kidney injury          0   51   75.4223   0.676192  
>  0.513900   0.889738 |
  | COVID-19 without acute kidney injury          1    9   21.9740   0.409575  
>  0.213108   0.787168 |
  |    COVID-19 with acute kidney injury          0    1    1.2074   0.828231  
>  0.116668   5.879673 |
  |    COVID-19 with acute kidney injury          1    1    2.1547   0.464104  
>  0.065375   3.294709 |
  +----------------------------------------------------------------------------
> ---------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id
(file ./output/egfr_reduction_covid_acute_kidney_injury.svg written in SVG form
> at)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |    COVID-19 kidney
        if |  replacement therapy
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |        65          6 |        71 
           |     52.85      60.00 |     53.38 
-----------+----------------------+----------
         1 |        58          4 |        62 
           |     47.15      40.00 |     46.62 
-----------+----------------------+----------
     Total |       123         10 |       133 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.1902   Pr = 0.663

         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------+
  |                                   covid_krt    D         Y      Rate     Lo
> wer     Upper |
  |----------------------------------------------------------------------------
> --------------|
  | COVID-19 without kidney replacement therapy   58   93.8645   0.61791   0.47
> 770   0.79927 |
  |    COVID-19 with kidney replacement therapy    4    6.8939   0.58022   0.21
> 777   1.54595 |
  +----------------------------------------------------------------------------
> --------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------------+
  |                                   covid_krt   agegroup    D         Y      
>  Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ----------------------------|
  | COVID-19 without kidney replacement therapy     18-<50   26   48.7940   0.5
> 32853   0.362805   0.782603 |
  | COVID-19 without kidney replacement therapy     50-<60   14   13.8782   1.0
> 08779   0.597452   1.703292 |
  | COVID-19 without kidney replacement therapy     60-<70    6   13.8836   0.4
> 32163   0.194154   0.961943 |
  | COVID-19 without kidney replacement therapy     70-<80    8   13.3826   0.5
> 97791   0.298954   1.195348 |
  | COVID-19 without kidney replacement therapy        80+    4    3.9261   1.0
> 18828   0.382385   2.714575 |
  |----------------------------------------------------------------------------
> ----------------------------|
  |    COVID-19 with kidney replacement therapy     18-<50    2    5.8070   0.3
> 44413   0.086137   1.377114 |
  |    COVID-19 with kidney replacement therapy     60-<70    1    0.0657    1.
> 5e+01   2.143766    1.1e+02 |
  |    COVID-19 with kidney replacement therapy        80+    1    1.0212   0.9
> 79223   0.137937   6.951571 |
  +----------------------------------------------------------------------------
> ----------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                                   covid_krt     male    D         Y       R
> ate      Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  | COVID-19 without kidney replacement therapy   Female   32   47.7563   0.670
> 068   0.473856   0.947527 |
  | COVID-19 without kidney replacement therapy     Male   26   46.1081   0.563
> 892   0.383938   0.828190 |
  |    COVID-19 with kidney replacement therapy   Female    2    1.6181   1.236
> 041   0.309131   4.942232 |
  |    COVID-19 with kidney replacement therapy     Male    2    5.2758   0.379
> 087   0.094809   1.515755 |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------------+
  |                                   covid_krt                ethnicity    D  
>        Y      Rate     Lower     Upper |
  |----------------------------------------------------------------------------
> ---------------------------------------|
  | COVID-19 without kidney replacement therapy                    White   37  
>  60.5394   0.61117   0.44282   0.84353 |
  | COVID-19 without kidney replacement therapy   Asian or Asian British    5  
>   5.9110   0.84588   0.35208   2.03225 |
  | COVID-19 without kidney replacement therapy                    Other    3  
>   6.8720   0.43655   0.14080   1.35357 |
  | COVID-19 without kidney replacement therapy                  Unknown   13  
>  20.5421   0.63285   0.36747   1.08988 |
  |    COVID-19 with kidney replacement therapy                    White    4  
>   3.5619   1.12298   0.42148   2.99208 |
  |----------------------------------------------------------------------------
> ---------------------------------------|
  |    COVID-19 with kidney replacement therapy                    Other    0  
>   2.2368   0.00000         .         . |
  |    COVID-19 with kidney replacement therapy                  Unknown    0  
>   1.0951   0.00000         .         . |
  +----------------------------------------------------------------------------
> ---------------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------------+
  |                                   covid_krt                imd    D        
>  Y       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------------------------|
  | COVID-19 without kidney replacement therapy   1 least deprived   13   19.75
> 91   0.657926   0.382029   1.133073 |
  | COVID-19 without kidney replacement therapy                  2   11   19.31
> 55   0.569490   0.315384   1.028331 |
  | COVID-19 without kidney replacement therapy                  3   13   21.15
> 54   0.614501   0.356814   1.058287 |
  | COVID-19 without kidney replacement therapy                  4    7   16.55
> 30   0.422883   0.201603   0.887042 |
  | COVID-19 without kidney replacement therapy    5 most deprived   14   17.08
> 15   0.819603   0.485412   1.383874 |
  |----------------------------------------------------------------------------
> ------------------------------------|
  |    COVID-19 with kidney replacement therapy   1 least deprived    1    2.28
> 06   0.438475   0.061765   3.112768 |
  |    COVID-19 with kidney replacement therapy                  2    0    0.12
> 32   0.000000          .          . |
  |    COVID-19 with kidney replacement therapy                  3    2    1.51
> 13   1.323370   0.330972   5.291411 |
  |    COVID-19 with kidney replacement therapy                  4    0    1.81
> 79   0.000000          .          . |
  |    COVID-19 with kidney replacement therapy    5 most deprived    1    1.16
> 08   0.861439   0.121345   6.115415 |
  +----------------------------------------------------------------------------
> ------------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |                                   covid_krt   baseli~t    D         Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without kidney replacement therapy      30-44    0   11.6222     0
> .0e+00           .           . |
  | COVID-19 without kidney replacement therapy      45-59    1   16.5257   0.0
> 605119   0.0085239   0.4295785 |
  | COVID-19 without kidney replacement therapy      60-74    3   15.5428   0.1
> 930157   0.0622517   0.5984585 |
  | COVID-19 without kidney replacement therapy      75-89    8   15.4223   0.5
> 187289   0.2594151     1.0e+00 |
  | COVID-19 without kidney replacement therapy     90-104   14   16.4189   0.8
> 526763   0.5049996     1.4e+00 |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without kidney replacement therapy       ≥105   32   18.3326     1
> .7e+00     1.2e+00     2.5e+00 |
  |    COVID-19 with kidney replacement therapy      15-29    1    0.0657     1
> .5e+01     2.1e+00     1.1e+02 |
  |    COVID-19 with kidney replacement therapy      45-59    0    1.9411     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      60-74    1    0.0602     1
> .7e+01     2.3e+00     1.2e+02 |
  |    COVID-19 with kidney replacement therapy      75-89    0    0.9610     0
> .0e+00           .           . |
  |----------------------------------------------------------------------------
> -------------------------------|
  |    COVID-19 with kidney replacement therapy     90-104    0    1.2758     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy       ≥105    2    2.5900   0.7
> 721987   0.1931251     3.1e+00 |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------+
  |                                   covid_krt   diabetes    D         Y      
> Rate     Lower     Upper |
  |----------------------------------------------------------------------------
> -------------------------|
  | COVID-19 without kidney replacement therapy          0   48   73.0678   0.6
> 5692   0.49506   0.87172 |
  | COVID-19 without kidney replacement therapy          1   10   20.7967   0.4
> 8085   0.25872   0.89367 |
  |    COVID-19 with kidney replacement therapy          0    4    3.5619   1.1
> 2298   0.42148   2.99208 |
  |    COVID-19 with kidney replacement therapy          1    0    3.3320   0.0
> 0000         .         . |
  +----------------------------------------------------------------------------
> -------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id
(file ./output/egfr_reduction_covid_krt.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |             Vaccination status
  censored | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         3          6         22         40 |        71 
           |     60.00      66.67      64.71      47.06 |     53.38 
-----------+--------------------------------------------+----------
         1 |         2          3         12         45 |        62 
           |     40.00      33.33      35.29      52.94 |     46.62 
-----------+--------------------------------------------+----------
     Total |         5          9         34         85 |       133 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   3.8439   Pr = 0.279

         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---+
  |                 covid_vax_status    D         Y      Rate     Lower     Upp
> er |
  |----------------------------------------------------------------------------
> ---|
  |  SARS-CoV-2 after 1 vaccine dose    2    3.6632   0.54596   0.13654   2.183
> 00 |
  | SARS-CoV-2 after 2 vaccine doses    3    7.0226   0.42719   0.13778   1.324
> 54 |
  | SARS-CoV-2 after 3 vaccine doses   12   31.2279   0.38427   0.21823   0.676
> 64 |
  | SARS-CoV-2 after 4 vaccine doses   45   58.8446   0.76473   0.57097   1.024
> 22 |
  +----------------------------------------------------------------------------
> ---+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------+
  |                 covid_vax_status   agegroup    D         Y       Rate      
> Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------|
  |  SARS-CoV-2 after 1 vaccine dose     18-<50    2    1.7112   1.168800   0.2
> 92314   4.673375 |
  |  SARS-CoV-2 after 1 vaccine dose     60-<70    0    1.9521   0.000000      
>     .          . |
  | SARS-CoV-2 after 2 vaccine doses     18-<50    2    1.2512   1.598468   0.3
> 99773   6.391377 |
  | SARS-CoV-2 after 2 vaccine doses     50-<60    1    0.1040   9.611842   1.3
> 53958    6.8e+01 |
  | SARS-CoV-2 after 2 vaccine doses     70-<80    0    3.4990   0.000000      
>     .          . |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 2 vaccine doses        80+    0    2.1684   0.000000      
>     .          . |
  | SARS-CoV-2 after 3 vaccine doses     18-<50    5   18.2533   0.273924   0.1
> 14015   0.658110 |
  | SARS-CoV-2 after 3 vaccine doses     50-<60    3    5.8015   0.517107   0.1
> 66778   1.603326 |
  | SARS-CoV-2 after 3 vaccine doses     60-<70    1    4.8022   0.208238   0.0
> 29333   1.478299 |
  | SARS-CoV-2 after 3 vaccine doses        80+    3    2.3710   1.265300   0.4
> 08086   3.923151 |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 4 vaccine doses     18-<50   19   33.3854   0.569112   0.3
> 63010   0.892230 |
  | SARS-CoV-2 after 4 vaccine doses     50-<60   10    7.9726   1.254293   0.6
> 74878   2.331162 |
  | SARS-CoV-2 after 4 vaccine doses     60-<70    6    7.1951   0.833904   0.3
> 74640   1.856170 |
  | SARS-CoV-2 after 4 vaccine doses     70-<80    8    9.8836   0.809418   0.4
> 04788   1.618520 |
  | SARS-CoV-2 after 4 vaccine doses        80+    2    0.4079   4.902685   1.2
> 26150    2.0e+01 |
  +----------------------------------------------------------------------------
> -----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 covid_vax_status     male    D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |  SARS-CoV-2 after 1 vaccine dose   Female    1    1.2813   0.780449   0.109
> 937   5.540461 |
  |  SARS-CoV-2 after 1 vaccine dose     Male    1    2.3819   0.419828   0.059
> 138   2.980386 |
  | SARS-CoV-2 after 2 vaccine doses   Female    2    4.0849   0.489611   0.122
> 451   1.957680 |
  | SARS-CoV-2 after 2 vaccine doses     Male    1    2.9377   0.340401   0.047
> 950   2.416529 |
  | SARS-CoV-2 after 3 vaccine doses   Female    7   17.9001   0.391060   0.186
> 432   0.820290 |
  |----------------------------------------------------------------------------
> ---------------|
  | SARS-CoV-2 after 3 vaccine doses     Male    5   13.3279   0.375154   0.156
> 150   0.901319 |
  | SARS-CoV-2 after 4 vaccine doses   Female   24   26.1081   0.919253   0.616
> 147   1.371469 |
  | SARS-CoV-2 after 4 vaccine doses     Male   21   32.7365   0.641486   0.418
> 254   0.983863 |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |                 covid_vax_status                ethnicity    D         Y   
>     Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  |  SARS-CoV-2 after 1 vaccine dose                    White    0    1.8891   
> 0.000000          .          . |
  |  SARS-CoV-2 after 1 vaccine dose                    Other    0    0.3559   
> 0.000000          .          . |
  |  SARS-CoV-2 after 1 vaccine dose                  Unknown    2    1.4182   
> 1.410232   0.352696   5.638724 |
  | SARS-CoV-2 after 2 vaccine doses                    White    3    4.3559   
> 0.688718   0.222126   2.135417 |
  | SARS-CoV-2 after 2 vaccine doses                    Other    0    2.6667   
> 0.000000          .          . |
  |----------------------------------------------------------------------------
> -------------------------------|
  | SARS-CoV-2 after 3 vaccine doses                    White   10   19.9726   
> 0.500685   0.269396   0.930547 |
  | SARS-CoV-2 after 3 vaccine doses   Asian or Asian British    0    2.0507   
> 0.000000          .          . |
  | SARS-CoV-2 after 3 vaccine doses                    Other    0    3.0089   
> 0.000000          .          . |
  | SARS-CoV-2 after 3 vaccine doses                  Unknown    2    6.1958   
> 0.322802   0.080732   1.290702 |
  | SARS-CoV-2 after 4 vaccine doses                    White   28   37.8836   
> 0.739105   0.510322   1.070455 |
  |----------------------------------------------------------------------------
> -------------------------------|
  | SARS-CoV-2 after 4 vaccine doses   Asian or Asian British    5    3.8604   
> 1.295213   0.539104   3.111788 |
  | SARS-CoV-2 after 4 vaccine doses                    Other    3    3.0773   
> 0.974867   0.314415   3.022641 |
  | SARS-CoV-2 after 4 vaccine doses                  Unknown    9   14.0233   
> 0.641790   0.333933   1.233466 |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------+
  |                 covid_vax_status                imd    D         Y       Ra
> te      Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------------|
  |  SARS-CoV-2 after 1 vaccine dose   1 least deprived    2    1.7112   1.1688
> 00   0.292314   4.673375 |
  |  SARS-CoV-2 after 1 vaccine dose                  4    0    1.9521   0.0000
> 00          .          . |
  | SARS-CoV-2 after 2 vaccine doses   1 least deprived    1    2.8501   0.3508
> 65   0.049424   2.490813 |
  | SARS-CoV-2 after 2 vaccine doses                  3    2    4.1725   0.4793
> 31   0.119879   1.916574 |
  | SARS-CoV-2 after 3 vaccine doses   1 least deprived    3    4.7447   0.6322
> 85   0.203925   1.960444 |
  |----------------------------------------------------------------------------
> -------------------------|
  | SARS-CoV-2 after 3 vaccine doses                  2    4    9.8590   0.4057
> 21   0.152274   1.081005 |
  | SARS-CoV-2 after 3 vaccine doses                  3    2    5.7331   0.3488
> 54   0.087248   1.394871 |
  | SARS-CoV-2 after 3 vaccine doses                  4    1    6.9788   0.1432
> 91   0.020185   1.017236 |
  | SARS-CoV-2 after 3 vaccine doses    5 most deprived    2    3.9124   0.5111
> 97   0.127849   2.043988 |
  | SARS-CoV-2 after 4 vaccine doses   1 least deprived    8   12.7337   0.6282
> 52   0.314187   1.256259 |
  |----------------------------------------------------------------------------
> -------------------------|
  | SARS-CoV-2 after 4 vaccine doses                  2    7    9.5797   0.7307
> 09   0.348354   1.532739 |
  | SARS-CoV-2 after 4 vaccine doses                  3   11   12.7611   0.8619
> 93   0.477372   1.556506 |
  | SARS-CoV-2 after 4 vaccine doses                  4    6    9.4401   0.6355
> 86   0.285544   1.414737 |
  | SARS-CoV-2 after 4 vaccine doses    5 most deprived   13   14.3299   0.9071
> 93   0.526768   1.562358 |
  +----------------------------------------------------------------------------
> -------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------+
  |                 covid_vax_status   baseli~t    D         Y       Rate      
> Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------|
  |  SARS-CoV-2 after 1 vaccine dose      60-74    0    1.9521   0.000000      
>     .          . |
  |  SARS-CoV-2 after 1 vaccine dose       ≥105    2    1.7112   1.168800   0.2
> 92314   4.673375 |
  | SARS-CoV-2 after 2 vaccine doses      30-44    0    2.9131   0.000000      
>     .          . |
  | SARS-CoV-2 after 2 vaccine doses      75-89    0    2.7543   0.000000      
>     .          . |
  | SARS-CoV-2 after 2 vaccine doses       ≥105    3    1.3552   2.213636   0.7
> 13945   6.863533 |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 3 vaccine doses      30-44    0    3.7016   0.000000      
>     .          . |
  | SARS-CoV-2 after 3 vaccine doses      45-59    0    6.2560   0.000000      
>     .          . |
  | SARS-CoV-2 after 3 vaccine doses      60-74    2    5.9466   0.336326   0.0
> 84114   1.344779 |
  | SARS-CoV-2 after 3 vaccine doses      75-89    4    7.7043   0.519190   0.1
> 94861   1.383334 |
  | SARS-CoV-2 after 3 vaccine doses     90-104    2    4.5695   0.437687   0.1
> 09465   1.750065 |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 3 vaccine doses       ≥105    4    3.0500   1.311490   0.4
> 92226   3.494345 |
  | SARS-CoV-2 after 4 vaccine doses      15-29    1    0.0657    1.5e+01   2.1
> 43766    1.1e+02 |
  | SARS-CoV-2 after 4 vaccine doses      30-44    0    5.0075   0.000000      
>     .          . |
  | SARS-CoV-2 after 4 vaccine doses      45-59    1   12.2108   0.081895   0.0
> 11536   0.581376 |
  | SARS-CoV-2 after 4 vaccine doses      60-74    2    7.7043   0.259595   0.0
> 64924   1.037974 |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 4 vaccine doses      75-89    4    5.9247   0.675139   0.2
> 53392   1.798845 |
  | SARS-CoV-2 after 4 vaccine doses     90-104   12   13.1253   0.914268   0.5
> 19222   1.609882 |
  | SARS-CoV-2 after 4 vaccine doses       ≥105   25   14.8063   1.688471   1.1
> 40915   2.498814 |
  +----------------------------------------------------------------------------
> -----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------+
  |                 covid_vax_status   diabetes    D         Y      Rate     Lo
> wer     Upper |
  |----------------------------------------------------------------------------
> --------------|
  |  SARS-CoV-2 after 1 vaccine dose          0    2    1.7741   1.12731   0.28
> 194   4.50750 |
  |  SARS-CoV-2 after 1 vaccine dose          1    0    1.8891   0.00000       
>   .         . |
  | SARS-CoV-2 after 2 vaccine doses          0    3    5.6016   0.53556   0.17
> 273   1.66053 |
  | SARS-CoV-2 after 2 vaccine doses          1    0    1.4209   0.00000       
>   .         . |
  | SARS-CoV-2 after 3 vaccine doses          0    9   22.5599   0.39894   0.20
> 757   0.76672 |
  |----------------------------------------------------------------------------
> --------------|
  | SARS-CoV-2 after 3 vaccine doses          1    3    8.6680   0.34610   0.11
> 162   1.07310 |
  | SARS-CoV-2 after 4 vaccine doses          0   38   46.6940   0.81381   0.59
> 216   1.11842 |
  | SARS-CoV-2 after 4 vaccine doses          1    7   12.1506   0.57610   0.27
> 465   1.20844 |
  +----------------------------------------------------------------------------
> --------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id
(file ./output/egfr_reduction_covid_vax_status.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |                    Calendar period
  censored | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        19          3         10         11         27 |        71 
           |     48.72      42.86      43.48      47.83      67.50 |     53.38 
-----------+-------------------------------------------------------+----------
         1 |        20          4         13         12         13 |        62 
           |     51.28      57.14      56.52      52.17      32.50 |     46.62 
-----------+-------------------------------------------------------+----------
     Total |        39          7         23         23         40 |       133 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


      1 if |
failure; 0 |  Calendar
        if |   period
  censored | December  |     Total
-----------+-----------+----------
         0 |         1 |        71 
           |    100.00 |     53.38 
-----------+-----------+----------
         1 |         0 |        62 
           |      0.00 |     46.62 
-----------+-----------+----------
     Total |         1 |       133 
           |    100.00 |    100.00 

          Pearson chi2(5) =   5.9214   Pr = 0.314

         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> --+
  |                 calendar_period    D         Y      Rate     Lower     Uppe
> r |
  |----------------------------------------------------------------------------
> --|
  |      February 2020 to June 2020   20   44.8350   0.44608   0.28779   0.6914
> 3 |
  |        July 2020 to August 2020    4    6.4148   0.62356   0.23403   1.6614
> 2 |
  | September 2020 to November 2020   13   19.0746   0.68153   0.39574   1.1737
> 3 |
  |  December 2020 to February 2021   12   15.3949   0.77948   0.44267   1.3725
> 4 |
  |     March 2021 to November 2021   13   15.0089   0.86615   0.50294   1.4916
> 8 |
  |----------------------------------------------------------------------------
> --|
  |   December 2021 to January 2022    0    0.0301   0.00000         .         
> . |
  +----------------------------------------------------------------------------
> --+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 calendar_period   agegroup   D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020     18-<50   8   22.9487   0.348604   0.174
> 336   0.697072 |
  |      February 2020 to June 2020     50-<60   5    8.2847   0.603519   0.251
> 202   1.449974 |
  |      February 2020 to June 2020     60-<70   3    7.3895   0.405984   0.130
> 938   1.258781 |
  |      February 2020 to June 2020     70-<80   2    5.7522   0.347692   0.086
> 957   1.390223 |
  |      February 2020 to June 2020        80+   2    0.4600   4.348214   1.087
> 478    1.7e+01 |
  |----------------------------------------------------------------------------
> ---------------|
  |        July 2020 to August 2020     18-<50   2    2.4312   0.822635   0.205
> 739   3.289256 |
  |        July 2020 to August 2020     50-<60   0    1.3689   0.000000        
>   .          . |
  |        July 2020 to August 2020     60-<70   1    1.0705   0.934143   0.131
> 587   6.631549 |
  |        July 2020 to August 2020     70-<80   0    1.4839   0.000000        
>   .          . |
  |        July 2020 to August 2020        80+   1    0.0602    1.7e+01   2.338
> 654    1.2e+02 |
  |----------------------------------------------------------------------------
> ---------------|
  | September 2020 to November 2020     18-<50   7   10.0780   0.694580   0.331
> 130   1.456956 |
  | September 2020 to November 2020     50-<60   3    0.9829   3.052228   0.984
> 409   9.463646 |
  | September 2020 to November 2020     60-<70   1    2.1081   0.474351   0.066
> 819   3.367449 |
  | September 2020 to November 2020     70-<80   1    3.5921   0.278392   0.039
> 215   1.976323 |
  | September 2020 to November 2020        80+   1    2.3135   0.432249   0.060
> 888   3.068563 |
  |----------------------------------------------------------------------------
> ---------------|
  |  December 2020 to February 2021     18-<50   5   10.9432   0.456905   0.190
> 177   1.097729 |
  |  December 2020 to February 2021     50-<60   3    0.6379   4.702790   1.516
> 750    1.5e+01 |
  |  December 2020 to February 2021     60-<70   1    1.0842   0.922348   0.129
> 925   6.547818 |
  |  December 2020 to February 2021     70-<80   3    1.7687   1.696207   0.547
> 063   5.259209 |
  |  December 2020 to February 2021        80+   0    0.9610   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |     March 2021 to November 2021     18-<50   6    8.1999   0.731720   0.328
> 733   1.628719 |
  |     March 2021 to November 2021     50-<60   3    2.5736   1.165691   0.375
> 960   3.614307 |
  |     March 2021 to November 2021     60-<70   1    2.2971   0.435340   0.061
> 323   3.090508 |
  |     March 2021 to November 2021     70-<80   2    0.7858   2.545296   0.636
> 573    1.0e+01 |
  |     March 2021 to November 2021        80+   1    1.1526   0.867577   0.122
> 210   6.158992 |
  |----------------------------------------------------------------------------
> ---------------|
  |   December 2021 to January 2022     50-<60   0    0.0301   0.000000        
>   .          . |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------+
  |                 calendar_period     male    D         Y      Rate     Lower
>       Upper |
  |----------------------------------------------------------------------------
> ------------|
  |      February 2020 to June 2020   Female   10   23.2991   0.42920   0.23093
>     0.79769 |
  |      February 2020 to June 2020     Male   10   21.5359   0.46434   0.24984
>     0.86300 |
  |        July 2020 to August 2020   Female    1    0.2957   3.38194   0.47639
>    24.00867 |
  |        July 2020 to August 2020     Male    3    6.1191   0.49027   0.15812
>     1.52011 |
  | September 2020 to November 2020   Female    8    9.0075   0.88815   0.44416
>     1.77594 |
  |----------------------------------------------------------------------------
> ------------|
  | September 2020 to November 2020     Male    5   10.0671   0.49667   0.20673
>     1.19326 |
  |  December 2020 to February 2021   Female    7    8.3395   0.83938   0.40016
>     1.76069 |
  |  December 2020 to February 2021     Male    5    7.0554   0.70867   0.29497
>     1.70261 |
  |     March 2021 to November 2021   Female    8    8.4326   0.94870   0.47444
>     1.89703 |
  |     March 2021 to November 2021     Male    5    6.5763   0.76030   0.31646
>     1.82665 |
  |----------------------------------------------------------------------------
> ------------|
  |   December 2021 to January 2022     Male    0    0.0301   0.00000         .
>           . |
  +----------------------------------------------------------------------------
> ------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------+
  |                 calendar_period                ethnicity    D         Y    
>    Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------------------|
  |      February 2020 to June 2020                    White   15   30.4832   0
> .492074   0.296655   0.816224 |
  |      February 2020 to June 2020   Asian or Asian British    1    3.6277   0
> .275660   0.038830   1.956933 |
  |      February 2020 to June 2020                    Other    1    2.1739   0
> .460013   0.064799   3.265662 |
  |      February 2020 to June 2020                  Unknown    3    8.5503   0
> .350865   0.113161   1.087880 |
  |        July 2020 to August 2020                    White    1    2.9131   0
> .343280   0.048356   2.436970 |
  |----------------------------------------------------------------------------
> ------------------------------|
  |        July 2020 to August 2020   Asian or Asian British    1    0.2957   3
> .381944   0.476393    2.4e+01 |
  |        July 2020 to August 2020                  Unknown    2    3.2060   0
> .623826   0.156017   2.494329 |
  | September 2020 to November 2020                    White   11   11.3539   0
> .968833   0.536540   1.749427 |
  | September 2020 to November 2020                    Other    1    4.2820   0
> .233536   0.032897   1.657887 |
  | September 2020 to November 2020                  Unknown    1    3.4387   0
> .290804   0.040964   2.064439 |
  |----------------------------------------------------------------------------
> ------------------------------|
  |  December 2020 to February 2021                    White    8   11.6934   0
> .684149   0.342141   1.368031 |
  |  December 2020 to February 2021   Asian or Asian British    1    1.2895   0
> .775478   0.109236   5.505172 |
  |  December 2020 to February 2021                    Other    0    0.9610   0
> .000000          .          . |
  |  December 2020 to February 2021                  Unknown    3    1.4511   2
> .067453   0.666798   6.410281 |
  |     March 2021 to November 2021                    White    6    7.6578   0
> .783518   0.352004   1.744016 |
  |----------------------------------------------------------------------------
> ------------------------------|
  |     March 2021 to November 2021   Asian or Asian British    2    0.6982   2
> .864706   0.716456    1.1e+01 |
  |     March 2021 to November 2021                    Other    1    1.6619   0
> .601730   0.084762   4.271723 |
  |     March 2021 to November 2021                  Unknown    4    4.9911   0
> .801426   0.300790   2.135327 |
  |   December 2021 to January 2022                    Other    0    0.0301   0
> .000000          .          . |
  +----------------------------------------------------------------------------
> ------------------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------+
  |                 calendar_period                imd   D         Y       Rate
>       Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------------|
  |      February 2020 to June 2020   1 least deprived   1    6.5791   0.151998
>    0.021411   1.079041 |
  |      February 2020 to June 2020                  2   4    8.8350   0.452742
>    0.169922   1.206291 |
  |      February 2020 to June 2020                  3   5   11.5181   0.434098
>    0.180684   1.042934 |
  |      February 2020 to June 2020                  4   3    8.8378   0.339452
>    0.109480   1.052493 |
  |      February 2020 to June 2020    5 most deprived   7    9.0650   0.772199
>    0.368133   1.619769 |
  |----------------------------------------------------------------------------
> -----------------------|
  |        July 2020 to August 2020   1 least deprived   0    1.4839   0.000000
>           .          . |
  |        July 2020 to August 2020                  2   0    1.3689   0.000000
>           .          . |
  |        July 2020 to August 2020                  3   2    2.5133   0.795752
>    0.199016   3.181764 |
  |        July 2020 to August 2020                  4   1    0.2957   3.381944
>    0.476393    2.4e+01 |
  |        July 2020 to August 2020    5 most deprived   1    0.7529   1.328182
>    0.187092   9.428858 |
  |----------------------------------------------------------------------------
> -----------------------|
  | September 2020 to November 2020   1 least deprived   6    8.2163   0.730257
>    0.328076   1.625463 |
  | September 2020 to November 2020                  2   2    4.3860   0.455993
>    0.114043   1.823258 |
  | September 2020 to November 2020                  3   3    2.0315   1.476752
>    0.476284   4.578772 |
  | September 2020 to November 2020                  4   1    3.2334   0.309272
>    0.043565   2.195543 |
  | September 2020 to November 2020    5 most deprived   1    1.2074   0.828231
>    0.116668   5.879673 |
  |----------------------------------------------------------------------------
> -----------------------|
  |  December 2020 to February 2021   1 least deprived   2    2.9815   0.670799
>    0.167765   2.682148 |
  |  December 2020 to February 2021                  2   2    1.5907   1.257315
>    0.314452   5.027296 |
  |  December 2020 to February 2021                  3   3    3.3018   0.908582
>    0.293037   2.817122 |
  |  December 2020 to February 2021                  4   1    2.4148   0.414116
>    0.058334   2.939837 |
  |  December 2020 to February 2021    5 most deprived   4    5.1061   0.783378
>    0.294016   2.087239 |
  |----------------------------------------------------------------------------
> -----------------------|
  |     March 2021 to November 2021   1 least deprived   5    2.7789   1.799261
>    0.748903   4.322780 |
  |     March 2021 to November 2021                  2   3    3.2580   0.920798
>    0.296977   2.854999 |
  |     March 2021 to November 2021                  3   2    3.3018   0.605721
>    0.151489   2.421940 |
  |     March 2021 to November 2021                  4   1    3.5893   0.278604
>    0.039245   1.977831 |
  |     March 2021 to November 2021    5 most deprived   2    2.0808   0.961184
>    0.240390   3.843236 |
  |----------------------------------------------------------------------------
> -----------------------|
  |   December 2021 to January 2022    5 most deprived   0    0.0301   0.000000
>           .          . |
  +----------------------------------------------------------------------------
> -----------------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 calendar_period   baseli~t    D         Y       Rate      L
> ower      Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020      30-44    0    5.4894   0.000000       
>    .          . |
  |      February 2020 to June 2020      45-59    0    9.9302   0.000000       
>    .          . |
  |      February 2020 to June 2020      60-74    2   10.4230   0.191883   0.04
> 7990   0.767234 |
  |      February 2020 to June 2020      75-89    5    7.4689   0.669446   0.27
> 8642   1.608366 |
  |      February 2020 to June 2020     90-104    6    7.7536   0.773835   0.34
> 7654   1.722463 |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020       ≥105    7    3.7700   1.856754   0.88
> 5178   3.894738 |
  |        July 2020 to August 2020      45-59    0    1.4839   0.000000       
>    .          . |
  |        July 2020 to August 2020      60-74    1    1.4292   0.699713   0.09
> 8564   4.967310 |
  |        July 2020 to August 2020      75-89    0    1.3826   0.000000       
>    .          . |
  |        July 2020 to August 2020     90-104    2    1.0486   1.907311   0.47
> 7014   7.626264 |
  |----------------------------------------------------------------------------
> ----------------|
  |        July 2020 to August 2020       ≥105    1    1.0705   0.934143   0.13
> 1587   6.631549 |
  | September 2020 to November 2020      30-44    0    3.6906   0.000000       
>    .          . |
  | September 2020 to November 2020      45-59    0    1.2485   0.000000       
>    .          . |
  | September 2020 to November 2020      60-74    1    1.1061   0.904084   0.12
> 7352   6.418158 |
  | September 2020 to November 2020      75-89    2    4.6379   0.431228   0.10
> 7849   1.724238 |
  |----------------------------------------------------------------------------
> ----------------|
  | September 2020 to November 2020     90-104    3    3.2033   0.936538   0.30
> 2054   2.903802 |
  | September 2020 to November 2020       ≥105    7    5.1882   1.349208   0.64
> 3213   2.830108 |
  |  December 2020 to February 2021      15-29    1    0.0657    1.5e+01   2.14
> 3766    1.1e+02 |
  |  December 2020 to February 2021      45-59    0    2.0123   0.000000       
>    .          . |
  |  December 2020 to February 2021      60-74    0    0.8460   0.000000       
>    .          . |
  |----------------------------------------------------------------------------
> ----------------|
  |  December 2020 to February 2021      75-89    0    1.9795   0.000000       
>    .          . |
  |  December 2020 to February 2021     90-104    1    4.7502   0.210519   0.02
> 9654   1.494488 |
  |  December 2020 to February 2021       ≥105   10    5.7413   1.741774   0.93
> 7170   3.237169 |
  |     March 2021 to November 2021      30-44    0    2.4422   0.000000       
>    .          . |
  |     March 2021 to November 2021      45-59    1    3.7919   0.263718   0.03
> 7148   1.872156 |
  |----------------------------------------------------------------------------
> ----------------|
  |     March 2021 to November 2021      60-74    0    1.7988   0.000000       
>    .          . |
  |     March 2021 to November 2021      75-89    1    0.9144   1.093563   0.15
> 4043   7.763281 |
  |     March 2021 to November 2021     90-104    2    0.9090   2.200301   0.55
> 0290   8.797768 |
  |     March 2021 to November 2021       ≥105    9    5.1526   1.746679   0.90
> 8823   3.356966 |
  |   December 2021 to January 2022     90-104    0    0.0301   0.000000       
>    .          . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(133 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 calendar_period   diabetes    D         Y       Rate      L
> ower      Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020          0   14   31.7864   0.440439   0.26
> 0851   0.743668 |
  |      February 2020 to June 2020          1    6   13.0486   0.459820   0.20
> 6579   1.023503 |
  |        July 2020 to August 2020          0    4    5.0459   0.792729   0.29
> 7525   2.112154 |
  |        July 2020 to August 2020          1    0    1.3689   0.000000       
>    .          . |
  | September 2020 to November 2020          0   12   15.9754   0.751157   0.42
> 6589   1.322669 |
  |----------------------------------------------------------------------------
> ----------------|
  | September 2020 to November 2020          1    1    3.0992   0.322659   0.04
> 5451   2.290579 |
  |  December 2020 to February 2021          0   10   11.4962   0.869850   0.46
> 8027   1.616657 |
  |  December 2020 to February 2021          1    2    3.8987   0.512992   0.12
> 8298   2.051165 |
  |     March 2021 to November 2021          0   12   12.3258   0.973567   0.55
> 2898   1.714300 |
  |     March 2021 to November 2021          1    1    2.6831   0.372704   0.05
> 2500   2.645853 |
  |----------------------------------------------------------------------------
> ----------------|
  |   December 2021 to January 2022          1    0    0.0301   0.000000       
>    .          . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  egfr_reduction50_outcome_date
   analysis time _t:  (exit_date_egfr_reduction-origin)/365.25
             origin:  time index_date_egfr_reduction
                 id:  patient_id
(file ./output/egfr_reduction_calendar_period.svg written in SVG format)

. 
. * Acute kidney injury rates (stratified)
. stset exit_date_aki, fail(aki_outcome_date) origin(index_date) id(patient_id)
>  scale(365.25)

                id:  patient_id
     failure event:  aki_outcome_date != 0 & aki_outcome_date < .
obs. time interval:  (exit_date_aki[_n-1], exit_date_aki]
 exit on or before:  failure
    t for analysis:  (time-origin)/365.25
            origin:  time index_date

------------------------------------------------------------------------------
        276  total observations
         47  observations end on or before enter()
------------------------------------------------------------------------------
        229  observations remaining, representing
        229  subjects
         23  failures in single-failure-per-subject data
     229.99  total analysis time at risk and under observation
                                                at risk from t =         0
                                     earliest observed entry t =         0
                                          last observed exit t =   1.91102

. foreach stratum of varlist      covid_severity                          ///
>                                                         covid_acute_kidney_in
> jury       ///
>                                                         covid_krt            
>                            ///
>                                                         covid_vax_status     
>                    ///
>                                                         calendar_period {
  2.         tab _d `stratum', col chi
  3.         strate `stratum'
  4.         strate `stratum' agegroup
  5.         strate `stratum' male
  6.         strate `stratum' ethnicity
  7.         strate `stratum' imd
  8.         strate `stratum' baseline_egfr_cat
  9.         strate `stratum' diabetes
 10.         sts graph, failure by(`stratum') title(Cumulative AKI after SARS-C
> oV-2 survival by `stratum') ylab(0(0.02)0.20, angle(horizontal)) ytitle(Cumul
> ative AKI) xtitle(Follow-up (years))
 11.         graph export ./output/aki_`stratum'.svg, replace
 12.         }

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |       SARS-CoV-2 severity
  censored | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        24          1        181 |       206 
           |     92.31     100.00      89.60 |     89.96 
-----------+---------------------------------+----------
         1 |         2          0         21 |        23 
           |      7.69       0.00      10.40 |     10.04 
-----------+---------------------------------+----------
     Total |        26          1        202 |       229 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.2985   Pr = 0.861

         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------+
  |                     covid_severity    D          Y       Rate      Lower   
>    Upper |
  |----------------------------------------------------------------------------
> ---------|
  | SARS-CoV-2 without hospitalisation    2    24.9254   0.080239   0.020068   
> 0.320832 |
  |      COVID-19 with hospitalisation    0     0.0575   0.000000          .   
>        . |
  |        COVID-19 with critical care   21   205.0075   0.102435   0.066789   
> 0.157107 |
  +----------------------------------------------------------------------------
> ---------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------+
  |                     covid_severity   agegroup    D          Y        Rate  
>      Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------|
  | SARS-CoV-2 without hospitalisation     18-<50    0    16.4244     0.0e+00  
>          .           . |
  | SARS-CoV-2 without hospitalisation     50-<60    1     6.1300   0.1631309  
>  0.0229792     1.2e+00 |
  | SARS-CoV-2 without hospitalisation     60-<70    1     1.7495   0.5715962  
>  0.0805170     4.1e+00 |
  | SARS-CoV-2 without hospitalisation     70-<80    0     0.6215     0.0e+00  
>          .           . |
  |      COVID-19 with hospitalisation     50-<60    0     0.0575     0.0e+00  
>          .           . |
  |----------------------------------------------------------------------------
> -----------------------|
  |        COVID-19 with critical care     18-<50   13   111.9233   0.1161509  
>  0.0674438   0.2000339 |
  |        COVID-19 with critical care     50-<60    1    34.7296   0.0287939  
>  0.0040560   0.2044096 |
  |        COVID-19 with critical care     60-<70    5    26.8638   0.1861241  
>  0.0774700   0.4471689 |
  |        COVID-19 with critical care     70-<80    1    18.6940   0.0534930  
>  0.0075352   0.3797504 |
  |        COVID-19 with critical care        80+    1    12.7967   0.0781451  
>  0.0110078   0.5547573 |
  +----------------------------------------------------------------------------
> -----------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                     covid_severity     male    D          Y       Rate     
>  Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------|
  | SARS-CoV-2 without hospitalisation   Female    1    13.2704   0.075356   0.
> 010615   0.534957 |
  | SARS-CoV-2 without hospitalisation     Male    1    11.6550   0.085800   0.
> 012086   0.609099 |
  |      COVID-19 with hospitalisation   Female    0     0.0575   0.000000     
>      .          . |
  |        COVID-19 with critical care   Female    9   108.9993   0.082569   0.
> 042962   0.158691 |
  |        COVID-19 with critical care     Male   12    96.0082   0.124989   0.
> 070983   0.220087 |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------------------+
  |                     covid_severity                ethnicity    D          Y
>        Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ----------------------------------|
  | SARS-CoV-2 without hospitalisation                    White    0    13.6591
>    0.000000          .          . |
  | SARS-CoV-2 without hospitalisation   Asian or Asian British    0     1.8782
>    0.000000          .          . |
  | SARS-CoV-2 without hospitalisation                    Other    1     0.3258
>    3.069328   0.432356    2.2e+01 |
  | SARS-CoV-2 without hospitalisation                  Unknown    1     9.0623
>    0.110347   0.015544   0.783364 |
  |      COVID-19 with hospitalisation                    White    0     0.0575
>    0.000000          .          . |
  |----------------------------------------------------------------------------
> ----------------------------------|
  |        COVID-19 with critical care                    White   10   123.9918
>    0.080651   0.043394   0.149893 |
  |        COVID-19 with critical care   Asian or Asian British    3    15.2690
>    0.196477   0.063368   0.609189 |
  |        COVID-19 with critical care                    Other    2    23.6222
>    0.084666   0.021175   0.338533 |
  |        COVID-19 with critical care                  Unknown    6    42.1246
>    0.142435   0.063990   0.317042 |
  +----------------------------------------------------------------------------
> ----------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                     covid_severity                imd   D         Y       R
> ate      Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  | SARS-CoV-2 without hospitalisation   1 least deprived   0    5.1088   0.000
> 000          .          . |
  | SARS-CoV-2 without hospitalisation                  2   0    4.1862   0.000
> 000          .          . |
  | SARS-CoV-2 without hospitalisation                  3   1    4.7283   0.211
> 494   0.029792   1.501410 |
  | SARS-CoV-2 without hospitalisation                  4   1    4.5421   0.220
> 163   0.031013   1.562951 |
  | SARS-CoV-2 without hospitalisation    5 most deprived   0    6.3600   0.000
> 000          .          . |
  |----------------------------------------------------------------------------
> --------------------------|
  |      COVID-19 with hospitalisation                  4   0    0.0575   0.000
> 000          .          . |
  |        COVID-19 with critical care   1 least deprived   4   37.1143   0.107
> 775   0.040450   0.287157 |
  |        COVID-19 with critical care                  2   6   42.0315   0.142
> 750   0.064132   0.317745 |
  |        COVID-19 with critical care                  3   6   40.2628   0.149
> 021   0.066949   0.331702 |
  |        COVID-19 with critical care                  4   5   38.5736   0.129
> 622   0.053952   0.311422 |
  |----------------------------------------------------------------------------
> --------------------------|
  |        COVID-19 with critical care    5 most deprived   0   47.0253   0.000
> 000          .          . |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(124 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                     covid_severity   baseli~t   D         Y       Rate     
>  Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------|
  | SARS-CoV-2 without hospitalisation      45-59   1    4.1697   0.239823   0.
> 033782   1.702519 |
  | SARS-CoV-2 without hospitalisation      75-89   0    2.2094   0.000000     
>      .          . |
  | SARS-CoV-2 without hospitalisation     90-104   0    4.2081   0.000000     
>      .          . |
  | SARS-CoV-2 without hospitalisation       ≥105   0    2.8720   0.000000     
>      .          . |
  |      COVID-19 with hospitalisation      45-59   0    0.0575   0.000000     
>      .          . |
  |----------------------------------------------------------------------------
> ------------------|
  |        COVID-19 with critical care      15-29   0    0.0657   0.000000     
>      .          . |
  |        COVID-19 with critical care      30-44   1   10.3354   0.096755   0.
> 013629   0.686870 |
  |        COVID-19 with critical care      45-59   1   13.8864   0.072013   0.
> 010144   0.511226 |
  |        COVID-19 with critical care      60-74   2   18.2806   0.109405   0.
> 027362   0.437451 |
  |        COVID-19 with critical care      75-89   5   15.0938   0.331262   0.
> 137881   0.795868 |
  |----------------------------------------------------------------------------
> ------------------|
  |        COVID-19 with critical care     90-104   2   17.7084   0.112941   0.
> 028246   0.451586 |
  |        COVID-19 with critical care       ≥105   4   33.4949   0.119421   0.
> 044821   0.318187 |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                     covid_severity   diabetes    D          Y       Rate   
>    Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 without hospitalisation          0    2    21.6674   0.092305   
> 0.023085   0.369075 |
  | SARS-CoV-2 without hospitalisation          1    0     3.2580   0.000000   
>        .          . |
  |      COVID-19 with hospitalisation          0    0     0.0575   0.000000   
>        .          . |
  |        COVID-19 with critical care          0   17   159.0116   0.106910   
> 0.066462   0.171976 |
  |        COVID-19 with critical care          1    4    45.9959   0.086964   
> 0.032639   0.231708 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/aki_covid_severity.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 | COVID-19 acute kidney
        if |        injury
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       196         10 |       206 
           |     89.91      90.91 |     89.96 
-----------+----------------------+----------
         1 |        22          1 |        23 
           |     10.09       9.09 |     10.04 
-----------+----------------------+----------
     Total |       218         11 |       229 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.0116   Pr = 0.914

         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------+
  |            covid_acute_kidney_injury    D          Y       Rate      Lower 
>      Upper |
  |----------------------------------------------------------------------------
> -----------|
  | COVID-19 without acute kidney injury   22   218.9459   0.100481   0.066162 
>   0.152603 |
  |    COVID-19 with acute kidney injury    1    11.0445   0.090543   0.012754 
>   0.642770 |
  +----------------------------------------------------------------------------
> -----------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------+
  |            covid_acute_kidney_injury   agegroup    D          Y        Rate
>        Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------|
  | COVID-19 without acute kidney injury     18-<50   12   124.0137   0.0967635
>    0.0549529   0.1703854 |
  | COVID-19 without acute kidney injury     50-<60    2    37.0075   0.0540431
>    0.0135160   0.2160878 |
  | COVID-19 without acute kidney injury     60-<70    6    27.1431   0.2210510
>    0.0993095   0.4920329 |
  | COVID-19 without acute kidney injury     70-<80    1    17.9849   0.0556021
>    0.0078323   0.3947231 |
  | COVID-19 without acute kidney injury        80+    1    12.7967   0.0781451
>    0.0110078   0.5547573 |
  |----------------------------------------------------------------------------
> -------------------------|
  |    COVID-19 with acute kidney injury     18-<50    1     4.3340   0.2307328
>    0.0325018     1.6e+00 |
  |    COVID-19 with acute kidney injury     50-<60    0     3.9097     0.0e+00
>            .           . |
  |    COVID-19 with acute kidney injury     60-<70    0     1.4702     0.0e+00
>            .           . |
  |    COVID-19 with acute kidney injury     70-<80    0     1.3306     0.0e+00
>            .           . |
  +----------------------------------------------------------------------------
> -------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |            covid_acute_kidney_injury     male    D          Y       Rate   
>    Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | COVID-19 without acute kidney injury   Female    9   115.8357   0.077696   
> 0.040426   0.149325 |
  | COVID-19 without acute kidney injury     Male   13   103.1102   0.126079   
> 0.073208   0.217131 |
  |    COVID-19 with acute kidney injury   Female    1     6.4914   0.154049   
> 0.021700   1.093604 |
  |    COVID-19 with acute kidney injury     Male    0     4.5530   0.000000   
>        .          . |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------------+
  |            covid_acute_kidney_injury                ethnicity    D         
>  Y       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------------------------|
  | COVID-19 without acute kidney injury                    White   10   130.44
> 49   0.076661   0.041248   0.142478 |
  | COVID-19 without acute kidney injury   Asian or Asian British    3    17.14
> 72   0.174956   0.056427   0.542463 |
  | COVID-19 without acute kidney injury                    Other    3    23.37
> 03   0.128368   0.041401   0.398014 |
  | COVID-19 without acute kidney injury                  Unknown    6    47.98
> 36   0.125043   0.056177   0.278330 |
  |    COVID-19 with acute kidney injury                    White    0     7.26
> 35   0.000000          .          . |
  |----------------------------------------------------------------------------
> ------------------------------------|
  |    COVID-19 with acute kidney injury                    Other    0     0.57
> 77   0.000000          .          . |
  |    COVID-19 with acute kidney injury                  Unknown    1     3.20
> 33   0.312179   0.043975   2.216184 |
  +----------------------------------------------------------------------------
> ------------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------------+
  |            covid_acute_kidney_injury                imd   D         Y      
>  Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ----------------------------|
  | COVID-19 without acute kidney injury   1 least deprived   4   41.7632   0.0
> 95778   0.035947   0.255192 |
  | COVID-19 without acute kidney injury                  2   6   44.3614   0.1
> 35253   0.060764   0.301056 |
  | COVID-19 without acute kidney injury                  3   7   43.4470   0.1
> 61116   0.076809   0.337958 |
  | COVID-19 without acute kidney injury                  4   5   41.7276   0.1
> 19825   0.049874   0.287883 |
  | COVID-19 without acute kidney injury    5 most deprived   0   47.6468   0.0
> 00000          .          . |
  |----------------------------------------------------------------------------
> ----------------------------|
  |    COVID-19 with acute kidney injury   1 least deprived   0    0.4600   0.0
> 00000          .          . |
  |    COVID-19 with acute kidney injury                  2   0    1.8563   0.0
> 00000          .          . |
  |    COVID-19 with acute kidney injury                  3   0    1.5441   0.0
> 00000          .          . |
  |    COVID-19 with acute kidney injury                  4   1    1.4456   0.6
> 91761   0.097444   4.910863 |
  |    COVID-19 with acute kidney injury    5 most deprived   0    5.7385   0.0
> 00000          .          . |
  +----------------------------------------------------------------------------
> ----------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(124 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |            covid_acute_kidney_injury   baseli~t   D         Y       Rate   
>    Lower      Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | COVID-19 without acute kidney injury      15-29   0    0.0657   0.000000   
>        .          . |
  | COVID-19 without acute kidney injury      30-44   1    9.8754   0.101261   
> 0.014264   0.718862 |
  | COVID-19 without acute kidney injury      45-59   2   17.3142   0.115512   
> 0.028889   0.461869 |
  | COVID-19 without acute kidney injury      60-74   2   16.5421   0.120904   
> 0.030238   0.483426 |
  | COVID-19 without acute kidney injury      75-89   5   17.3032   0.288964   
> 0.120275   0.694244 |
  |----------------------------------------------------------------------------
> --------------------|
  | COVID-19 without acute kidney injury     90-104   2   21.9165   0.091255   
> 0.022823   0.364879 |
  | COVID-19 without acute kidney injury       ≥105   3   34.9213   0.085907   
> 0.027707   0.266362 |
  |    COVID-19 with acute kidney injury      30-44   0    0.4600   0.000000   
>        .          . |
  |    COVID-19 with acute kidney injury      45-59   0    0.7995   0.000000   
>        .          . |
  |    COVID-19 with acute kidney injury      60-74   0    1.7385   0.000000   
>        .          . |
  |----------------------------------------------------------------------------
> --------------------|
  |    COVID-19 with acute kidney injury       ≥105   1    1.4456   0.691761   
> 0.097444   4.910863 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------+
  |            covid_acute_kidney_injury   diabetes    D          Y       Rate 
>      Lower      Upper |
  |----------------------------------------------------------------------------
> ----------------------|
  | COVID-19 without acute kidney injury          0   18   171.8905   0.104718 
>   0.065977   0.166208 |
  | COVID-19 without acute kidney injury          1    4    47.0554   0.085006 
>   0.031904   0.226491 |
  |    COVID-19 with acute kidney injury          0    1     8.8460   0.113045 
>   0.015924   0.802518 |
  |    COVID-19 with acute kidney injury          1    0     2.1985   0.000000 
>          .          . |
  +----------------------------------------------------------------------------
> ----------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/aki_covid_acute_kidney_injury.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |    COVID-19 kidney
        if |  replacement therapy
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       190         16 |       206 
           |     90.48      84.21 |     89.96 
-----------+----------------------+----------
         1 |        20          3 |        23 
           |      9.52      15.79 |     10.04 
-----------+----------------------+----------
     Total |       210         19 |       229 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.7571   Pr = 0.384

         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                                   covid_krt    D          Y       Rate     
>  Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------|
  | COVID-19 without kidney replacement therapy   20   212.6571   0.094048   0.
> 060676   0.145776 |
  |    COVID-19 with kidney replacement therapy    3    17.3333   0.173077   0.
> 055821   0.536637 |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |                                   covid_krt   agegroup    D          Y     
>    Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  | COVID-19 without kidney replacement therapy     18-<50   12   114.5873   0.
> 1047237   0.0594736   0.1844020 |
  | COVID-19 without kidney replacement therapy     50-<60    1    39.2964   0.
> 0254476   0.0035846   0.1806546 |
  | COVID-19 without kidney replacement therapy     60-<70    6    28.5476   0.
> 2101755   0.0944236   0.4678253 |
  | COVID-19 without kidney replacement therapy     70-<80    1    19.3155   0.
> 0517718   0.0072928   0.3675317 |
  | COVID-19 without kidney replacement therapy        80+    0    10.9103     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |    COVID-19 with kidney replacement therapy     18-<50    1    13.7604   0.
> 0726721   0.0102368   0.5159045 |
  |    COVID-19 with kidney replacement therapy     50-<60    1     1.6208   0.
> 6169764   0.0869094     4.4e+00 |
  |    COVID-19 with kidney replacement therapy     60-<70    0     0.0657     
> 0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy        80+    1     1.8864   0.
> 5301161   0.0746740     3.8e+00 |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------+
  |                                   covid_krt     male    D          Y       
> Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------------|
  | COVID-19 without kidney replacement therapy   Female    9   116.0000   0.07
> 7586   0.040369   0.149114 |
  | COVID-19 without kidney replacement therapy     Male   11    96.6571   0.11
> 3804   0.063025   0.205497 |
  |    COVID-19 with kidney replacement therapy   Female    1     6.3272   0.15
> 8048   0.022263   1.121997 |
  |    COVID-19 with kidney replacement therapy     Male    2    11.0062   0.18
> 1716   0.045447   0.726582 |
  +----------------------------------------------------------------------------
> ---------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------------------+
  |                                   covid_krt                ethnicity    D  
>         Y       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------------------------------|
  | COVID-19 without kidney replacement therapy                    White   10  
>  127.8877   0.078194   0.042072   0.145326 |
  | COVID-19 without kidney replacement therapy   Asian or Asian British    3  
>   15.9069   0.188597   0.060827   0.584759 |
  | COVID-19 without kidney replacement therapy                    Other    2  
>   22.1410   0.090330   0.022591   0.361180 |
  | COVID-19 without kidney replacement therapy                  Unknown    5  
>   46.7214   0.107017   0.044544   0.257112 |
  |    COVID-19 with kidney replacement therapy                    White    0  
>    9.8207   0.000000          .          . |
  |----------------------------------------------------------------------------
> -------------------------------------------|
  |    COVID-19 with kidney replacement therapy   Asian or Asian British    0  
>    1.2402   0.000000          .          . |
  |    COVID-19 with kidney replacement therapy                    Other    1  
>    1.8070   0.553409   0.077955   3.928691 |
  |    COVID-19 with kidney replacement therapy                  Unknown    2  
>    4.4654   0.447885   0.112015   1.790839 |
  +----------------------------------------------------------------------------
> -------------------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------------+
  |                                   covid_krt                imd   D         
> Y       Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------------------------|
  | COVID-19 without kidney replacement therapy   1 least deprived   3   37.141
> 7   0.080772   0.026051   0.250439 |
  | COVID-19 without kidney replacement therapy                  2   6   44.131
> 4   0.135958   0.061080   0.302625 |
  | COVID-19 without kidney replacement therapy                  3   6   39.797
> 4   0.150764   0.067732   0.335582 |
  | COVID-19 without kidney replacement therapy                  4   5   39.362
> 1   0.127026   0.052872   0.305183 |
  | COVID-19 without kidney replacement therapy    5 most deprived   0   52.224
> 5   0.000000          .          . |
  |----------------------------------------------------------------------------
> -----------------------------------|
  |    COVID-19 with kidney replacement therapy   1 least deprived   1    5.081
> 5   0.196794   0.027721   1.397056 |
  |    COVID-19 with kidney replacement therapy                  2   0    2.086
> 2   0.000000          .          . |
  |    COVID-19 with kidney replacement therapy                  3   1    5.193
> 7   0.192541   0.027122   1.366861 |
  |    COVID-19 with kidney replacement therapy                  4   1    3.811
> 1   0.262392   0.036961   1.862741 |
  |    COVID-19 with kidney replacement therapy    5 most deprived   0    1.160
> 8   0.000000          .          . |
  +----------------------------------------------------------------------------
> -----------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(124 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------+
  |                                   covid_krt   baseli~t   D         Y       
> Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> ---------------------------|
  | COVID-19 without kidney replacement therapy      30-44   1   10.3354   0.09
> 6755   0.013629   0.686870 |
  | COVID-19 without kidney replacement therapy      45-59   2   16.1725   0.12
> 3667   0.030929   0.494474 |
  | COVID-19 without kidney replacement therapy      60-74   2   16.9254   0.11
> 8166   0.029553   0.472478 |
  | COVID-19 without kidney replacement therapy      75-89   4   16.7721   0.23
> 8492   0.089510   0.635439 |
  | COVID-19 without kidney replacement therapy     90-104   2   20.6407   0.09
> 6896   0.024233   0.387433 |
  |----------------------------------------------------------------------------
> ---------------------------|
  | COVID-19 without kidney replacement therapy       ≥105   3   32.0739   0.09
> 3534   0.030167   0.290008 |
  |    COVID-19 with kidney replacement therapy      15-29   0    0.0657   0.00
> 0000          .          . |
  |    COVID-19 with kidney replacement therapy      45-59   0    1.9411   0.00
> 0000          .          . |
  |    COVID-19 with kidney replacement therapy      60-74   0    1.3552   0.00
> 0000          .          . |
  |    COVID-19 with kidney replacement therapy      75-89   1    0.5311   1.88
> 2732   0.265208    1.3e+01 |
  |----------------------------------------------------------------------------
> ---------------------------|
  |    COVID-19 with kidney replacement therapy     90-104   0    1.2758   0.00
> 0000          .          . |
  |    COVID-19 with kidney replacement therapy       ≥105   1    4.2930   0.23
> 2940   0.032813   1.653658 |
  +----------------------------------------------------------------------------
> ---------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------+
  |                                   covid_krt   diabetes    D          Y     
>   Rate      Lower      Upper |
  |----------------------------------------------------------------------------
> -----------------------------|
  | COVID-19 without kidney replacement therapy          0   17   166.3053   0.
> 102222   0.063547   0.164433 |
  | COVID-19 without kidney replacement therapy          1    3    46.3518   0.
> 064722   0.020874   0.200676 |
  |    COVID-19 with kidney replacement therapy          0    2    14.4312   0.
> 138589   0.034661   0.554138 |
  |    COVID-19 with kidney replacement therapy          1    1     2.9021   0.
> 344575   0.048538   2.446166 |
  +----------------------------------------------------------------------------
> -----------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/aki_covid_krt.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |             Vaccination status
  censored | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         4         11         46        145 |       206 
           |    100.00      91.67      86.79      90.62 |     89.96 
-----------+--------------------------------------------+----------
         1 |         0          1          7         15 |        23 
           |      0.00       8.33      13.21       9.38 |     10.04 
-----------+--------------------------------------------+----------
     Total |         4         12         53        160 |       229 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   1.1518   Pr = 0.765

         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> -------+
  |                 covid_vax_status    D          Y       Rate      Lower     
>  Upper |
  |----------------------------------------------------------------------------
> -------|
  |  SARS-CoV-2 after 1 vaccine dose    0     4.1889   0.000000          .     
>      . |
  | SARS-CoV-2 after 2 vaccine doses    1    12.6680   0.078939   0.011120   0.
> 560392 |
  | SARS-CoV-2 after 3 vaccine doses    7    54.6174   0.128164   0.061100   0.
> 268838 |
  | SARS-CoV-2 after 4 vaccine doses   15   158.5161   0.094628   0.057048   0.
> 156963 |
  +----------------------------------------------------------------------------
> -------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                 covid_vax_status   agegroup    D         Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  |  SARS-CoV-2 after 1 vaccine dose     18-<50    0    2.2368     0.0e+00     
>       .           . |
  |  SARS-CoV-2 after 1 vaccine dose     60-<70    0    1.9521     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     18-<50    0    3.4168     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     50-<60    0    1.6235     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     60-<70    0    1.7002     0.0e+00     
>       .           . |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 2 vaccine doses     70-<80    0    3.4990     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses        80+    1    2.4285   0.4117813   0.
> 0580050     2.9e+00 |
  | SARS-CoV-2 after 3 vaccine doses     18-<50    3   36.2136   0.0828419   0.
> 0267183   0.2568571 |
  | SARS-CoV-2 after 3 vaccine doses     50-<60    1    9.8809   0.1012053   0.
> 0142561   0.7184638 |
  | SARS-CoV-2 after 3 vaccine doses     60-<70    3    3.2416   0.9254645   0.
> 2984821     2.9e+00 |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 3 vaccine doses     70-<80    0    0.8378     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses        80+    0    4.4435     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 4 vaccine doses     18-<50   10   86.4805   0.1156330   0.
> 0622169   0.2149094 |
  | SARS-CoV-2 after 4 vaccine doses     50-<60    1   29.4127   0.0339989   0.
> 0047892   0.2413605 |
  | SARS-CoV-2 after 4 vaccine doses     60-<70    3   21.7194   0.1381256   0.
> 0445484   0.4282678 |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 4 vaccine doses     70-<80    1   14.9788   0.0667611   0.
> 0094042   0.4739418 |
  | SARS-CoV-2 after 4 vaccine doses        80+    0    5.9247     0.0e+00     
>       .           . |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 covid_vax_status     male    D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |  SARS-CoV-2 after 1 vaccine dose   Female    0    1.4100   0.000000        
>   .          . |
  |  SARS-CoV-2 after 1 vaccine dose     Male    0    2.7789   0.000000        
>   .          . |
  | SARS-CoV-2 after 2 vaccine doses   Female    0    9.6537   0.000000        
>   .          . |
  | SARS-CoV-2 after 2 vaccine doses     Male    1    3.0144   0.331744   0.046
> 731   2.355073 |
  | SARS-CoV-2 after 3 vaccine doses   Female    5   29.1143   0.171737   0.071
> 482   0.412603 |
  |----------------------------------------------------------------------------
> ---------------|
  | SARS-CoV-2 after 3 vaccine doses     Male    2   25.5031   0.078422   0.019
> 613   0.313565 |
  | SARS-CoV-2 after 4 vaccine doses   Female    5   82.1492   0.060865   0.025
> 334   0.146230 |
  | SARS-CoV-2 after 4 vaccine doses     Male   10   76.3669   0.130947   0.070
> 457   0.243371 |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------+
  |                 covid_vax_status                ethnicity   D         Y    
>     Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------------------|
  |  SARS-CoV-2 after 1 vaccine dose                    White   0    1.5962    
>  0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                    Other   0    0.3559    
>  0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                  Unknown   0    2.2368    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    White   0    7.3183    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    Other   1    4.6270   0
> .2161243   0.0304440     1.5e+00 |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  Unknown   0    0.7228    
>  0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                    White   4   35.7864   0
> .1117742   0.0419508   0.2978120 |
  | SARS-CoV-2 after 3 vaccine doses   Asian or Asian British   1    2.4504   0
> .4081006   0.0574865     2.9e+00 |
  | SARS-CoV-2 after 3 vaccine doses                    Other   1    2.8638   0
> .3491874   0.0491878     2.5e+00 |
  | SARS-CoV-2 after 3 vaccine doses                  Unknown   1   13.5168   0
> .0739822   0.0104214   0.5252047 |
  |----------------------------------------------------------------------------
> ---------------------------------|
  | SARS-CoV-2 after 4 vaccine doses                    White   6   93.0075   0
> .0645109   0.0289822   0.1435935 |
  | SARS-CoV-2 after 4 vaccine doses   Asian or Asian British   2   14.6968   0
> .1360842   0.0340343   0.5441243 |
  | SARS-CoV-2 after 4 vaccine doses                    Other   1   16.1013   0
> .0621068   0.0087486   0.4409005 |
  | SARS-CoV-2 after 4 vaccine doses                  Unknown   6   34.7105   0
> .1728585   0.0776585   0.3847621 |
  +----------------------------------------------------------------------------
> ---------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------+
  |                 covid_vax_status                imd   D         Y       Rat
> e      Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------------|
  |  SARS-CoV-2 after 1 vaccine dose   1 least deprived   0    1.0541   0.00000
> 0          .          . |
  |  SARS-CoV-2 after 1 vaccine dose                  4   0    3.1348   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses   1 least deprived   1    2.2368   0.44706
> 2   0.062975   3.173728 |
  | SARS-CoV-2 after 2 vaccine doses                  2   0    2.4230   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses                  3   0    6.3463   0.00000
> 0          .          . |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  4   0    0.6899   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses    5 most deprived   0    0.9719   0.00000
> 0          .          . |
  | SARS-CoV-2 after 3 vaccine doses   1 least deprived   1    8.9582   0.11162
> 9   0.015724   0.792462 |
  | SARS-CoV-2 after 3 vaccine doses                  2   2   15.2526   0.13112
> 5   0.032794   0.524297 |
  | SARS-CoV-2 after 3 vaccine doses                  3   2    8.3997   0.23810
> 3   0.059549   0.952040 |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 3 vaccine doses                  4   2   10.7379   0.18625
> 7   0.046582   0.744737 |
  | SARS-CoV-2 after 3 vaccine doses    5 most deprived   0   11.2690   0.00000
> 0          .          . |
  | SARS-CoV-2 after 4 vaccine doses   1 least deprived   2   29.9740   0.06672
> 5   0.016688   0.266794 |
  | SARS-CoV-2 after 4 vaccine doses                  2   4   28.5421   0.14014
> 4   0.052599   0.373401 |
  | SARS-CoV-2 after 4 vaccine doses                  3   5   30.2450   0.16531
> 6   0.068809   0.397178 |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 4 vaccine doses                  4   4   28.6105   0.13980
> 9   0.052473   0.372507 |
  | SARS-CoV-2 after 4 vaccine doses    5 most deprived   0   41.1444   0.00000
> 0          .          . |
  +----------------------------------------------------------------------------
> ------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(124 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 covid_vax_status   baseli~t   D         Y       Rate      L
> ower      Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |  SARS-CoV-2 after 1 vaccine dose      60-74   0    1.9521   0.000000       
>    .          . |
  |  SARS-CoV-2 after 1 vaccine dose       ≥105   0    1.0541   0.000000       
>    .          . |
  | SARS-CoV-2 after 2 vaccine doses      30-44   0    2.9131   0.000000       
>    .          . |
  | SARS-CoV-2 after 2 vaccine doses      75-89   1    2.3244   0.430212   0.06
> 0601   3.054106 |
  | SARS-CoV-2 after 2 vaccine doses       ≥105   0    3.3457   0.000000       
>    .          . |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 3 vaccine doses      30-44   1    2.4148   0.414116   0.05
> 8334   2.939837 |
  | SARS-CoV-2 after 3 vaccine doses      45-59   1    6.1109   0.163642   0.02
> 3051   1.161710 |
  | SARS-CoV-2 after 3 vaccine doses      60-74   0    6.2012   0.000000       
>    .          . |
  | SARS-CoV-2 after 3 vaccine doses      75-89   2    7.5455   0.265058   0.06
> 6290   1.059818 |
  | SARS-CoV-2 after 3 vaccine doses     90-104   0    5.6646   0.000000       
>    .          . |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 3 vaccine doses       ≥105   1    5.3333   0.187500   0.02
> 6412   1.331076 |
  | SARS-CoV-2 after 4 vaccine doses      15-29   0    0.0657   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      30-44   0    5.0075   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      45-59   1   12.0027   0.083314   0.01
> 1736   0.591454 |
  | SARS-CoV-2 after 4 vaccine doses      60-74   2   10.1273   0.197486   0.04
> 9391   0.789635 |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 4 vaccine doses      75-89   2    7.4333   0.269061   0.06
> 7291   1.075823 |
  | SARS-CoV-2 after 4 vaccine doses     90-104   2   16.2519   0.123063   0.03
> 0778   0.492058 |
  | SARS-CoV-2 after 4 vaccine doses       ≥105   3   26.6338   0.112639   0.03
> 6328   0.349244 |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 covid_vax_status   diabetes    D          Y       Rate     
>  Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |  SARS-CoV-2 after 1 vaccine dose          0    0     2.5927   0.000000     
>      .          . |
  |  SARS-CoV-2 after 1 vaccine dose          1    0     1.5962   0.000000     
>      .          . |
  | SARS-CoV-2 after 2 vaccine doses          0    0    11.6769   0.000000     
>      .          . |
  | SARS-CoV-2 after 2 vaccine doses          1    1     0.9911   1.008978   0.
> 142128   7.162806 |
  | SARS-CoV-2 after 3 vaccine doses          0    7    41.1006   0.170314   0.
> 081194   0.357251 |
  |----------------------------------------------------------------------------
> ------------------|
  | SARS-CoV-2 after 3 vaccine doses          1    0    13.5168   0.000000     
>      .          . |
  | SARS-CoV-2 after 4 vaccine doses          0   12   125.3662   0.095720   0.
> 054360   0.168547 |
  | SARS-CoV-2 after 4 vaccine doses          1    3    33.1499   0.090498   0.
> 029188   0.280595 |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/aki_covid_vax_status.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |                    Calendar period
  censored | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        59         17         31         36         56 |       206 
           |     86.76      80.95      91.18      90.00      94.92 |     89.96 
-----------+-------------------------------------------------------+----------
         1 |         9          4          3          4          3 |        23 
           |     13.24      19.05       8.82      10.00       5.08 |     10.04 
-----------+-------------------------------------------------------+----------
     Total |        68         21         34         40         59 |       229 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


      1 if |
failure; 0 |  Calendar
        if |   period
  censored | December  |     Total
-----------+-----------+----------
         0 |         7 |       206 
           |    100.00 |     89.96 
-----------+-----------+----------
         1 |         0 |        23 
           |      0.00 |     10.04 
-----------+-----------+----------
     Total |         7 |       229 
           |    100.00 |    100.00 

          Pearson chi2(5) =   5.0945   Pr = 0.404

         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ----+
  |                 calendar_period   D         Y       Rate      Lower      Up
> per |
  |----------------------------------------------------------------------------
> ----|
  |      February 2020 to June 2020   9   98.8939   0.091007   0.047352   0.174
> 907 |
  |        July 2020 to August 2020   4   26.4695   0.151117   0.056717   0.402
> 638 |
  | September 2020 to November 2020   3   38.8994   0.077122   0.024874   0.239
> 122 |
  |  December 2020 to February 2021   4   34.8172   0.114886   0.043119   0.306
> 102 |
  |     March 2021 to November 2021   3   30.5654   0.098150   0.031656   0.304
> 322 |
  |----------------------------------------------------------------------------
> ----|
  |   December 2021 to January 2022   0    0.3450   0.000000          .        
>   . |
  +----------------------------------------------------------------------------
> ----+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 calendar_period   agegroup   D         Y        Rate       
> Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |      February 2020 to June 2020     18-<50   5   49.1773   0.1016730   0.04
> 23191   0.2442724 |
  |      February 2020 to June 2020     50-<60   1   23.1348   0.0432249   0.00
> 60888   0.3068563 |
  |      February 2020 to June 2020     60-<70   2   19.8932   0.1005367   0.02
> 51440   0.4019900 |
  |      February 2020 to June 2020     70-<80   1    5.0157   0.1993723   0.02
> 80843     1.4e+00 |
  |      February 2020 to June 2020        80+   0    1.6728     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |        July 2020 to August 2020     18-<50   2   11.2663   0.1775213   0.04
> 43977   0.7098078 |
  |        July 2020 to August 2020     50-<60   0    5.6810     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     60-<70   2    3.1157   0.6419156   0.16
> 05416     2.6e+00 |
  |        July 2020 to August 2020     70-<80   0    4.4025     0.0e+00       
>     .           . |
  |        July 2020 to August 2020        80+   0    2.0041     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  | September 2020 to November 2020     18-<50   2   28.9254   0.0691434   0.01
> 72926   0.2764656 |
  | September 2020 to November 2020     50-<60   1    3.5866   0.2788168   0.03
> 92751     2.0e+00 |
  | September 2020 to November 2020     70-<80   0    3.8631     0.0e+00       
>     .           . |
  | September 2020 to November 2020        80+   0    2.5243     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     18-<50   3   22.0808   0.1358648   0.04
> 38193   0.4212584 |
  |----------------------------------------------------------------------------
> ------------------|
  |  December 2020 to February 2021     50-<60   0    4.6215     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     60-<70   0    3.0363     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     70-<80   0    2.5982     0.0e+00       
>     .           . |
  |  December 2020 to February 2021        80+   1    2.4805   0.4031457   0.05
> 67885     2.9e+00 |
  |     March 2021 to November 2021     18-<50   1   16.6954   0.0598967   0.00
> 84373   0.4252109 |
  |----------------------------------------------------------------------------
> ------------------|
  |     March 2021 to November 2021     50-<60   0    3.8001     0.0e+00       
>     .           . |
  |     March 2021 to November 2021     60-<70   2    2.5681   0.7787846   0.19
> 47722     3.1e+00 |
  |     March 2021 to November 2021     70-<80   0    3.4086     0.0e+00       
>     .           . |
  |     March 2021 to November 2021        80+   0    4.0931     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     18-<50   0    0.2026     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |   December 2021 to January 2022     50-<60   0    0.0931     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     70-<80   0    0.0274     0.0e+00       
>     .           . |
  |   December 2021 to January 2022        80+   0    0.0219     0.0e+00       
>     .           . |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 calendar_period     male   D         Y        Rate       Lo
> wer       Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020   Female   4   49.2950   0.0811441   0.0304
> 548   0.2162011 |
  |      February 2020 to June 2020     Male   5   49.5989   0.1008087   0.0419
> 594   0.2421959 |
  |        July 2020 to August 2020   Female   1   13.7851   0.0725422   0.0102
> 185   0.5149823 |
  |        July 2020 to August 2020     Male   3   12.6845   0.2365098   0.0762
> 795   0.7333151 |
  | September 2020 to November 2020   Female   1   22.2313   0.0449815   0.0063
> 363   0.3193271 |
  |----------------------------------------------------------------------------
> ----------------|
  | September 2020 to November 2020     Male   2   16.6680   0.1199901   0.0300
> 093   0.4797732 |
  |  December 2020 to February 2021   Female   1   20.3997   0.0490203   0.0069
> 052   0.3479984 |
  |  December 2020 to February 2021     Male   3   14.4175   0.2080801   0.0671
> 103   0.6451669 |
  |     March 2021 to November 2021   Female   3   16.4901   0.1819276   0.0586
> 756   0.5640792 |
  |     March 2021 to November 2021     Male   0   14.0753     0.0e+00         
>   .           . |
  |----------------------------------------------------------------------------
> ----------------|
  |   December 2021 to January 2022   Female   0    0.1259     0.0e+00         
>   .           . |
  |   December 2021 to January 2022     Male   0    0.2190     0.0e+00         
>   .           . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |                 calendar_period                ethnicity   D         Y     
>    Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  |      February 2020 to June 2020                    White   6   58.9651   0.
> 1017551   0.0457146   0.2264946 |
  |      February 2020 to June 2020   Asian or Asian British   0   10.8255     
> 0.0e+00           .           . |
  |      February 2020 to June 2020                    Other   1   12.3340   0.
> 0810766   0.0114207   0.5755684 |
  |      February 2020 to June 2020                  Unknown   2   16.7693   0.
> 1192653   0.0298280   0.4768750 |
  |        July 2020 to August 2020                    White   0   17.7221     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |        July 2020 to August 2020   Asian or Asian British   1    0.9199     
> 1.1e+00   0.1531262     7.7e+00 |
  |        July 2020 to August 2020                  Unknown   3    7.8275   0.
> 3832634   0.1236106     1.2e+00 |
  | September 2020 to November 2020                    White   3   21.5277   0.
> 1393552   0.0449450   0.4320805 |
  | September 2020 to November 2020   Asian or Asian British   0    1.2402     
> 0.0e+00           .           . |
  | September 2020 to November 2020                    Other   0    7.4634     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  | September 2020 to November 2020                  Unknown   0    8.6680     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                    White   1   22.8747   0.
> 0437163   0.0061580   0.3103454 |
  |  December 2020 to February 2021   Asian or Asian British   1    1.7851   0.
> 5601994   0.0789116     4.0e+00 |
  |  December 2020 to February 2021                    Other   1    0.5311     
> 1.9e+00   0.2652082     1.3e+01 |
  |  December 2020 to February 2021                  Unknown   1    9.6263   0.
> 1038823   0.0146332   0.7374675 |
  |----------------------------------------------------------------------------
> --------------------------------|
  |     March 2021 to November 2021                    White   0   16.3450     
> 0.0e+00           .           . |
  |     March 2021 to November 2021   Asian or Asian British   1    2.3765   0.
> 4207949   0.0592746     3.0e+00 |
  |     March 2021 to November 2021                    Other   1    3.5893   0.
> 2786041   0.0392451     2.0e+00 |
  |     March 2021 to November 2021                  Unknown   1    8.2546   0.
> 1211443   0.0170648   0.8600119 |
  |   December 2021 to January 2022                    White   0    0.2738     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |   December 2021 to January 2022                    Other   0    0.0301     
> 0.0e+00           .           . |
  |   December 2021 to January 2022                  Unknown   0    0.0411     
> 0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                 calendar_period                imd   D         Y        Rat
> e       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  |      February 2020 to June 2020   1 least deprived   1   13.5880   0.073594
> 6   0.0103668   0.5224533 |
  |      February 2020 to June 2020                  2   2   18.3272   0.109127
> 6   0.0272926   0.4363399 |
  |      February 2020 to June 2020                  3   4   20.7228   0.193024
> 2   0.0724454   0.5142952 |
  |      February 2020 to June 2020                  4   2   15.8220   0.126406
> 0   0.0316138   0.5054264 |
  |      February 2020 to June 2020    5 most deprived   0   30.4339     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |        July 2020 to August 2020   1 least deprived   0    4.2765     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  2   1    8.8953   0.112419
> 2   0.0158358   0.7980720 |
  |        July 2020 to August 2020                  3   2    6.6502   0.300741
> 0   0.0752146     1.2e+00 |
  |        July 2020 to August 2020                  4   1    3.8166   0.262015
> 8   0.0369085     1.9e+00 |
  |        July 2020 to August 2020    5 most deprived   0    2.8309     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  | September 2020 to November 2020   1 least deprived   1   14.6502   0.068258
> 3   0.0096151   0.4845703 |
  | September 2020 to November 2020                  2   1    7.4853   0.133595
> 5   0.0188187   0.9484037 |
  | September 2020 to November 2020                  3   1    4.7036   0.212601
> 9   0.0299478     1.5e+00 |
  | September 2020 to November 2020                  4   0    8.5503     0.0e+0
> 0           .           . |
  | September 2020 to November 2020    5 most deprived   0    3.5099     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |  December 2020 to February 2021   1 least deprived   1    6.1739   0.161973
> 4   0.0228161     1.1e+00 |
  |  December 2020 to February 2021                  2   2    3.9316   0.508704
> 7   0.1272259     2.0e+00 |
  |  December 2020 to February 2021                  3   0    7.6851     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  4   1    7.4825   0.133644
> 3   0.0188256   0.9487508 |
  |  December 2020 to February 2021    5 most deprived   0    9.5441     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |     March 2021 to November 2021   1 least deprived   1    3.3785   0.295988
> 7   0.0416940     2.1e+00 |
  |     March 2021 to November 2021                  2   0    7.4935     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  3   0    5.1554     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  4   2    7.5017   0.266605
> 8   0.0666775     1.1e+00 |
  |     March 2021 to November 2021    5 most deprived   0    7.0363     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |   December 2021 to January 2022   1 least deprived   0    0.1561     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  2   0    0.0849     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  3   0    0.0739     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022    5 most deprived   0    0.0301     0.0e+0
> 0           .           . |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(124 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 calendar_period   baseli~t   D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020      30-44   1    5.4401   0.183820   0.025
> 894   1.304950 |
  |      February 2020 to June 2020      45-59   1    9.7221   0.102858   0.014
> 489   0.730199 |
  |      February 2020 to June 2020      60-74   1   10.6420   0.093967   0.013
> 237   0.667079 |
  |      February 2020 to June 2020      75-89   2    9.2621   0.215933   0.054
> 004   0.863393 |
  |      February 2020 to June 2020     90-104   1    9.8152   0.101883   0.014
> 352   0.723274 |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020       ≥105   0   13.6701   0.000000        
>   .          . |
  |        July 2020 to August 2020      45-59   0    1.4839   0.000000        
>   .          . |
  |        July 2020 to August 2020      60-74   0    2.7242   0.000000        
>   .          . |
  |        July 2020 to August 2020      75-89   1    0.5859   1.706776   0.240
> 422    1.2e+01 |
  |        July 2020 to August 2020     90-104   1    2.3025   0.434304   0.061
> 178   3.083158 |
  |----------------------------------------------------------------------------
> ---------------|
  |        July 2020 to August 2020       ≥105   1    0.3970   2.518966   0.354
> 830    1.8e+01 |
  | September 2020 to November 2020      30-44   0    2.4531   0.000000        
>   .          . |
  | September 2020 to November 2020      45-59   0    1.2485   0.000000        
>   .          . |
  | September 2020 to November 2020      60-74   1    2.2697   0.440591   0.062
> 063   3.127787 |
  | September 2020 to November 2020      75-89   1    4.6954   0.212974   0.030
> 000   1.511916 |
  |----------------------------------------------------------------------------
> ---------------|
  | September 2020 to November 2020     90-104   0    3.9754   0.000000        
>   .          . |
  | September 2020 to November 2020       ≥105   0    6.0507   0.000000        
>   .          . |
  |  December 2020 to February 2021      15-29   0    0.0657   0.000000        
>   .          . |
  |  December 2020 to February 2021      45-59   0    2.0123   0.000000        
>   .          . |
  |  December 2020 to February 2021      60-74   0    0.8460   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |  December 2020 to February 2021      75-89   1    1.5496   0.645318   0.090
> 902   4.581159 |
  |  December 2020 to February 2021     90-104   0    4.0438   0.000000        
>   .          . |
  |  December 2020 to February 2021       ≥105   1    9.1882   0.108835   0.015
> 331   0.772627 |
  |     March 2021 to November 2021      30-44   0    2.4422   0.000000        
>   .          . |
  |     March 2021 to November 2021      45-59   1    3.6468   0.274212   0.038
> 626   1.946649 |
  |----------------------------------------------------------------------------
> ---------------|
  |     March 2021 to November 2021      60-74   0    1.7988   0.000000        
>   .          . |
  |     March 2021 to November 2021      75-89   0    1.2101   0.000000        
>   .          . |
  |     March 2021 to November 2021     90-104   0    1.7495   0.000000        
>   .          . |
  |     March 2021 to November 2021       ≥105   2    7.0609   0.283249   0.070
> 840   1.132555 |
  |   December 2021 to January 2022     90-104   0    0.0301   0.000000        
>   .          . |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(229 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 calendar_period   diabetes   D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020          0   7   72.7885   0.096169   0.045
> 847   0.201725 |
  |      February 2020 to June 2020          1   2   26.1054   0.076612   0.019
> 161   0.306330 |
  |        July 2020 to August 2020          0   4   23.7016   0.168765   0.063
> 341   0.449659 |
  |        July 2020 to August 2020          1   0    2.7680   0.000000        
>   .          . |
  | September 2020 to November 2020          0   2   30.4887   0.065598   0.016
> 406   0.262290 |
  |----------------------------------------------------------------------------
> ---------------|
  | September 2020 to November 2020          1   1    8.4107   0.118896   0.016
> 748   0.844055 |
  |  December 2020 to February 2021          0   3   27.7290   0.108190   0.034
> 894   0.335451 |
  |  December 2020 to February 2021          1   1    7.0883   0.141078   0.019
> 873   1.001520 |
  |     March 2021 to November 2021          0   3   25.7139   0.116668   0.037
> 628   0.361739 |
  |     March 2021 to November 2021          1   0    4.8515   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |   December 2021 to January 2022          0   0    0.3149   0.000000        
>   .          . |
  |   December 2021 to January 2022          1   0    0.0301   0.000000        
>   .          . |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  aki_outcome_date
   analysis time _t:  (exit_date_aki-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/aki_calendar_period.svg written in SVG format)

.         
. * Death rates (stratified)
. stset exit_date_death, fail(death_date) origin(index_date) id(patient_id) sca
> le(365.25)

                id:  patient_id
     failure event:  death_date != 0 & death_date < .
obs. time interval:  (exit_date_death[_n-1], exit_date_death]
 exit on or before:  failure
    t for analysis:  (time-origin)/365.25
            origin:  time index_date

------------------------------------------------------------------------------
        276  total observations
         27  observations end on or before enter()
------------------------------------------------------------------------------
        249  observations remaining, representing
        249  subjects
          5  failures in single-failure-per-subject data
    270.138  total analysis time at risk and under observation
                                                at risk from t =         0
                                     earliest observed entry t =         0
                                          last observed exit t =   1.91102

. foreach stratum of varlist      covid_severity                          ///
>                                                         covid_acute_kidney_in
> jury       ///
>                                                         covid_krt            
>                            ///
>                                                         covid_vax_status     
>                    ///
>                                                         calendar_period {
  2.         tab _d `stratum', col chi
  3.         strate `stratum'
  4.         strate `stratum' agegroup
  5.         strate `stratum' male
  6.         strate `stratum' ethnicity
  7.         strate `stratum' imd
  8.         strate `stratum' baseline_egfr_cat
  9.         strate `stratum' diabetes
 10.         sts graph, failure by(`stratum') title(Cumulative mortality after 
> SARS-CoV-2 survival by `stratum') ylab(0(0.10)0.50, angle(horizontal)) ytitle
> (Cumulative mortality) xtitle(Follow-up (years))
 11.         graph export ./output/mortality_`stratum'.svg,  replace
 12.         }

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |       SARS-CoV-2 severity
  censored | SARS-CoV-  COVID-19   COVID-19  |     Total
-----------+---------------------------------+----------
         0 |        26          1        217 |       244 
           |     96.30     100.00      98.19 |     97.99 
-----------+---------------------------------+----------
         1 |         1          0          4 |         5 
           |      3.70       0.00       1.81 |      2.01 
-----------+---------------------------------+----------
     Total |        27          1        221 |       249 
           |    100.00     100.00     100.00 |    100.00 

          Pearson chi2(2) =   0.4591   Pr = 0.795

         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------+
  |                     covid_severity   D          Y        Rate       Lower  
>      Upper |
  |----------------------------------------------------------------------------
> -----------|
  | SARS-CoV-2 without hospitalisation   1    28.6379   0.0349187   0.0049188  
>  0.2478906 |
  |      COVID-19 with hospitalisation   0     0.7721     0.0e+00           .  
>          . |
  |        COVID-19 with critical care   4   240.7283   0.0166162   0.0062364  
>  0.0442725 |
  +----------------------------------------------------------------------------
> -----------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------+
  |                     covid_severity   agegroup   D          Y        Rate   
>     Lower       Upper |
  |----------------------------------------------------------------------------
> ----------------------|
  | SARS-CoV-2 without hospitalisation     18-<50   1    16.7173   0.0598182   
> 0.0084262   0.4246538 |
  | SARS-CoV-2 without hospitalisation     50-<60   0     7.0007     0.0e+00   
>         .           . |
  | SARS-CoV-2 without hospitalisation     60-<70   0     2.6502     0.0e+00   
>         .           . |
  | SARS-CoV-2 without hospitalisation     70-<80   0     2.2697     0.0e+00   
>         .           . |
  |      COVID-19 with hospitalisation     50-<60   0     0.7721     0.0e+00   
>         .           . |
  |----------------------------------------------------------------------------
> ----------------------|
  |        COVID-19 with critical care     18-<50   3   135.6961   0.0221082   
> 0.0071304   0.0685481 |
  |        COVID-19 with critical care     50-<60   0    37.0513     0.0e+00   
>         .           . |
  |        COVID-19 with critical care     60-<70   1    32.2163   0.0310402   
> 0.0043724   0.2203566 |
  |        COVID-19 with critical care     70-<80   0    21.7248     0.0e+00   
>         .           . |
  |        COVID-19 with critical care        80+   0    14.0397     0.0e+00   
>         .           . |
  +----------------------------------------------------------------------------
> ----------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                     covid_severity     male   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 without hospitalisation   Female   0    14.4641     0.0e+00     
>       .           . |
  | SARS-CoV-2 without hospitalisation     Male   1    14.1739   0.0705524   0.
> 0099383   0.5008568 |
  |      COVID-19 with hospitalisation   Female   0     0.7721     0.0e+00     
>       .           . |
  |        COVID-19 with critical care   Female   0   124.7611     0.0e+00     
>       .           . |
  |        COVID-19 with critical care     Male   4   115.9671   0.0344925   0.
> 0129457   0.0919022 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------------+
  |                     covid_severity                ethnicity   D          Y 
>        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------------------|
  | SARS-CoV-2 without hospitalisation                    White   0    13.9521 
>     0.0e+00           .           . |
  | SARS-CoV-2 without hospitalisation   Asian or Asian British   0     1.8782 
>     0.0e+00           .           . |
  | SARS-CoV-2 without hospitalisation                    Other   0     2.1191 
>     0.0e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  Unknown   1    10.6886 
>   0.0935579   0.0131789   0.6641741 |
  |      COVID-19 with hospitalisation                    White   0     0.7721 
>     0.0e+00           .           . |
  |----------------------------------------------------------------------------
> ------------------------------------|
  |        COVID-19 with critical care                    White   2   149.5770 
>   0.0133710   0.0033441   0.0534633 |
  |        COVID-19 with critical care   Asian or Asian British   0    19.0992 
>     0.0e+00           .           . |
  |        COVID-19 with critical care                    Other   1    24.4682 
>   0.0408694   0.0057570   0.2901349 |
  |        COVID-19 with critical care                  Unknown   1    47.5838 
>   0.0210155   0.0029603   0.1491908 |
  +----------------------------------------------------------------------------
> ------------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------+
  |                     covid_severity                imd   D         Y        
> Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------------|
  | SARS-CoV-2 without hospitalisation   1 least deprived   0    7.0500     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  2   0    4.9418     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  3   0    5.5989     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation                  4   0    4.6872     0.0
> e+00           .           . |
  | SARS-CoV-2 without hospitalisation    5 most deprived   1    6.3600   0.157
> 2320   0.0221483     1.1e+00 |
  |----------------------------------------------------------------------------
> -----------------------------|
  |      COVID-19 with hospitalisation                  4   0    0.7721     0.0
> e+00           .           . |
  |        COVID-19 with critical care   1 least deprived   0   45.9822     0.0
> e+00           .           . |
  |        COVID-19 with critical care                  2   2   51.4497   0.038
> 8729   0.0097220   0.1554310 |
  |        COVID-19 with critical care                  3   1   47.5838   0.021
> 0155   0.0029603   0.1491908 |
  |        COVID-19 with critical care                  4   0   44.9555     0.0
> e+00           .           . |
  |----------------------------------------------------------------------------
> -----------------------------|
  |        COVID-19 with critical care    5 most deprived   1   50.7570   0.019
> 7017   0.0027753   0.1398638 |
  +----------------------------------------------------------------------------
> -----------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(135 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------+
  |                     covid_severity   baseli~t   D         Y        Rate    
>    Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------|
  | SARS-CoV-2 without hospitalisation      45-59   0    4.3149     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation      75-89   0    2.2094     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation     90-104   0    4.2081     0.0e+00    
>        .           . |
  | SARS-CoV-2 without hospitalisation       ≥105   0    3.1650     0.0e+00    
>        .           . |
  |      COVID-19 with hospitalisation      45-59   0    0.7721     0.0e+00    
>        .           . |
  |----------------------------------------------------------------------------
> ---------------------|
  |        COVID-19 with critical care      15-29   0    1.0513     0.0e+00    
>        .           . |
  |        COVID-19 with critical care      30-44   0   11.6222     0.0e+00    
>        .           . |
  |        COVID-19 with critical care      45-59   0   14.6612     0.0e+00    
>        .           . |
  |        COVID-19 with critical care      60-74   1   20.1971   0.0495120   0
> .0069744   0.3514892 |
  |        COVID-19 with critical care      75-89   0   18.9870     0.0e+00    
>        .           . |
  |----------------------------------------------------------------------------
> ---------------------|
  |        COVID-19 with critical care     90-104   0   21.6263     0.0e+00    
>        .           . |
  |        COVID-19 with critical care       ≥105   0   43.6140     0.0e+00    
>        .           . |
  +----------------------------------------------------------------------------
> ---------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------+
  |                     covid_severity   diabetes   D          Y        Rate   
>     Lower       Upper |
  |----------------------------------------------------------------------------
> ----------------------|
  | SARS-CoV-2 without hospitalisation          0   1    25.3799   0.0394013   
> 0.0055502   0.2797126 |
  | SARS-CoV-2 without hospitalisation          1   0     3.2580     0.0e+00   
>         .           . |
  |      COVID-19 with hospitalisation          0   0     0.7721     0.0e+00   
>         .           . |
  |        COVID-19 with critical care          0   1   191.9206   0.0052105   
> 0.0007340   0.0369896 |
  |        COVID-19 with critical care          1   3    48.8077   0.0614658   
> 0.0198240   0.1905788 |
  +----------------------------------------------------------------------------
> ----------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/mortality_covid_severity.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 | COVID-19 acute kidney
        if |        injury
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       234         10 |       244 
           |     98.32      90.91 |     97.99 
-----------+----------------------+----------
         1 |         4          1 |         5 
           |      1.68       9.09 |      2.01 
-----------+----------------------+----------
     Total |       238         11 |       249 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   2.9341   Pr = 0.087

         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------+
  |            covid_acute_kidney_injury   D          Y        Rate       Lower
>        Upper |
  |----------------------------------------------------------------------------
> -------------|
  | COVID-19 without acute kidney injury   4   259.0691   0.0154399   0.0057949
>    0.0411382 |
  |    COVID-19 with acute kidney injury   1    11.0691   0.0903413   0.0127258
>    0.6413396 |
  +----------------------------------------------------------------------------
> -------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------+
  |            covid_acute_kidney_injury   agegroup   D          Y        Rate 
>       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------|
  | COVID-19 without acute kidney injury     18-<50   3   148.0548   0.0202628 
>   0.0065352   0.0628261 |
  | COVID-19 without acute kidney injury     50-<60   0    40.9144     0.0e+00 
>           .           . |
  | COVID-19 without acute kidney injury     60-<70   1    33.3963   0.0299434 
>   0.0042179   0.2125706 |
  | COVID-19 without acute kidney injury     70-<80   0    22.6639     0.0e+00 
>           .           . |
  | COVID-19 without acute kidney injury        80+   0    14.0397     0.0e+00 
>           .           . |
  |----------------------------------------------------------------------------
> ------------------------|
  |    COVID-19 with acute kidney injury     18-<50   1     4.3587   0.2294284 
>   0.0323181     1.6e+00 |
  |    COVID-19 with acute kidney injury     50-<60   0     3.9097     0.0e+00 
>           .           . |
  |    COVID-19 with acute kidney injury     60-<70   0     1.4702     0.0e+00 
>           .           . |
  |    COVID-19 with acute kidney injury     70-<80   0     1.3306     0.0e+00 
>           .           . |
  +----------------------------------------------------------------------------
> ------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------+
  |            covid_acute_kidney_injury     male   D          Y       Rate    
>   Lower      Upper |
  |----------------------------------------------------------------------------
> -------------------|
  | COVID-19 without acute kidney injury   Female   0   133.4812   0.000000    
>       .          . |
  | COVID-19 without acute kidney injury     Male   4   125.5880   0.031850   0
> .011954   0.084862 |
  |    COVID-19 with acute kidney injury   Female   0     6.5161   0.000000    
>       .          . |
  |    COVID-19 with acute kidney injury     Male   1     4.5530   0.219633   0
> .030938   1.559192 |
  +----------------------------------------------------------------------------
> -------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------------+
  |            covid_acute_kidney_injury                ethnicity   D          
> Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------------|
  | COVID-19 without acute kidney injury                    White   2   157.037
> 6   0.0127358   0.0031852   0.0509233 |
  | COVID-19 without acute kidney injury   Asian or Asian British   0    20.977
> 4     0.0e+00           .           . |
  | COVID-19 without acute kidney injury                    Other   0    26.009
> 6     0.0e+00           .           . |
  | COVID-19 without acute kidney injury                  Unknown   2    55.044
> 5   0.0363342   0.0090871   0.1452802 |
  |    COVID-19 with acute kidney injury                    White   0     7.263
> 5     0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------------|
  |    COVID-19 with acute kidney injury                    Other   1     0.577
> 7     1.7e+00   0.2438407     1.2e+01 |
  |    COVID-19 with acute kidney injury                  Unknown   0     3.227
> 9     0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |            covid_acute_kidney_injury                imd   D         Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without acute kidney injury   1 least deprived   0   52.5722     0
> .0e+00           .           . |
  | COVID-19 without acute kidney injury                  2   1   54.5352   0.0
> 183368   0.0025830   0.1301740 |
  | COVID-19 without acute kidney injury                  3   1   51.6386   0.0
> 193654   0.0027279   0.1374761 |
  | COVID-19 without acute kidney injury                  4   0   48.9446     0
> .0e+00           .           . |
  | COVID-19 without acute kidney injury    5 most deprived   2   51.3785   0.0
> 389268   0.0097355   0.1556463 |
  |----------------------------------------------------------------------------
> -------------------------------|
  |    COVID-19 with acute kidney injury   1 least deprived   0    0.4600     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury                  2   1    1.8563   0.5
> 387168   0.0758855     3.8e+00 |
  |    COVID-19 with acute kidney injury                  3   0    1.5441     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury                  4   0    1.4702     0
> .0e+00           .           . |
  |    COVID-19 with acute kidney injury    5 most deprived   0    5.7385     0
> .0e+00           .           . |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(135 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------+
  |            covid_acute_kidney_injury   baseli~t   D         Y        Rate  
>      Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------|
  | COVID-19 without acute kidney injury      15-29   0    1.0513     0.0e+00  
>          .           . |
  | COVID-19 without acute kidney injury      30-44   0   11.1622     0.0e+00  
>          .           . |
  | COVID-19 without acute kidney injury      45-59   0   18.9487     0.0e+00  
>          .           . |
  | COVID-19 without acute kidney injury      60-74   1   18.4586   0.0541753  
>  0.0076313   0.3845945 |
  | COVID-19 without acute kidney injury      75-89   0   21.1964     0.0e+00  
>          .           . |
  |----------------------------------------------------------------------------
> -----------------------|
  | COVID-19 without acute kidney injury     90-104   0   25.8344     0.0e+00  
>          .           . |
  | COVID-19 without acute kidney injury       ≥105   0   45.3087     0.0e+00  
>          .           . |
  |    COVID-19 with acute kidney injury      30-44   0    0.4600     0.0e+00  
>          .           . |
  |    COVID-19 with acute kidney injury      45-59   0    0.7995     0.0e+00  
>          .           . |
  |    COVID-19 with acute kidney injury      60-74   0    1.7385     0.0e+00  
>          .           . |
  |----------------------------------------------------------------------------
> -----------------------|
  |    COVID-19 with acute kidney injury       ≥105   0    1.4702     0.0e+00  
>          .           . |
  +----------------------------------------------------------------------------
> -----------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------+
  |            covid_acute_kidney_injury   diabetes   D          Y        Rate 
>       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------|
  | COVID-19 without acute kidney injury          0   1   209.2019   0.0047801 
>   0.0006733   0.0339341 |
  | COVID-19 without acute kidney injury          1   3    49.8672   0.0601598 
>   0.0194028   0.1865295 |
  |    COVID-19 with acute kidney injury          0   1     8.8706   0.1127315 
>   0.0158798   0.8002888 |
  |    COVID-19 with acute kidney injury          1   0     2.1985     0.0e+00 
>           .           . |
  +----------------------------------------------------------------------------
> ------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/mortality_covid_acute_kidney_injury.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |    COVID-19 kidney
        if |  replacement therapy
  censored | COVID-19   COVID-19  |     Total
-----------+----------------------+----------
         0 |       224         20 |       244 
           |     98.25      95.24 |     97.99 
-----------+----------------------+----------
         1 |         4          1 |         5 
           |      1.75       4.76 |      2.01 
-----------+----------------------+----------
     Total |       228         21 |       249 
           |    100.00     100.00 |    100.00 

          Pearson chi2(1) =   0.8839   Pr = 0.347

         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                                   covid_krt   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  | COVID-19 without kidney replacement therapy   4   247.6660   0.0161508   0.
> 0060617   0.0430323 |
  |    COVID-19 with kidney replacement therapy   1    22.4723   0.0444993   0.
> 0062683   0.3159035 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |                                   covid_krt   agegroup   D          Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without kidney replacement therapy     18-<50   3   135.8001   0.0
> 220913   0.0071249   0.0684956 |
  | COVID-19 without kidney replacement therapy     50-<60   0    42.3326     0
> .0e+00           .           . |
  | COVID-19 without kidney replacement therapy     60-<70   1    33.8152   0.0
> 295725   0.0041657   0.2099373 |
  | COVID-19 without kidney replacement therapy     70-<80   0    23.9945     0
> .0e+00           .           . |
  | COVID-19 without kidney replacement therapy        80+   0    11.7235     0
> .0e+00           .           . |
  |----------------------------------------------------------------------------
> -------------------------------|
  |    COVID-19 with kidney replacement therapy     18-<50   1    16.6133   0.0
> 601928   0.0084790   0.4273131 |
  |    COVID-19 with kidney replacement therapy     50-<60   0     2.4914     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy     60-<70   0     1.0513     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy        80+   0     2.3162     0
> .0e+00           .           . |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------------------+
  |                                   covid_krt     male   D          Y        
> Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -----------------------------|
  | COVID-19 without kidney replacement therapy   Female   0   132.4298     0.0
> e+00           .           . |
  | COVID-19 without kidney replacement therapy     Male   4   115.2361   0.034
> 7113   0.0130278   0.0924852 |
  |    COVID-19 with kidney replacement therapy   Female   0     7.5674     0.0
> e+00           .           . |
  |    COVID-19 with kidney replacement therapy     Male   1    14.9049   0.067
> 0922   0.0094508   0.4762924 |
  +----------------------------------------------------------------------------
> -----------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------------------------------------+
  |                                   covid_krt                ethnicity   D   
>        Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ---------------------------------------------|
  | COVID-19 without kidney replacement therapy                    White   1   
> 150.6667   0.0066372   0.0009349   0.0471177 |
  | COVID-19 without kidney replacement therapy   Asian or Asian British   0   
>  19.7372     0.0e+00           .           . |
  | COVID-19 without kidney replacement therapy                    Other   1   
>  24.3504   0.0410670   0.0057848   0.2915376 |
  | COVID-19 without kidney replacement therapy                  Unknown   2   
>  52.9117   0.0377988   0.0094534   0.1511362 |
  |    COVID-19 with kidney replacement therapy                    White   1   
>  13.6345   0.0733434   0.0103314   0.5206698 |
  |----------------------------------------------------------------------------
> ---------------------------------------------|
  |    COVID-19 with kidney replacement therapy   Asian or Asian British   0   
>   1.2402     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                    Other   0   
>   2.2368     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  Unknown   0   
>   5.3607     0.0e+00           .           . |
  +----------------------------------------------------------------------------
> ---------------------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------------+
  |                                   covid_krt                imd   D         
> Y        Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------------|
  | COVID-19 without kidney replacement therapy   1 least deprived   0   47.227
> 9     0.0e+00           .           . |
  | COVID-19 without kidney replacement therapy                  2   1   53.147
> 2   0.0188157   0.0026504   0.1335739 |
  | COVID-19 without kidney replacement therapy                  3   1   47.118
> 4   0.0212231   0.0029896   0.1506645 |
  | COVID-19 without kidney replacement therapy                  4   0   45.201
> 9     0.0e+00           .           . |
  | COVID-19 without kidney replacement therapy    5 most deprived   2   54.970
> 6   0.0363831   0.0090993   0.1454756 |
  |----------------------------------------------------------------------------
> --------------------------------------|
  |    COVID-19 with kidney replacement therapy   1 least deprived   0    5.804
> 2     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  2   1    3.244
> 4   0.3082278   0.0434181     2.2e+00 |
  |    COVID-19 with kidney replacement therapy                  3   0    6.064
> 3     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy                  4   0    5.212
> 9     0.0e+00           .           . |
  |    COVID-19 with kidney replacement therapy    5 most deprived   0    2.146
> 5     0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(135 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------------+
  |                                   covid_krt   baseli~t   D         Y       
>  Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------------------|
  | COVID-19 without kidney replacement therapy      30-44   0   11.6222     0.
> 0e+00           .           . |
  | COVID-19 without kidney replacement therapy      45-59   0   17.8070     0.
> 0e+00           .           . |
  | COVID-19 without kidney replacement therapy      60-74   1   18.8419   0.05
> 30732   0.0074761   0.3767707 |
  | COVID-19 without kidney replacement therapy      75-89   0   20.2355     0.
> 0e+00           .           . |
  | COVID-19 without kidney replacement therapy     90-104   0   24.5585     0.
> 0e+00           .           . |
  |----------------------------------------------------------------------------
> ------------------------------|
  | COVID-19 without kidney replacement therapy       ≥105   0   42.1684     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      15-29   0    1.0513     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      45-59   0    1.9411     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      60-74   0    1.3552     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy      75-89   0    0.9610     0.
> 0e+00           .           . |
  |----------------------------------------------------------------------------
> ------------------------------|
  |    COVID-19 with kidney replacement therapy     90-104   0    1.2758     0.
> 0e+00           .           . |
  |    COVID-19 with kidney replacement therapy       ≥105   0    4.6105     0.
> 0e+00           .           . |
  +----------------------------------------------------------------------------
> ------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -------------------------------+
  |                                   covid_krt   diabetes   D          Y      
>   Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> -------------------------------|
  | COVID-19 without kidney replacement therapy          0   2   199.1677   0.0
> 100418   0.0025114   0.0401515 |
  | COVID-19 without kidney replacement therapy          1   2    48.4983   0.0
> 412386   0.0103137   0.1648899 |
  |    COVID-19 with kidney replacement therapy          0   0    18.9049     0
> .0e+00           .           . |
  |    COVID-19 with kidney replacement therapy          1   1     3.5674   0.2
> 803147   0.0394861     2.0e+00 |
  +----------------------------------------------------------------------------
> -------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/mortality_covid_krt.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |             Vaccination status
  censored | SARS-CoV-  SARS-CoV-  SARS-CoV-  SARS-CoV- |     Total
-----------+--------------------------------------------+----------
         0 |         7         14         56        167 |       244 
           |    100.00     100.00      98.25      97.66 |     97.99 
-----------+--------------------------------------------+----------
         1 |         0          0          1          4 |         5 
           |      0.00       0.00       1.75       2.34 |      2.01 
-----------+--------------------------------------------+----------
     Total |         7         14         57        171 |       249 
           |    100.00     100.00     100.00     100.00 |    100.00 

          Pearson chi2(3) =   0.5443   Pr = 0.909

         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------+
  |                 covid_vax_status   D          Y        Rate       Lower    
>    Upper |
  |----------------------------------------------------------------------------
> ---------|
  |  SARS-CoV-2 after 1 vaccine dose   0     6.0260     0.0e+00           .    
>        . |
  | SARS-CoV-2 after 2 vaccine doses   0    15.3621     0.0e+00           .    
>        . |
  | SARS-CoV-2 after 3 vaccine doses   1    64.2190   0.0155717   0.0021935   0
> .1105447 |
  | SARS-CoV-2 after 4 vaccine doses   4   184.5311   0.0216766   0.0081356   0
> .0577552 |
  +----------------------------------------------------------------------------
> ---------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                 covid_vax_status   agegroup   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  |  SARS-CoV-2 after 1 vaccine dose     18-<50   0     4.0739     0.0e+00     
>       .           . |
  |  SARS-CoV-2 after 1 vaccine dose     60-<70   0     1.9521     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     18-<50   0     5.6810     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     50-<60   0     1.6235     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses     60-<70   0     1.7002     0.0e+00     
>       .           . |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 2 vaccine doses     70-<80   0     3.4990     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses        80+   0     2.8583     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses     18-<50   1    41.9466   0.0238398   0.
> 0033582   0.1692406 |
  | SARS-CoV-2 after 3 vaccine doses     50-<60   0     9.9110     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses     60-<70   0     6.2669     0.0e+00     
>       .           . |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 3 vaccine doses     70-<80   0     0.8378     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses        80+   0     5.2567     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 4 vaccine doses     18-<50   3   100.7118   0.0297880   0.
> 0096073   0.0923596 |
  | SARS-CoV-2 after 4 vaccine doses     50-<60   0    33.2895     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 4 vaccine doses     60-<70   1    24.9473   0.0400845   0.
> 0056464   0.2845628 |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 4 vaccine doses     70-<80   0    19.6578     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 4 vaccine doses        80+   0     5.9247     0.0e+00     
>       .           . |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> -----------------+
  |                 covid_vax_status     male   D         Y        Rate       L
> ower       Upper |
  |----------------------------------------------------------------------------
> -----------------|
  |  SARS-CoV-2 after 1 vaccine dose   Female   0    2.3326     0.0e+00        
>    .           . |
  |  SARS-CoV-2 after 1 vaccine dose     Male   0    3.6934     0.0e+00        
>    .           . |
  | SARS-CoV-2 after 2 vaccine doses   Female   0   10.6913     0.0e+00        
>    .           . |
  | SARS-CoV-2 after 2 vaccine doses     Male   0    4.6708     0.0e+00        
>    .           . |
  | SARS-CoV-2 after 3 vaccine doses   Female   0   35.0034     0.0e+00        
>    .           . |
  |----------------------------------------------------------------------------
> -----------------|
  | SARS-CoV-2 after 3 vaccine doses     Male   1   29.2156   0.0342283   0.004
> 8215   0.2429890 |
  | SARS-CoV-2 after 4 vaccine doses   Female   0   91.9699     0.0e+00        
>    .           . |
  | SARS-CoV-2 after 4 vaccine doses     Male   4   92.5613   0.0432146   0.016
> 2192   0.1151414 |
  +----------------------------------------------------------------------------
> -----------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------------------------+
  |                 covid_vax_status                ethnicity   D          Y   
>      Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> ----------------------------------|
  |  SARS-CoV-2 after 1 vaccine dose                    White   0     2.8118   
>   0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                    Other   0     0.3559   
>   0.0e+00           .           . |
  |  SARS-CoV-2 after 1 vaccine dose                  Unknown   0     2.8583   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    White   0     9.5825   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 2 vaccine doses                    Other   0     5.0568   
>   0.0e+00           .           . |
  |----------------------------------------------------------------------------
> ----------------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  Unknown   0     0.7228   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                    White   1    43.1458   
> 0.0231772   0.0032648   0.1645368 |
  | SARS-CoV-2 after 3 vaccine doses   Asian or Asian British   0     2.6639   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                    Other   0     3.0089   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 3 vaccine doses                  Unknown   0    15.4004   
>   0.0e+00           .           . |
  |----------------------------------------------------------------------------
> ----------------------------------|
  | SARS-CoV-2 after 4 vaccine doses                    White   1   108.7611   
> 0.0091945   0.0012952   0.0652721 |
  | SARS-CoV-2 after 4 vaccine doses   Asian or Asian British   0    18.3135   
>   0.0e+00           .           . |
  | SARS-CoV-2 after 4 vaccine doses                    Other   1    18.1656   
> 0.0550490   0.0077544   0.3907967 |
  | SARS-CoV-2 after 4 vaccine doses                  Unknown   2    39.2909   
> 0.0509024   0.0127306   0.2035300 |
  +----------------------------------------------------------------------------
> ----------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------------+
  |                 covid_vax_status                imd   D         Y       Rat
> e      Lower      Upper |
  |----------------------------------------------------------------------------
> ------------------------|
  |  SARS-CoV-2 after 1 vaccine dose   1 least deprived   0    1.9685   0.00000
> 0          .          . |
  |  SARS-CoV-2 after 1 vaccine dose                  2   0    0.9227   0.00000
> 0          .          . |
  |  SARS-CoV-2 after 1 vaccine dose                  4   0    3.1348   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses   1 least deprived   0    3.8932   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses                  2   0    2.4230   0.00000
> 0          .          . |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 2 vaccine doses                  3   0    6.3463   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses                  4   0    0.6899   0.00000
> 0          .          . |
  | SARS-CoV-2 after 2 vaccine doses    5 most deprived   0    2.0096   0.00000
> 0          .          . |
  | SARS-CoV-2 after 3 vaccine doses   1 least deprived   0   10.7707   0.00000
> 0          .          . |
  | SARS-CoV-2 after 3 vaccine doses                  2   0   18.5681   0.00000
> 0          .          . |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 3 vaccine doses                  3   1    9.8590   0.10143
> 0   0.014288   0.720060 |
  | SARS-CoV-2 after 3 vaccine doses                  4   0   12.6571   0.00000
> 0          .          . |
  | SARS-CoV-2 after 3 vaccine doses    5 most deprived   0   12.3641   0.00000
> 0          .          . |
  | SARS-CoV-2 after 4 vaccine doses   1 least deprived   0   36.3997   0.00000
> 0          .          . |
  | SARS-CoV-2 after 4 vaccine doses                  2   2   34.4778   0.05800
> 8   0.014508   0.231943 |
  |----------------------------------------------------------------------------
> ------------------------|
  | SARS-CoV-2 after 4 vaccine doses                  3   0   36.9774   0.00000
> 0          .          . |
  | SARS-CoV-2 after 4 vaccine doses                  4   0   33.9329   0.00000
> 0          .          . |
  | SARS-CoV-2 after 4 vaccine doses    5 most deprived   2   42.7433   0.04679
> 1   0.011702   0.187091 |
  +----------------------------------------------------------------------------
> ------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(135 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 covid_vax_status   baseli~t   D         Y       Rate      L
> ower      Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |  SARS-CoV-2 after 1 vaccine dose      60-74   0    1.9521   0.000000       
>    .          . |
  |  SARS-CoV-2 after 1 vaccine dose       ≥105   0    1.9685   0.000000       
>    .          . |
  | SARS-CoV-2 after 2 vaccine doses      30-44   0    2.9131   0.000000       
>    .          . |
  | SARS-CoV-2 after 2 vaccine doses      75-89   0    2.7543   0.000000       
>    .          . |
  | SARS-CoV-2 after 2 vaccine doses       ≥105   0    4.5722   0.000000       
>    .          . |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 3 vaccine doses      30-44   0    3.7016   0.000000       
>    .          . |
  | SARS-CoV-2 after 3 vaccine doses      45-59   0    6.2560   0.000000       
>    .          . |
  | SARS-CoV-2 after 3 vaccine doses      60-74   0    6.2012   0.000000       
>    .          . |
  | SARS-CoV-2 after 3 vaccine doses      75-89   0    9.0048   0.000000       
>    .          . |
  | SARS-CoV-2 after 3 vaccine doses     90-104   0    5.6646   0.000000       
>    .          . |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 3 vaccine doses       ≥105   0    8.2409   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      15-29   0    1.0513   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      30-44   0    5.0075   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      45-59   0   13.4921   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses      60-74   1   12.0438   0.083030   0.01
> 1696   0.589438 |
  |----------------------------------------------------------------------------
> ----------------|
  | SARS-CoV-2 after 4 vaccine doses      75-89   0    9.4374   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses     90-104   0   20.1697   0.000000       
>    .          . |
  | SARS-CoV-2 after 4 vaccine doses       ≥105   0   31.9973   0.000000       
>    .          . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------+
  |                 covid_vax_status   diabetes   D          Y        Rate     
>   Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------|
  |  SARS-CoV-2 after 1 vaccine dose          0   0     4.1369     0.0e+00     
>       .           . |
  |  SARS-CoV-2 after 1 vaccine dose          1   0     1.8891     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses          0   0    13.9411     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 2 vaccine doses          1   0     1.4209     0.0e+00     
>       .           . |
  | SARS-CoV-2 after 3 vaccine doses          0   0    50.7023     0.0e+00     
>       .           . |
  |----------------------------------------------------------------------------
> --------------------|
  | SARS-CoV-2 after 3 vaccine doses          1   1    13.5168   0.0739822   0.
> 0104214   0.5252047 |
  | SARS-CoV-2 after 4 vaccine doses          0   2   149.2923   0.0133965   0.
> 0033504   0.0535652 |
  | SARS-CoV-2 after 4 vaccine doses          1   2    35.2389   0.0567555   0.
> 0141944   0.2269333 |
  +----------------------------------------------------------------------------
> --------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/mortality_covid_vax_status.svg written in SVG format)

+-------------------+
| Key               |
|-------------------|
|     frequency     |
| column percentage |
+-------------------+

      1 if |
failure; 0 |
        if |                    Calendar period
  censored | February   July 2020  September  December   March 202 |     Total
-----------+-------------------------------------------------------+----------
         0 |        66         22         39         43         66 |       244 
           |     98.51     100.00      97.50      97.73      97.06 |     97.99 
-----------+-------------------------------------------------------+----------
         1 |         1          0          1          1          2 |         5 
           |      1.49       0.00       2.50       2.27       2.94 |      2.01 
-----------+-------------------------------------------------------+----------
     Total |        67         22         40         44         68 |       249 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 


      1 if |
failure; 0 |  Calendar
        if |   period
  censored | December  |     Total
-----------+-----------+----------
         0 |         8 |       244 
           |    100.00 |     97.99 
-----------+-----------+----------
         1 |         0 |         5 
           |      0.00 |      2.01 
-----------+-----------+----------
     Total |         8 |       249 
           |    100.00 |    100.00 

          Pearson chi2(5) =   1.0710   Pr = 0.957

         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------+
  |                 calendar_period   D          Y        Rate       Lower     
>   Upper |
  |----------------------------------------------------------------------------
> --------|
  |      February 2020 to June 2020   1   112.3943   0.0088973   0.0012533   0.
> 0631622 |
  |        July 2020 to August 2020   0    31.0691     0.0e+00           .     
>       . |
  | September 2020 to November 2020   1    47.6550   0.0209841   0.0029559   0.
> 1489679 |
  |  December 2020 to February 2021   1    42.4778   0.0235417   0.0033162   0.
> 1671244 |
  |     March 2021 to November 2021   2    36.1095   0.0553871   0.0138522   0.
> 2214618 |
  |----------------------------------------------------------------------------
> --------|
  |   December 2021 to January 2022   0     0.4326     0.0e+00           .     
>       . |
  +----------------------------------------------------------------------------
> --------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 calendar_period   agegroup   D         Y        Rate       
> Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |      February 2020 to June 2020     18-<50   0   55.5017     0.0e+00       
>     .           . |
  |      February 2020 to June 2020     50-<60   0   25.3251     0.0e+00       
>     .           . |
  |      February 2020 to June 2020     60-<70   1   21.1472   0.0472877   0.00
> 66611   0.3356986 |
  |      February 2020 to June 2020     70-<80   0    8.7474     0.0e+00       
>     .           . |
  |      February 2020 to June 2020        80+   0    1.6728     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |        July 2020 to August 2020     18-<50   0   13.9822     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     50-<60   0    5.6810     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     60-<70   0    4.1862     0.0e+00       
>     .           . |
  |        July 2020 to August 2020     70-<80   0    4.4025     0.0e+00       
>     .           . |
  |        July 2020 to August 2020        80+   0    2.8172     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  | September 2020 to November 2020     18-<50   1   35.4661   0.0281959   0.00
> 39718   0.2001649 |
  | September 2020 to November 2020     50-<60   0    3.6167     0.0e+00       
>     .           . |
  | September 2020 to November 2020     60-<70   0    1.2375     0.0e+00       
>     .           . |
  | September 2020 to November 2020     70-<80   0    4.8104     0.0e+00       
>     .           . |
  | September 2020 to November 2020        80+   0    2.5243     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |  December 2020 to February 2021     18-<50   1   27.3539   0.0365579   0.00
> 51497   0.2595272 |
  |  December 2020 to February 2021     50-<60   0    5.5934     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     60-<70   0    4.0219     0.0e+00       
>     .           . |
  |  December 2020 to February 2021     70-<80   0    2.5982     0.0e+00       
>     .           . |
  |  December 2020 to February 2021        80+   0    2.9103     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |     March 2021 to November 2021     18-<50   2   19.8193   0.1009117   0.02
> 52378   0.4034893 |
  |     March 2021 to November 2021     50-<60   0    4.5147     0.0e+00       
>     .           . |
  |     March 2021 to November 2021     60-<70   0    4.2738     0.0e+00       
>     .           . |
  |     March 2021 to November 2021     70-<80   0    3.4086     0.0e+00       
>     .           . |
  |     March 2021 to November 2021        80+   0    4.0931     0.0e+00       
>     .           . |
  |----------------------------------------------------------------------------
> ------------------|
  |   December 2021 to January 2022     18-<50   0    0.2902     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     50-<60   0    0.0931     0.0e+00       
>     .           . |
  |   December 2021 to January 2022     70-<80   0    0.0274     0.0e+00       
>     .           . |
  |   December 2021 to January 2022        80+   0    0.0219     0.0e+00       
>     .           . |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ----------------+
  |                 calendar_period     male   D         Y        Rate       Lo
> wer       Upper |
  |----------------------------------------------------------------------------
> ----------------|
  |      February 2020 to June 2020   Female   0   52.4326     0.0e+00         
>   .           . |
  |      February 2020 to June 2020     Male   1   59.9617   0.0166773   0.0023
> 492   0.1183935 |
  |        July 2020 to August 2020   Female   0   15.7043     0.0e+00         
>   .           . |
  |        July 2020 to August 2020     Male   0   15.3648     0.0e+00         
>   .           . |
  | September 2020 to November 2020   Female   0   27.4689     0.0e+00         
>   .           . |
  |----------------------------------------------------------------------------
> ----------------|
  | September 2020 to November 2020     Male   1   20.1862   0.0495389   0.0069
> 782   0.3516799 |
  |  December 2020 to February 2021   Female   0   24.2710     0.0e+00         
>   .           . |
  |  December 2020 to February 2021     Male   1   18.2067   0.0549248   0.0077
> 369   0.3899152 |
  |     March 2021 to November 2021   Female   0   19.9945     0.0e+00         
>   .           . |
  |     March 2021 to November 2021     Male   2   16.1150   0.1241081   0.0310
> 391   0.4962384 |
  |----------------------------------------------------------------------------
> ----------------|
  |   December 2021 to January 2022   Female   0    0.1259     0.0e+00         
>   .           . |
  |   December 2021 to January 2022     Male   0    0.3066     0.0e+00         
>   .           . |
  +----------------------------------------------------------------------------
> ----------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------------+
  |                 calendar_period                ethnicity   D         Y     
>    Rate       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------------|
  |      February 2020 to June 2020                    White   0   67.8275     
> 0.0e+00           .           . |
  |      February 2020 to June 2020   Asian or Asian British   0   12.4435     
> 0.0e+00           .           . |
  |      February 2020 to June 2020                    Other   0   13.8070     
> 0.0e+00           .           . |
  |      February 2020 to June 2020                  Unknown   1   18.3162   0.
> 0545964   0.0076906   0.3875838 |
  |        July 2020 to August 2020                    White   0   19.9507     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |        July 2020 to August 2020   Asian or Asian British   0    1.4237     
> 0.0e+00           .           . |
  |        July 2020 to August 2020                  Unknown   0    9.6947     
> 0.0e+00           .           . |
  | September 2020 to November 2020                    White   0   29.0459     
> 0.0e+00           .           . |
  | September 2020 to November 2020   Asian or Asian British   0    1.2402     
> 0.0e+00           .           . |
  | September 2020 to November 2020                    Other   1    7.4634   0.
> 1339875   0.0188740   0.9511870 |
  |----------------------------------------------------------------------------
> --------------------------------|
  | September 2020 to November 2020                  Unknown   0    9.9055     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                    White   0   28.4791     
> 0.0e+00           .           . |
  |  December 2020 to February 2021   Asian or Asian British   0    2.7652     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                    Other   0    0.9610     
> 0.0e+00           .           . |
  |  December 2020 to February 2021                  Unknown   1   10.2724   0.
> 0973481   0.0137128   0.6910810 |
  |----------------------------------------------------------------------------
> --------------------------------|
  |     March 2021 to November 2021                    White   2   18.7242   0.
> 1068139   0.0267139   0.4270886 |
  |     March 2021 to November 2021   Asian or Asian British   0    3.1047     
> 0.0e+00           .           . |
  |     March 2021 to November 2021                    Other   0    4.3258     
> 0.0e+00           .           . |
  |     March 2021 to November 2021                  Unknown   0    9.9548     
> 0.0e+00           .           . |
  |   December 2021 to January 2022                    White   0    0.2738     
> 0.0e+00           .           . |
  |----------------------------------------------------------------------------
> --------------------------------|
  |   December 2021 to January 2022                    Other   0    0.0301     
> 0.0e+00           .           . |
  |   December 2021 to January 2022                  Unknown   0    0.1287     
> 0.0e+00           .           . |
  +----------------------------------------------------------------------------
> --------------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> --------------------------+
  |                 calendar_period                imd   D         Y        Rat
> e       Lower       Upper |
  |----------------------------------------------------------------------------
> --------------------------|
  |      February 2020 to June 2020   1 least deprived   0   16.8405     0.0e+0
> 0           .           . |
  |      February 2020 to June 2020                  2   0   19.0527     0.0e+0
> 0           .           . |
  |      February 2020 to June 2020                  3   0   25.4428     0.0e+0
> 0           .           . |
  |      February 2020 to June 2020                  4   0   20.6242     0.0e+0
> 0           .           . |
  |      February 2020 to June 2020    5 most deprived   1   30.4339   0.032858
> 0   0.0046285   0.2332616 |
  |----------------------------------------------------------------------------
> --------------------------|
  |        July 2020 to August 2020   1 least deprived   0    5.6920     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  2   0    9.8097     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  3   0    8.4162     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020                  4   0    4.3203     0.0e+0
> 0           .           . |
  |        July 2020 to August 2020    5 most deprived   0    2.8309     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  | September 2020 to November 2020   1 least deprived   0   18.3491     0.0e+0
> 0           .           . |
  | September 2020 to November 2020                  2   1   10.2560   0.097504
> 0   0.0137348   0.6921879 |
  | September 2020 to November 2020                  3   0    5.8946     0.0e+0
> 0           .           . |
  | September 2020 to November 2020                  4   0    8.5503     0.0e+0
> 0           .           . |
  | September 2020 to November 2020    5 most deprived   0    4.6051     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |  December 2020 to February 2021   1 least deprived   0    6.8966     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  2   0    7.8357     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  3   0    7.6851     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021                  4   0    7.8795     0.0e+0
> 0           .           . |
  |  December 2020 to February 2021    5 most deprived   1   12.1807   0.082097
> 1   0.0115645   0.5828132 |
  |----------------------------------------------------------------------------
> --------------------------|
  |     March 2021 to November 2021   1 least deprived   0    5.0979     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021                  2   1    9.3525   0.106923
> 3   0.0150616   0.7590562 |
  |     March 2021 to November 2021                  3   1    5.6701   0.176364
> 1   0.0248433     1.3e+00 |
  |     March 2021 to November 2021                  4   0    8.9528     0.0e+0
> 0           .           . |
  |     March 2021 to November 2021    5 most deprived   0    7.0363     0.0e+0
> 0           .           . |
  |----------------------------------------------------------------------------
> --------------------------|
  |   December 2021 to January 2022   1 least deprived   0    0.1561     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  2   0    0.0849     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  3   0    0.0739     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022                  4   0    0.0876     0.0e+0
> 0           .           . |
  |   December 2021 to January 2022    5 most deprived   0    0.0301     0.0e+0
> 0           .           . |
  +----------------------------------------------------------------------------
> --------------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(135 records included in the analysis)

  +----------------------------------------------------------------------------
> ---------------+
  |                 calendar_period   baseli~t   D         Y       Rate      Lo
> wer      Upper |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020      30-44   0    5.4894   0.000000        
>   .          . |
  |      February 2020 to June 2020      45-59   0    9.9302   0.000000        
>   .          . |
  |      February 2020 to June 2020      60-74   1   11.3429   0.088161   0.012
> 419   0.625859 |
  |      February 2020 to June 2020      75-89   0   11.8987   0.000000        
>   .          . |
  |      February 2020 to June 2020     90-104   0   12.1944   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |      February 2020 to June 2020       ≥105   0   13.6701   0.000000        
>   .          . |
  |        July 2020 to August 2020      45-59   0    1.4839   0.000000        
>   .          . |
  |        July 2020 to August 2020      60-74   0    2.7242   0.000000        
>   .          . |
  |        July 2020 to August 2020      75-89   0    1.3826   0.000000        
>   .          . |
  |        July 2020 to August 2020     90-104   0    2.8063   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |        July 2020 to August 2020       ≥105   0    1.3662   0.000000        
>   .          . |
  | September 2020 to November 2020      30-44   0    3.6906   0.000000        
>   .          . |
  | September 2020 to November 2020      45-59   0    1.2485   0.000000        
>   .          . |
  | September 2020 to November 2020      60-74   0    2.4887   0.000000        
>   .          . |
  | September 2020 to November 2020      75-89   0    4.7255   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  | September 2020 to November 2020     90-104   0    4.9227   0.000000        
>   .          . |
  | September 2020 to November 2020       ≥105   0   12.0958   0.000000        
>   .          . |
  |  December 2020 to February 2021      15-29   0    1.0513   0.000000        
>   .          . |
  |  December 2020 to February 2021      45-59   0    2.0123   0.000000        
>   .          . |
  |  December 2020 to February 2021      60-74   0    1.8426   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |  December 2020 to February 2021      75-89   0    1.9795   0.000000        
>   .          . |
  |  December 2020 to February 2021     90-104   0    4.0438   0.000000        
>   .          . |
  |  December 2020 to February 2021       ≥105   0   11.4333   0.000000        
>   .          . |
  |     March 2021 to November 2021      30-44   0    2.4422   0.000000        
>   .          . |
  |     March 2021 to November 2021      45-59   0    5.0732   0.000000        
>   .          . |
  |----------------------------------------------------------------------------
> ---------------|
  |     March 2021 to November 2021      60-74   0    1.7988   0.000000        
>   .          . |
  |     March 2021 to November 2021      75-89   0    1.2101   0.000000        
>   .          . |
  |     March 2021 to November 2021     90-104   0    1.7495   0.000000        
>   .          . |
  |     March 2021 to November 2021       ≥105   0    8.2136   0.000000        
>   .          . |
  |   December 2021 to January 2022     90-104   0    0.1177   0.000000        
>   .          . |
  +----------------------------------------------------------------------------
> ---------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id

Estimated rates and lower/upper bounds of 95% confidence intervals
(249 records included in the analysis)

  +----------------------------------------------------------------------------
> ------------------+
  |                 calendar_period   diabetes   D         Y        Rate       
> Lower       Upper |
  |----------------------------------------------------------------------------
> ------------------|
  |      February 2020 to June 2020          0   0   84.7118     0.0e+00       
>     .           . |
  |      February 2020 to June 2020          1   1   27.6824   0.0361240   0.00
> 50886   0.2564470 |
  |        July 2020 to August 2020          0   0   28.3012     0.0e+00       
>     .           . |
  |        July 2020 to August 2020          1   0    2.7680     0.0e+00       
>     .           . |
  | September 2020 to November 2020          0   1   38.9678   0.0256622   0.00
> 36149   0.1821777 |
  |----------------------------------------------------------------------------
> ------------------|
  | September 2020 to November 2020          1   0    8.6872     0.0e+00       
>     .           . |
  |  December 2020 to February 2021          0   1   34.9596   0.0286044   0.00
> 40293   0.2030649 |
  |  December 2020 to February 2021          1   0    7.5181     0.0e+00       
>     .           . |
  |     March 2021 to November 2021          0   0   30.7296     0.0e+00       
>     .           . |
  |     March 2021 to November 2021          1   2    5.3799   0.3717557   0.09
> 29752     1.5e+00 |
  |----------------------------------------------------------------------------
> ------------------|
  |   December 2021 to January 2022          0   0    0.4025     0.0e+00       
>     .           . |
  |   December 2021 to January 2022          1   0    0.0301     0.0e+00       
>     .           . |
  +----------------------------------------------------------------------------
> ------------------+


         failure _d:  death_date
   analysis time _t:  (exit_date_death-origin)/365.25
             origin:  time index_date
                 id:  patient_id
(file ./output/mortality_calendar_period.svg written in SVG format)

.         
. save ./output/covid_descriptive.dta, replace 
(note: file ./output/covid_descriptive.dta not found)
file ./output/covid_descriptive.dta saved

. log close
      name:  <unnamed>
       log:  /workspace/logs/covid_descriptive.log
  log type:  text
 closed on:  11 Jul 2022, 21:30:11
-------------------------------------------------------------------------------
